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ABSTRACT 
 Nationally, African Americans suffer disproportionately from diabetes; with 
13.2% of African Americans diagnosed with diabetes compared to 7.6% of non-Hispanic 
whites (CDC, 2014). Nearly one-half of all people with diabetes are non-adherent to their 
oral medications; adherence to insulin therapy was 60%-80% (Brunton et al., 2011; 
Cramer, 2004; Rubin, 2005). This study explored the question, “What mechanisms are 
associated with adherence to diabetes medication, including insulin, for African 
Americans in the Southwest?”  Twenty-three people participated in the study; 17 
participated in interviews and six participated in gendered focus groups. A community-
based participatory research (CBPR) approach engaged the African American community 
as partners in research.  
 Major themes emerging from the data included illness perception, support, and 
the process of medication adherence. Acceptance of the diabetes diagnosis was 
imperative for medication adherence. Stigmatization of diabetes was salient in the 
recruitment process and as it related to mechanisms for adherence. Furthermore, many 
informants were not aware of a family history of diabetes before their own diagnosis. 
Four gendered emerging typologies were identified, which further illuminated major 
themes. Moreover, an eight-step process of medication adherence model is discussed. 
The researcher was able to identify culturally compatible strategies that may be extended 
to those struggling with medication adherence. The implications section suggests a set of 
strategies that healthcare providers can present to people with diabetes in order to 
increase medication adherence.  
Keywords: African Americans, diabetes, medication adherence, illness perception 
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Chapter 1 
 
INTRODUCTION 
  
 Traditionally, medication adherence has been viewed from a problem-orientation, 
deficit perspective focused on those who are non-adherent to medication. This approach 
has been useful in describing the scope of medication non-adherence and has facilitated 
understanding about why people do not take medication as prescribed. However, there 
are many people who take medication as prescribed and much could be learned from 
those people who, theoretically, have encountered similar barriers to adherence. In 
addition, there are cultural influences that support medication adherence in African 
American populations. Therefore, this study will engage in a shift from non-adherence as 
viewed through the lens of problem-orientation to adherence as viewed through 
resiliency. The lens of resiliency theory will focus on strengths exhibited by African 
Americans with diabetes who are adherent to diabetes medication(s).  
 Nationally, African Americans suffer disproportionately from diabetes; with 
13.2% of African Americans diagnosed with diabetes as compared to 7.6% of non-
Hispanic whites (CDC, 2014). Similarly, Arizona Blacks have diagnosed diabetes 
(16.2%) at more than twice the rate of non-Hispanic whites (8%) (Bass & Porter, 2011).  
Social determinants of health are related to higher rates of diabetes in African Americans; 
however, social determinants do not explain all of the disparity (Barr, 2008). Some health 
disparities have been associated with neighborhood effects, lack of insurance, and racial 
differences in access to quality health care (Barr, 2008; Luftey & Freese, 2005). These 
factors help explain the disparity in diabetes for African Americans; however, they do not 
change the fact that poor glycemic control is having a devastating effect. 
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 In the U.S., uncontrolled diabetes is the seventh leading cause of death  
(Xu, Kochanek, Murphy, & Tejada-Vera, 2010). Complications from poor glycemic 
control include heart disease and stroke (Stratton et al., 2000; Turner et al., 1998; 
UKPDS, 1998), neuropathy (Li et al., 2010), nephropathy (Gorina & Lentzer, 2008), 
retinopathy (Zhang, 2010), and amputation (Gregg et al., 2014). These complications 
may be prevented or reduced if patients properly use medication(s) to control blood sugar 
(Breitscheidel Stamentis, Dippel, & Schoffski, 2010; Shenolikar et al., 2006a). Moreover, 
Lee, Balu, Cobden, Joshi and Pashos (2006) suggest that improved medication adherence 
could reduce healthcare costs by as much as 28.9%. Furthermore, Roebuck, Liberman, 
Gemmill-Toyama, and Brennan (2011) demonstrate that adherence to prescription 
medication reduces total healthcare costs by more than the cost of the drugs themselves. 
More specifically, Jha, Aubert, Yao, Teagarden, and Epstein (2012) linked increased 
diabetes medication adherence to less hospital use and an annual healthcare savings of 
nearly five billion dollars. 
 Medication is prescribed to 85.6% of people with diabetes (CDC, 2014; NHIS, 
2010–2012). Yet, nearly one-half of people with diabetes are non-adherent to their oral 
hyperglycemic agents (OHA) (Brunton et al., 2011; Cramer, 2004; Rubin, 2005). 
Adherence to insulin therapy was 60%-80% and most patients admitted to missing an 
occasional dose (Brunton et al., 2011; Cramer, 2004; Rubin, 2005).  
 Self-management of diabetes through lifestyle changes and medication adherence 
are necessary for avoiding serious complications. Heisler, Faul, Hayward, Langa, Blaum, 
and Weir (2007) found that Blacks had poorer glycemic control, lower rates of adherence 
to medications, and more diabetes-related comorbidities than whites.   
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 Knowing the reasons that people with diabetes reported for non-adherence is 
instructive; it suggests potential barriers that must be overcome by people who are 
adherent with their diabetes medication(s). This study will contribute to the existing 
knowledge by exploring mechanisms for overcoming known barriers to medication 
adherence such as financial costs, personal fears, and negative responses from loved ones 
and medical professionals, which can assist in guiding African American patients toward 
improved medication adherence and healthier outcomes.   
 By uncovering mechanisms used by African Americans with diabetes related to 
diabetes medication(s) adherence, specific strategies may be better understood, temporal 
ordering may be observed (Miles & Huberman, 1994), and then be extended to those who 
are struggling with diabetes medication(s) adherence. As the strategies come from within 
the African American community, cultural congruence is assured.   
 Furthermore, public health implications for uncovering mechanisms related to 
medication adherence along with the temporal ordering of those mechanisms  
(Miles & Huberman, 1994) have the potential to influence health messages and enhance 
effective communication with African American people with diabetes who need to take 
medication to avoid consequences related to poorly managed blood sugar. Creating 
positive messages for medication adherence based upon the strengths present in the 
African American community has the potential to reduce the rate and severity of 
complications due to poor glucose management in this population.   
 Moreover, resiliency theory will allow for exploration of internal and external 
qualities that enable people to experience insight and growth in the process (Hill, 2007). 
This person in environment, strengths-based approach is useful in uncovering culturally 
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grounded strategies already active in the African American community, which allows for  
culturally appropriate replication of those strategies for the benefit of others in the 
community.  
 Furthermore, this resiliency framework distinguishes protective mechanisms at 
four ecological levels including individual, family, community, and society.  At the 
individual level, the focus was on processes associated with internalizing positive regard 
for self, increasing self-efficacy, and promoting internal locus of control (Hill, 2007). At 
the family level, processes that increase support, foster healthy social interaction, and 
strategies that actively encourage and assist African Americans with diabetes were 
uncovered (Hill, 2007).  At the broader community level, the focus was on identifying the 
role of mediating structures, both formal and informal (e.g. church, workplace, healthcare 
team, neighborhood). Mediating structures can be defined as, “informal or formal groups 
at the family or community levels that offset or buffer the adverse consequences of 
threatening risk factors” (Hill, 2007, p. 87). The society level focused on understanding 
the social determinants of health (e.g. education, income, access to health care) affecting 
management of diabetes (Barr, 2008; WHO, 2010). 
 As is consistent with a community-based participatory (CBPR) research approach, 
the researcher intentionally viewed the African American community as the experts and 
sought input and advice from the community at every stage to facilitate quality, culturally 
grounded research (Castro & Gildar, 2013; Cornwall & Jewkes, 1995).  
 The qualitative research study collected data through gendered focus groups. A 
screening tool used to assess eligibility of potential participants through inclusion criteria 
and collect demographics and information known to be associated with the social 
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determinants of health.. The inclusion criteria included (1) Self-identified as African 
American or Black; (2) diagnosed with Type 2 diabetes; (3) currently on insulin therapy; 
and (4) adherent to their medication(s) as assessed by four questions in the Simplified 
Medication Adherence Questionnaire (SMAQ) (Knobel et al., 2002; Moritsky, Green & 
Levine, 1986). Three gendered focus groups were facilitated; there were two women’s 
groups and one men’s group with two participants in each.  
 In-depth individual interview questions were formulated to target diabetes 
medication adherence mechanisms and strategies used by African American men and 
women from varying demographics. Nine women and eight men were recruited for the 
individual interviews. The social determinants of health including education level, 
income, and access to health care are related to health disparities; therefore, participants 
were asked about highest education level, category of income, and insurance status. This 
information was used to stratify sampling to represent a wider range of income levels, 
educational attainment, and access to health care for participants.  
 The researcher utilized the lens of resiliency theory to uncover mechanisms and 
processes that lead to adherence to diabetes medication(s). Content analysis included 
inductive coding to allow themes and categories to emerge from the data. Member 
checking included sharing the findings with the community as a means of confirmability 
and to build trustworthiness into the study. The strength inherent in triangulation of data 
was achieved through focus groups, individual interviews, and member checking.   
Study Aims 
 This study is guided by a main question, “What mechanisms are associated with 
adherence to diabetes medication(s), including insulin, for African Americans?” By 
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focusing on the resilient strategies, supports, and processes employed by African 
Americans with diabetes, the researcher was able to identify culturally compatible 
strategies and supports for diabetes medication adherence that may be able to be extended 
to others who struggle to take their medication consistently. This research project had two 
primary aims: 
  Aim 1: To examine what individual and broader environmental mechanisms 
 are associated with adherence to diabetes medication(s) for adult African 
 Americans with Type 2 diabetes.  
 Aim 2: To identify internal and external factors that enable African Americans 
 with diabetes to go beyond adherence and to develop a broader understanding of 
 the disease and how to manage it. 
Innovation 
 
 The study is innovative in that previous studies of medication adherence have 
taken a deficit perspective. This study suggests that much can be learned from African 
Americans who are adherent with their diabetes medication(s) in spite of having similar 
obstacles as those who struggle with adherence. Since many barriers to medication 
adherence are already known, learning how African American people with diabetes have 
successfully overcome those barriers and navigated the risks and adversity associated 
with non-adherence can provide strategies and processes that may be able to assist others.  
 This study is an initial step in understanding medication adherence from the 
African American perspective and to detect what protective mechanisms related to 
adherence may need to be strengthened. Knowing “how” and “what” are important in the 
process of medication adherence. There are identifiable processes leading to adherence 
 7 
that can be shared with patients as a way of providing a “road map” to guide them and 
reduce anxiety about the process. Understanding the process of adherence may help some 
to better engage in self-management and move forward rather than getting stuck in a non-
adherence loop. 
Definition of Key Terms 
 Adherence: Cramer (2004) defines adherence as “taking medication as prescribed 
and/or agreed between the patients and the health care provider” (p. 1219). 
 African American/Black: The Census (2010) defines “’Black or African 
American’ as a person who has origins in any Black racial group of Africa” (p.2). For the 
purposes of this study, participants self-identified as African American or Black.  
 Community-based Participatory Research (CBPR): The researcher intentionally 
seeks input and advice from members of the local community to accurately represent 
ideas and views of the community (Castro & Gildar, 2013). Therefore, CPBR research 
seeks to include the community of interest at every stage and seeks to learn from the 
community how they perceive the question of interest and how the question can best be 
answered from within the community (Cornwall & Jewkes, 1995). 
Compliance: The notion of compliance with medical treatment is a concept 
requiring a dominant medical professional and a dependent patient; the patient is 
expected to comply with the health care professional’s treatment decision (Trostle, 1988). 
Concordance: This concept of places emphasis on the shared decision-making 
process between patient and health care professionals when making decisions about 
prescribing treatments (Horne et al., 2005). 
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 Culture: “The set of values held by a community and its corresponding 
worldview” (Marsiglia & Kulis, 2009, p. 4).  Hruschka (2009) further asserts, “Culture 
has inertia and that culture is to some extent shared” (p. 237).   
 Glycated hemoglobin (A1C): The American Diabetes Association (ADA; 2012) 
defines A1C as a blood test that measures average blood glucose control over the  
previous two to three months. It is expressed in terms of the percentage of glycated 
hemoglobin, or A1C, in the blood.  
Heath Care Providers (HCP): This term is broadly used to include a wide variety 
of healthcare professionals including, but not limited to primary care physicians, 
specialists (e.g. endocrinologists, nephrologists, cardiologists, etc.), nurse practitioners, 
physician assistants, diabetes educators, nurses, medical assistants, and pharmacists.   
Oral Hypoglycemic Agents (OHA): This term is broadly used to include the wide 
variety prescription pills used to assist in controlling blood glucose.  
 Protective mechanisms: The “processes at the individual, family, community or 
societal levels that buffer or mediate the adverse consequences of threatening risk 
factors” (Hill, 2007, p. 87). 
 Resiliency: Resiliency is defined as, “the process of coping with stressors, 
adversity, change, or opportunity in a manner that enables the identification, fortification, 
and enhancement of protective factors” (Richardson, 2002, p. 308). 
 Resiliency research: Resiliency research seeks to identify mechanisms that 
enhance protection and resiliency within a given population (Billingsley & Morrison-
Rodriguez, 2007; Hill, 2007). 
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 Social constructivism: The goal of research from a social constructivist 
perspective is to trust the participant view of the experience (Creswell & Clark, 2011). 
There is no one reality; knowledge and reality are created by social relationships and 
interactions. Therefore, it is important to understand a given phenomena from the  
perspectives of the individuals who are experiencing the phenomena  
(Creswell & Clark, 2011).  
 Social determinants of health: “The circumstances in which people are born, 
grow up, live, work, and age, as well as systems put in place to deal with illness. These 
circumstances are in turn shaped by a wider set of forces: economics, social policies, and 
politics” (WHO, 2010). 
 Type 1 diabetes: Type 1 diabetes is an autoimmune disease that develops quickly 
and accounts for about 5% of all diabetes (ADA, 2014). The pancreatic beta cell function 
is destroyed; therefore, the body is unable to produce insulin and the patient requires 
insulin therapy administered through injections or an insulin pump (ADA, 2014).  
 Type 2 diabetes: Type 2 diabetes develops gradually and accounts for about 90%-
95% of all diagnosed cases of diabetes in adults (ADA, 2014). Type 2 diabetes is 
progressive and over time the pancreas may gradually lose the ability to produce insulin 
(ADA, 2014). Known risk factors for Type 2 diabetes include older age, obesity, family 
history of diabetes, gestational diabetes, sedentary lifestyle, and race/ethnicity  
(Choi & Shi, 2001). African Americans, Latino Americans, American Indians/Alaskan 
Natives, and some Asian Americans are at increased risk for Type 2 diabetes (CDC, 
2014).  
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Chapter 2 
BACKGROUND AND SIGNIFICANCE 
 
 In spite of concerted prevention efforts, Type 2 diabetes remains one of the most 
common chronic diseases in America and affects approximately 29.1 million people or 
9.3% of the general population including 21.0 million who have been diagnosed and 
another estimated 8.1 million people who are undiagnosed according the most recent data 
from the 2009–2012 National Health and Nutrition Examination Survey (NHANES) 
(CDC, 2014). In order to maintain healthy blood glucose levels, 85.6% of people with 
diabetes must take prescription medication(s) according to data from the 2010-2012 
National Health Interview Survey (NHIS) (CDC, 2014). Nearly half of people with 
diabetes do not take their prescription diabetes medication(s) as recommended  
(Aikens & Piette, 2009; Evans, Donnan, & Morris, 2002) and 60% of patients on insulin 
therapy report missing injections occasionally (Brunton et al., 2011). In a study by 
Polonsky, Fisher, Guzman, Villa-Caballero and Edelman (2005) 28% of patients with 
diabetes were unwilling to start insulin therapy; women and minorities were even less 
willing. Due to the progressive nature of diabetes, some patients will require insulin 
therapy to obtain optimal glycemic control. As proper medication is necessary for most 
people with diabetes to maintain consistent, healthy blood glucose, the risk of 
complications from uncontrolled diabetes significantly increases if patients are non-
adherent to prescription medications. 
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Social Determinants of Health 
 Social determinants of health include “the circumstances in which people are 
born, grow up, live, work, and age, as well as systems put in place to deal with illness. 
These circumstances are influenced by a broader set of forces: economics, social policies, 
and politics” (WHO, 2010).  Diverse ethnic groups suffer from diabetes at much higher 
rates than non-Hispanic whites (Figure 1).  
 
Figure X. Age-adjusted Percentage of People aged ≥20 Years with Diagnosed Diabetes, 
by Race/Ethnicity in the U.S., 2010-2012 
Source: 2010-2012 National Health Interview Survey and 2012 Indian Health Service’s 
Patient Information Reporting System. 
 
 Using National Health Interview Survey (NHIS) data from 2010-2012, the CDC 
(2014) reported rates of diagnosed diabetes in non-Hispanic whites (7.6%) were lower 
than for non-Hispanic blacks (13.2%) and other racial groups. Moreover, men (13.6%) 
suffer from diabetes at higher rates than women (11.2 %) and older Americans are at  
higher risk for diabetes as 11.2 million (25.9%) of those who have been diagnosed with 
diabetes are 65 years and older (CDC, 2014; NHIS, 2009-2012). 
7.6% 
9.0% 
12.8% 
13.2% 
15.9% American Indians/Alaskan Natives 
Non-Hispanic Blacks 
Hispanics 
Asian Americans 
Non-Hispanic Whites 
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 In Arizona, the rate of diabetes has steadily increased from 6.4% in 2002 to 9.1% 
in 2010 (Figure 2) (Bass & Porter, 2011). Prevalence of diabetes in Arizona varies by 
ethnicity and race with non-Hispanic whites (8%) having the lowest rate, while 16.2% of 
African Americans have diagnosed diabetes (Bass & Porter, 2011).   
 
Figure 2. Percentage of Arizona and National BRFSS respondents who reported that they 
were told they have diabetes in 2002-2010 (Bass & Porter, 2011)  
 
 In addition, when the percentage of Arizona adults diagnosed with diabetes is 
broken out by age categories, dramatic differences can be seen as older adults are being 
diagnosed with diabetes at much higher rates in recent years (Figure 3). 
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 The importance of the effects of societal determinants of health and their 
influence on the occurrence of diabetes among the poor and excluded in America cannot 
be stressed enough.  While lifestyle behaviors including inactivity, and poor diet along 
with obesity are associated with increased incidence of diabetes and increased risk for 
complications, the underlying causes for these lifestyle behaviors have not been 
adequately understood.  Raphael et al. (2003) suggest simply identifying unhealthy 
behaviors is insufficient; an investigation of social determinants needs to be included in 
interventions aimed at changing unhealthy behaviors to prevent and manage diabetes in 
underserved and at-risk populations.  
 Socioeconomic status (SES) is often measured via education and income  
(e.g., percent of poverty level).  At the most basic level, education is associated with 
knowledge acquisition, economic potential and cognitive ability; income determines 
Figure 3. Arizona - Percentage of Adults with Diagnosed Diabetes by Age, 1994 – 
2010 
Source: Center for Disease Control and Prevention (CDC) Behavioral Risk Factor Surveillance 
System (BRFSS)  
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financial resources.  Evans and Kim (2010) suggest exposure to both environmental 
factors and psychosocial risks (e.g., adverse interpersonal relationships, disordered 
neighborhoods) explain some of the negative health outcomes for individuals with low 
SES. Link, Phelan, Miech and Westin (2008) have described SES and its association with 
health outcomes as “fundamental causes” of disease and mortality. Because they have 
access to money, resources, knowledge, prestige, and social networks, individuals with 
higher SES are more likely to have access to new medical technologies and methods of 
health care than individuals with lower SES (Barr, 2008; Link et al., 2008).  Thus, 
disparities in health outcomes become evident.   
 The relationship between SES and mortality is more apparent in the case of highly 
preventable conditions, such as Type 2 diabetes, than in conditions, such as multiple 
sclerosis and certain types of cancer, with low preventability.  The Barker hypothesis, 
posited by Barker (1995), suggests that the potential for poor health outcomes begins in 
the womb with inadequate prenatal and early life nutrition having the potential to 
predispose an individual to the development of Type 2 diabetes in later life. In addition, 
persistent low social status contributes to this risk in both psychosocial and physiological 
ways (Barr, 2008; Marmot & Wilkinson, 2003; Mechanic, 2007). 
 Although the association between income and health is strongest at the lowest 
income levels, the effects of income persist even above the poverty level  
(Backlund, Sorlie, & Johnson, 1999; Barr, 2008). In America, rates of diabetes increase 
as the poverty to income ratio (PIR) decreases (Beckles, Zhu, & Moonesinghe, 2011).  
The incidence rate of diagnosed diabetes among the poor (11.7%) PIR category and the 
incidence rate in the high income PIR category (5.5%) were more than double (Figure 4).  
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Figure 4. Poverty to Income Ratio (PIR) and Rates of Diabetes in the U.S. 
 Consistent with national data, Arizona’s rates of diabetes are closely associated 
with income (Figure 5); those at the lowest income level (< $10,000) are four times more 
likely to have diabetes as compared to those who earn $75,000 or more (Bass & Porter, 
2011). It is clear that the very poor in Arizona suffer disproportionately from diabetes. 
 
 Figure 5. Income Level and Rates of Diabetes in Arizona 
 Higher education has long been accepted as a stronger individual predictor of 
good health than either employment or income alone, as it influences both employment 
and income (Mechanic, 2007; Winkleby, Jatulis, Frank, & Fortmann, 1992).  Even when 
individuals have achieved comparable income levels, more highly-educated individuals 
tend to experience less hardship due to enhanced cognitive capacity, access to 
11.7% 
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5.5% 
0% 
2% 
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information, empowerment, and coping skills, all of which enable them to more readily 
recognize symptoms of health problems, to seek information about treatment, and to 
more effectively moderate stress, including health-related stress (Barr, 2008;  
Gottfredson, 2004; Mechanic, 2007; Ross & Wu, 1995). In America, the threshold at 
which educational differences are substantial is the completion of high school and beyond 
(Mechanic, 2007).  Rates for Type 2 diabetes in America vary considerably according to 
educational status (Figure 6). In fact, rates of diabetes are nearly double for those who 
have not completed high school (11.8%) as compared to those who have obtained 
education beyond high school (6.2%) (Beckles et al., 2011).  
 
Figure 6. Education Level and Rates of Diabetes in the U.S. 
 In Arizona, rates of diabetes have a linear relationship with education level 
(Figure 7). Arizona adults who did not complete high school (17%) are nearly three times 
more likely to suffer from diabetes compared to those who earned a college degree 
(5.7%) (Bass & Porter, 2011).  
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Figure 7. Education Level and Rates of Diabetes in Arizona 
 
 Moreover, urban versus rural residency is an important social determinant of 
health. Bennett, Olatosi, and Probst (2008) combined data from three sources to compare 
residents in American rural and urban areas.  Residents in rural areas were more likely to 
report fair or poor overall health than those in urban areas (19.5% compared to 15.6%) 
(Bennett et al., 2008). Furthermore, higher incidence of Type 2 diabetes was found in 
rural residents (9.6%) as compared to urban residents (8.4%); rates of diabetes were 
highest for rural American Indians (15.2%) and non-Hispanic blacks (15.1%)  
(Bennett et al., 2008).  
 While SES factors and health insurance do account for much of the disparity in 
health for African Americans, it does not explain all of the difference. Barr (2008) reports 
that even when accounting for SES and health insurance differences, Blacks are still 
burdened with higher rates of many chronic illnesses, including diabetes. Some of these 
differences can be attributed to “neighborhood effects” of decreased social capital linked 
with residential segregation (Barr, 2008).  The accumulated stress of living in an unsafe 
neighborhood where people do not trust their neighbors, do not feel safe walking outside,  
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and live in a generally chaotic environment negatively contributes to physiological and 
mental state, which can have a negative affect on health (Barr, 2008).  
 Furthermore, some disparities in health outcomes can be traced to racial variation 
in access to quality medical care (Barr, 2008). This is independent of health insurance 
and its relationship to access to health care; not all health care is created equal. Clinics 
available to those who live in impoverished areas may provide very basic services that 
are inadequate in ensuring optimal resources for treatment of chronic illness.  
 Luftey and Freese (2005) asserted, “social processes influence people’s health in 
ways that cannot be identified and contained in medical interventions”; therefore, 
researchers sought to identify “mechanisms for linking SES and health” (p. 1328).  
Luftey and Freese (2005) conducted an ethnographic study of two diabetes clinics that 
varied substantially on SES and ethnicity. Park Clinic was the diabetes clinic with 
patients from higher SES backgrounds (mean income of $56,000), few Black patients 
(12%), and higher education levels (89% with more than a high school education). In 
stark contrast, County Clinic patients had lower SES (mean income of $12,000), nearly 
half of the patients were Black (45%), and 36% did not complete high school.  
 A salient difference between the clinics was that Park Clinic offered a higher level 
of continuity of care, which means the same physician saw patients over a long period of 
time (Luftey & Freese, 2005). This allowed for an open, trusting physician-patient 
relationship to be built over time; healthcare providers got to know their patients and their 
subsequent needs. County Clinic utilized medical residents on four-week rotations who  
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were responsible for 75% of face-to-face care. This made it impossible, for patients to 
develop a strong relationship with one primary healthcare provider  
(Luftey & Freese, 2005).  
 Moreover, Luftey and Freese (2005) reported substantial differences in 
educational resources available at each diabetes clinic. Park Clinic employed several 
diabetes educators in their on-site diabetes education center who were available for 
consultation immediately following medical exams. County Clinic did not have this type 
of on-site resource; instead there was one volunteer diabetes educator available for 
scheduled appointments one day a week.  
 Furthermore, more than 40% of County Clinic patients did not have health 
insurance, which meant they were burdened with additional paperwork before being 
treated or obtaining necessary medication at the clinic (Luftey & Freese, 2005). Even 
though financial counselors were available to assist with paperwork, many patients did 
not use this service and were subsequently not receiving benefits to which they were 
entitled. Moreover, Luftey and Freese (2005) concluded that many patients “failed to take 
prescribed medication as a result” (p. 1349). Luftey and Freese (2005) demonstrated that 
the type of health-related services provided to patients with diabetes are important in 
evaluating access and quality of care for patients. 
Management of Diabetes 
 At the present time, there is no cure for diabetes; therefore, maintaining healthy 
blood glucose levels through proper self-management is crucial for avoiding serious 
complications. Prescribing medication to treat diabetes varies for individuals. Some 
adults manage diabetes by taking only insulin (12%), while others benefit from both 
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insulin and oral medication(s) (14%), and the majority requires only oral medication(s) 
(58%) (CDC, 2014; NHIS, 2007–2009). Approximately 16% of people with diabetes do 
not take any prescription medication, as they are able to adequately manage diabetes with 
lifestyle changes including a healthy diet and regular activity (CDC, 2014; NHIS, 2007–
2009).  Furthermore, diabetes is a progressive illness and increases in medication dosage 
and types are typically required during the disease process. 
 Adhering to medical recommendations can present challenges for even the most 
engaged patients. Effectively controlling blood glucose is complex and requires patients 
to be engaged daily in their self-care; there is no vacation from diabetes management. 
While people with diabetes may see their physician often for tests and medication 
management, the burden of diabetes management rests upon the patient. The patient is 
responsible for lifestyle changes such as regular exercise, eating healthy foods, daily 
blood sugar testing, and medication management.  
Complications from Uncontrolled Diabetes 
 Uncontrolled diabetes is the seventh leading cause of death in the United States 
and can lower life expectancy by as much as 15 years (Xu et al., 2010). In 2007, diabetes 
was listed as the underlying cause on 71,382 death certificates; poorly controlled diabetes 
was a contributing factor on an additional 160,022 death certificates for a total of 231,404 
deaths (Xu et al., 2010). Overall, Xu et al. (2010) estimate the risk of death for people 
with diabetes is about twice that of people of comparable age who do not have diabetes.  
 Complications related to poorly controlled diabetes are generally categorized into 
microvascular complications or macrovascular complications (ADA, 2012). 
Microvascular complications affect small blood vessels, thereby contributing to diseases 
 21 
of the eyes (retinopathy), the nerves (neuropathy), and the kidneys (nephropathy).  
Macrovascular complications affect larger blood vessels and contribute to risk for heart 
disease and stroke.  
 In America, poorly controlled diabetes is the leading cause of blindness among 
adults over 20 years old (Zhang et al., 2010).  From 2005 to 2008, nearly 1 in 3 people 
with diabetes aged 40 years or older had diabetic retinopathy (28.5%)  
(Zhang et al., 2010). Of those with diabetic retinopathy, 4.4% were so advanced that they 
were at risk for severe vision loss (Zhang et al., 2010). In 2006, advanced diabetic nerve 
disease was a major contributory cause of lower-extremity amputations as 60 % of all 
lower-limb amputations were performed on people with diabetes (Gregg et al., 2014). 
Uncontrolled diabetes is the leading cause of nephropathy; accounting for 44% of all 
newly diagnosed kidney failure in 2008 (Gorina & Lentzer, 2008). As of 2008, more than  
202,000 people with diabetes-related end-stage renal disease (ESRD) were living on 
dialysis or with a kidney transplant (Gorina & Lentzer, 2008).  
 People with poorly controlled diabetes are at increased risk for macrovascular 
damage, which leads to cardiovascular disease (CVD). In 2004, for those aged 65 and 
older who died of diabetes-related complications, heart disease was noted on 68% of 
death certificates and stroke was noted on 16% of death certificates  
(Gorina & Lentzer, 2008). Furthermore, adults with uncontrolled diabetes die from heart 
disease at rates two to four times higher than people who do not have diabetes (Gorina & 
Lentzer, 2008). Moreover, stroke risk is two to four times higher among people with 
poorly controlled diabetes (Gorina & Lentzer, 2008).   
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 Prevention is the primary strategy for avoiding microvascular and macrovascular 
complications. Improving glucose control can benefit people with diabetes as every 
percentage point drop in glycated hemoglobin (A1C), for example, from 9.0% to 8.0%, 
can significantly reduce the risk of microvascular complications like retinopathy, 
nephropathy, and other nerve damage by 40% (DCCT, 1993; Stratton et al., 2000).  
The ADA (2012) defines A1C as a blood test that measures average blood glucose 
control over the previous two to three months. It is expressed in terms of the percentage 
of glycated hemoglobin in the blood. In addition to adequate blood sugar control, 
prevention efforts for people with diabetes must include being proactive in maintaining 
healthy cholesterol levels and controlling blood pressure.  
 Complications from uncontrolled diabetes can be reduced or prevented if patients 
with diabetes take the proper medication(s) to adequately control blood glucose levels 
(DCCT, 1993). Breitscheidel et al. (2010) report increased health care costs and higher 
rates of hospitalization are associated with poor medication adherence. Furthermore, 
when diabetes medications are taken consistently, both microvascular and macrovascular 
complications are significantly reduced (DCCT, 1993; Gorina & Lentzer, 2008; Stratton 
et al., 2000).  Thus, adherence to a medication regimen is crucial for the health of people 
with diabetes.  
The Conceptualization of Medication Adherence 
 Trostle (1988) discusses the notion of compliance with medical treatment as a 
concept requiring a dominant medical professional and a dependent patient. He asserts 
that compliance research was dominated by ideological conceptions of the roles of the 
physician and the patient in medical care. Furthermore, Trostle (1998) asserts that 
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negatively labeling clients as “non-compliant” because they follow their own ideas about 
treatment assumes patients should not have a say in their own care and are disobedient to 
physician mandates. More recently, Horne et al. (2005) discuss compliance as used in 
modern medicine, “it betrays a paternalistic attitude towards the patient on the 
prescriber’s part” and suggest the term compliance should not be used (p. 383). 
 Horne et al. (2005) assert the concept of “concordance”, which places emphasis 
on the shared decision-making process between patient and HCP is ideal when making 
decisions about prescribing treatments. Concordance has an even broader implication as 
the physician and patient are free to share their views about treatment and move toward  
the mutual decision about the potential use of medication; in the concordance approach, a 
decision not to take medication is acceptable (Horne et al., 2005).  
 After this concordant process, the decision about how to proceed with medical 
treatment is ideally agreed upon by both parties. Horne et al. (2005) prefer the term 
adherence to best describe the notion of “sticking to a therapeutic regimen” (p. 383). 
Cramer (2004) concurs as she defines adherence as “taking medication as prescribed 
and/or agreed between the patients and the health care provider” (p. 1219). Therefore, the 
term adherence will be used as a term to describe whether or not the patient has followed 
the medication plan agreed to by both physician and patient.  
Diabetes Medication Adherence 
  Non-adherence to diabetes medication is associated with an 80% increased risk of 
death in people with diabetes (Elliot, 2009). Unintentional non-adherence occurs when 
patients forget to take their medication or take it incorrectly; this accounts for about half 
of all non-adherence (Elliott, 2009). Conversely, at least half of non-adherence is 
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intentional. For example, the patient may experience unpleasant side effects or have 
concerns about long-term effects associated with the medication and make a decision to 
not take a medication (Elliott, 2009).  
 Shah et al. (2009) examined rates of filling an initial prescription for diabetes 
medication in more than 1,000 patients who were primarily Caucasian (95%). The overall 
first-fill adherence rate for diabetes medication in this sample was 85%; 15% of patients 
did not receive their initial prescription for diabetes medication. Factors associated with 
filling their initial prescription were copays less than $10 and baseline A1C greater than 
9%; sex and age had no association.  
 Kirkman et al. (2015) examined data from more than 200,000 people with 
diabetes who were prescribed noninsulin medications. Nearly two-thirds (69%) were 
adherent to their medication. Adherence was associated with older age, being male, social 
determinants of health (higher education and higher income), lower out of pocket costs, 
and use of mail order pharmacy. Furthermore, patients who were newly diagnosed with 
diabetes were significantly less likely to be adherent to diabetes medication  
(Kirkman et al., 2015). 
 Rubin (2005) conducted a review of twenty-seven studies, which included a 
measurement of medication adherence in patients with diabetes. Most studies (25) were 
only concerned with oral blood glucose lowering medications as opposed to insulin 
therapy. Adherence to oral hypoglycemic agents (OHA) varied widely from 65% to 85%. 
Although in some populations, for example, Medicaid recipients (Dailey, Kim, & Lian, 
2001) and those taking multiple medications (Melikian, White, Vanderplas, Dezii, & 
Chang, 2002) even lower rates of adherence were reported at 36% to 54%. Rubin (2005) 
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reported six factors influencing adherence: (1) comprehension of the medication regimen; 
(2) perception of benefits; (3) side effects; (4) cost of the medication; (5) complexity of 
the medication regimen; and (6) emotional well-being of the patient.  
 Cramer (2004) reviewed fifteen studies that included a measurement of 
medication adherence and discovered wide variation in rates of adherence (36% to 93%). 
Cramer (2004) reviewed five studies that used electronic monitoring to track adherence 
of dosing and found OHA adherence rates of 61% to 85%, which more closely matched  
the Rubin (2005) review. Brunton et al. (2011) reported broad adherence rates to OHA  
among patients with Type 2 diabetes to be 36% to 93%, which is consistent with Cramer 
(2004). 
 Moreover, medication adherence varies by type of OHA. Shenolikar, Balkrishnan, 
Camacho, Whitmire, & Anderson (2006b) found adherence for the diabetes medication 
pioglitazone was lower in African American Medicaid enrollees as compared to white 
peers; there was a 12% overall lower rate of adherence for African Americans as 
compared to whites.  However, after controlling for demographics (e.g. age, gender), 
African Americans were not different in adherence rates to pioglitazone as compared to 
whites (Shenolikar, Balkrishnan, Camacho, Whitmire, & Anderson, 2006a). 
 Evans et al. (2002) found especially low adherence rates for two commonly used 
OHAs, metformin and sulphonylureas, for Type 2 diabetes patients only taking oral 
medication. Half of those who were prescribed metformin were not taking the medication 
as prescribed. Moreover, Pladevall et al. (2004) found adherence rates for metformin was 
57% in a diverse sample of more than 1000 patients, which included 41% African 
Americans. Non-adherence was significantly associated with poorer glucose control as 
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evidenced by higher A1C.  In addition, more than one-third of those who were prescribed 
sulphonylureas were non-adherent (Pladevall et al., 2004). 
 Few studies examined rates of adherence for insulin therapy.  Rubin (2005) 
reviewed two studies that evaluated adherence to insulin therapy in people with Type 2 
diabetes and concluded that the adherence rate was 60% to 80%. Cramer (2004) found 
that younger patients were less adherent to insulin than older patients and filled 
prescriptions for only about one-third of their prescribed insulin. Brunton et al. (2011) 
reported adherence to insulin therapy to be 70% and 60% of patients reported missing an 
occasional injection.  
 The estimated diabetes costs in the United States for 2012 are $245 billion; this 
includes $176 billion for direct medical costs and another $69 billion in indirect costs 
(disability, work loss, premature death) (CDC, 2014). Breitscheidel et al. (2010) reviewed 
eleven studies of healthcare costs and the relationship with diabetes medication 
adherence. They concluded that improving overall medical adherence, including 
prescription adherence, could lead to reductions on the total healthcare costs for Type 2 
diabetes. Annual cost savings per patient for the treatment of Type 2 diabetes ranged 
from $4,570 to $17,338. In a review of seven studies, non-adherence to diabetes 
medication was associated with higher overall healthcare costs. Furthermore, non-
adherence to diabetes medications was related to higher hospitalization costs 
(Breitscheidel et al., 2010; Shenolikar, et al., 2006a).   
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 Lee et al. (2006) conducted another meta-analysis of studies on adherence among 
people with diabetes to calculate the economic effect. They concluded that improved  
adherence would result in decreased health care costs of about 8.6% to 28.9%. Most of 
this decrease in costs would be in lower hospitalization costs of 4.1% to 31%.  
Barriers to Medication Adherence 
 Many patients with diabetes are prescribed multiple medications, including 
medication for other conditions such as hypertension, hyperlipidemia, or CVD. For 
patients who were taking OHA and antihypertensive medications, half underused these 
medications, citing cost as the primary barrier (Aikens & Piette, 2009). In fact, the 
majority of patients reported the cost of medication or related copays as the primary 
reason they did not take their diabetes medication as prescribed (Aikens & Piette, 2009; 
Piette, Heisler, & Wagner, 2004; Rubin, 2005). 
 Piette et al. (2004) surveyed 660 veterans with chronic illness who reported 
underusing their prescription medications due to cost. Many patients stated they knew in 
advance they would not be taking the medication as prescribed, with nearly two-thirds 
choosing not to discuss with their health care provider their inability to afford the 
medication (Piette et al., 2004). Of these chronically ill patients who did not talk to their 
physician about the prohibitive cost of medications, 66% reported that nobody asked 
them about their capacity to afford the prescribed medication(s) and 58% thought there 
was nothing their healthcare provider could do about helping them pay for prescription 
medication (Piette et al., 2004). Rubin (2005) found patients reported a variety of reasons 
for not discussing medication costs with physicians including the patients did not believe 
their healthcare providers could help with costs (50%), cost was not important enough to 
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mention (39%), embarrassment (35%), and patients did not believe there was enough 
time to discuss costs (30%).   
 Piette, Beard, Rosland, and McHorney (2011) concluded that addressing patient 
beliefs about their medication could decrease cost related non-adherence. From survey 
data of patients with chronic illness from diverse SES backgrounds, Piette et al. (2011) 
suggest that cost-related non-adherence may be associated with other factors including 
patient beliefs about medication, which influences the value that a patient places on 
prescription medication.  For example, respondents who reported greater concerns about 
negative side effects from prescription medication had twice the odds of reporting cost 
related non-adherence to medication (Piette et al., 2011). In addition, patients who did not 
believe they really needed their medication were more than twice as likely to report non-
adherence due to cost. Furthermore, beliefs about susceptibility to complications and 
efficacy of prescribed medication were considerations when patients were deciding 
whether or not to take prescription medication as directed (Piette et al., 2011).  
 Beyond cost related non-adherence, Rubin and Peyrot (2001) discussed common 
fears regarding initiating insulin therapy. The first reason many people offered for their 
resistance to insulin treatment was that injections are painful. While this may be the most 
readily expressed reason, it may not the most salient reason for resistance to insulin 
therapy (Leslie & Satin-Rapaport, 1995).  
 Many people with diabetes are concerned that taking insulin injections will 
further restrict and complicate their life, thereby reducing quality of life  
(Peyrot et al., 2005; Rubin & Peyrot, 2001). Insulin therapy has the potential of making 
life more complex as it requires carrying insulin, syringes, and a glucose meter 
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everywhere. Moreover, new skills must be acquired to maintain a healthy balance of 
insulin and glucose in the body to avoid dangerous extremes.  
 Some people with diabetes were opposed to insulin therapy because they were 
concerned that their diabetes, and therefore, their health, was substantially declining 
(Peyrot et al., 2005; Rubin & Peyrot, 2001). Coupled with this concern were feelings of 
failure associated with past mismanagement of their diabetes that they believe may have 
prevented the need for insulin (Peyrot et al., 2005). Perfect management of diabetes is not 
possible and, as stated earlier, as many as one-half of diabetes patients are non-adherent 
to their prescription medications (Brunton et al., 2011; Cramer, 2004; Rubin, 2005).  
 Other fears included unwanted side effects from insulin therapy  
(Peyrot et al., 2005; Rubin & Peyrot, 2001). For example, weight gain is common with 
insulin therapy and this becomes particularly distressing for those who have been 
struggling to lose weight (Rubin & Peyrot, 2001). Moreover, hypoglycemia  
(insulin reaction or low blood sugar) is more likely when patients are on insulin therapy. 
Hypoglycemia can be frightening, embarrassing, and even dangerous. Many patients  
prefer having elevated glucose, even if they recognize it is harmful in the long-term, as 
opposed to the discomfort of an insulin reaction (Rubin & Peyrot, 2001). 
 Some people reported resistance toward insulin therapy because they believe that 
insulin actually causes complications (Rubin & Peyrot, 2001). These people often cited 
serious complications experienced by relatives or friends shortly after initiating insulin 
therapy. This is a spurious relationship as insulin therapy is actually related to the  
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prevention of diabetes-related complications, which has been confirmed in numerous 
reliable studies (DCCT, 1993; Turner et al., 1998; U.K. Prospective Diabetes Study, 
1998).  
 Some people with diabetes were concerned about negative social pressures, as 
they believed others would view them differently if they use insulin to control their 
diabetes (Peyrot et al., 2005; Rubin & Peyrot, 2001). If in the past, family and friends 
communicated blame and judgment toward the person with diabetes, it would be 
reasonable to assume initiation of insulin therapy would only increase anxiety, negativity, 
or judgment from others.  
 In addition to these fears, many people with diabetes do not have a trusting 
relationship with their healthcare provider (Peyrot et al., 2005; Rubin & Peyrot, 2001).  
Polonsky (2005) confirmed that many people with diabetes did not feel physicians had 
sufficiently provided diabetes education, support, encouragement, or discussion about 
treatment options. These patients were particularly oppositional, even resentful, toward 
insulin therapy. In fact, Corbie-Smith, Thomas, & St. George (2002) found that African 
American patients were significantly more likely than whites to believe their physicians  
exposed them to unnecessary risks. In addition, African American respondents had a 
significantly higher overall mistrust for physicians than white respondents 
(Corbie-Smith et al., 2002).  
Medication Adherence in Culturally Diverse Populations 
 Mann, Ponieman, Leventhal, and Halm (2009) surveyed 151 low-income Latinos 
(58%) and African Americans (34%) with diabetes. Eighteen percent reported having 
difficulty taking their diabetes medication, 16% were worried about the possibility of 
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becoming addicted to their medication, and 12% believed they only had diabetes when 
they were experiencing elevated blood sugar. More concerning was that nearly half of  
people with diabetes in this study (49%) believed they had little control over their illness 
(Mann et al., 2009). All of these beliefs can have a detrimental effect on medication 
adherence.  
 In a survey of veterans with bipolar disorder by Zeber et al. (2011) minority 
patients were less likely to be adherent to their medications to treat bipolar disorder than 
non-Hispanic whites. Moreover, Zeber (2011) concluded financial barriers were not as 
influential as other psychosocial barriers. Potentially modifiable risks that were found to 
have an effect on medication adherence included beliefs about the efficacy of the 
medication, the patient’s relationship with the healthcare provider, substance abuse, 
degree of social support, and illness perceptions.  
 In their study of 542 African Americans with Type 2 diabetes, Hill-Briggs et al. 
(2006) examined the role of problem-solving and self-management behaviors. 
Medication adherence was measured by the 9-item Moritsky Medication Adherence 
Scale (Moritsky et al., 1986). The ability to effectively engage in problem solving was 
significantly associated with greater medication adherence. They concluded that knowing 
what strategies are successfully used to problem-solve medication barriers may be useful 
to others who struggle with overcoming barriers to medication adherence. 
Medication Adherence and Glycemic Control in African Americans 
 Hill-Briggs, Gary, Bone, Hill, Levine, and Brancati (2005) examined medication 
adherence in 181 urban dwelling African Americans with Type 2 diabetes. Almost 75% 
of participants were adherent with diabetes medications. Older age was associated with 
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greater adherence and better glycemic control. A1C was significantly lower for those 
who were adherent in taking diabetes medications as measured by 4-items from the 
Moritsky Medication Adherence Scale (Moritsky et al., 1986) plus one additional item, 
“Do you ever run out of your medication?” Significant differences in A1C were 
observed between participants who reported running out of medication and carelessness 
with taking medication as compared to those who did not report these behaviors.  
 Heisler et al. (2007) suggest that understanding mechanisms associated with 
medication adherence may be a means to addressing barriers to adherence. Heisler, et al. 
(2007) examined 1034 patients with diabetes to determine racial differences related to 
disparities in glycemic control. Clinical characteristics included type of 
antihyperglycemic treatment regimen (no medication, oral medication with daily glucose 
testing, oral medication without daily glucose testing, and insulin either with or without 
oral meds). Blacks had significantly worse glycemic control than whites  
(Heisler, et al., 2007). More Blacks were taking insulin and also reported lower rates of 
medication adherence (Heisler, et al., 2007); lower A1C was associated with adherence to 
diabetes medication(s). Furthermore, Blacks also reported more diabetes-related 
comorbidities (Heisler, et al., 2007). This further demonstrates the need to address the 
potentially modifiable behavior of medication adherence as a means of improving 
glycemic control in African Americans.  
Social Support and Medication Adherence in African Americans 
 Chlebowy and Garvin (2006) conducted a study (N=91), which included 27 
African Americans living in the southeastern United States to investigate psychosocial 
variables (social support, self-efficacy, and outcome expectations), the relationship to 
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self-care behaviors (glucose testing, exercise, diet, and medication taking) and glycemic 
control. They found a significant relationship between outcome expectations and the total 
score for self-care behaviors for African Americans and Caucasians. Understanding more 
about how outcome expectations may affect medication adherence would be valuable. 
 Chlebowy, Hood, and La Joie (2010) conducted focus groups with 38 African 
American adults with Type 2 diabetes living in a southeast urban community to 
determine facilitators and barriers to diabetes self-management. Family support was a 
facilitator to medication management; some family members provided direct assistance in 
the administration of medications and/or provided cues that prompted taking medications.  
 Tang, Brown, Funnell, and Anderson (2008) conducted a study with 89 African 
Americans with Type 2 diabetes living in Detroit, Michigan and examined social support 
and its relationship with self-care behaviors (diet, exercise, glucose testing, foot care, and 
medication use). Medication use was assessed by one question that asked, On how many 
of the last 7 days did you take your medication as your physician recommended? 
Negative social support was predictive of greater non-adherence to diabetes 
medication(s). In other words, some comments from family and friends reminding the 
person with diabetes to take his or her medication may be perceived as nagging and result 
in decreased medication adherence. Tang et al. (2008) suggest that because taking 
medication is often done in solitude, there is less opportunity to receive positive 
feedback.  
 Brody, Kogan, Murry, Chen, and Brown  (2008) conducted a study of 200 
southern, rural dwelling African Americans with Type 2 diabetes and were primarily 
concerned with social support and the relationship to glucose testing and A1C. Self-
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esteem, optimism, and depressive symptoms in both the patient and support person were 
significantly related to blood sugar control. Brody et al. (2008) did not include any 
measurement of medication adherence. However, this does suggest that personal 
psychological characteristics of both the person with diabetes and the support person are 
important factors in controlling blood sugar. 
 While the challenges to diabetes medication adherence in the African American 
population are well documented, little attention has been given to those who have 
successfully overcome these barriers. For that reason, this study engaged in a shift from 
non-adherence as viewed through the lens of problem-orientation to adherence as viewed 
through resiliency with consideration of the eco-systems theoretical framework. 
Resiliency Theory and Eco-systems Theory  
 Resiliency theory provides the lens through which the data can be interpreted and 
eco-systems theory provides the framework for viewing resiliency at various levels. 
Thus, resiliency was observed at the individual, family and friends, community (e.g. 
healthcare providers, co-workers, church relationships), and society levels (e.g. historical 
context, policies, health insurance). Furthermore, the interview questions were developed 
with these theoretical perspectives as framework (Appendix C).  The questions begin 
with the individual, family and friends, and broaden to include community and societal 
influences on resiliency. Moreover, questions were formulated with resiliency 
perspectives of asset, competence, risk, and adversity identified as aspects of potential 
resiliency. 
 The lens of resiliency theory focused on strengths exhibited by African 
Americans with diabetes who have been adherent to diabetes medication(s). Resiliency is 
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defined as, “the process of coping with stressors, adversity, change, or opportunity in a 
manner that results in the identification, fortification, and enhancement of protective 
factors” (Richardson, 2002, p. 308). Furthermore, resiliency theory allowed for the 
exploration of internal and external qualities that enable people to go beyond simply 
rebounding from difficulty, to experiencing insight and growth in the process. This 
process may include individual traits of resiliency, the disruptive and integrative process 
of adhering to medication(s) for diabetes, and any other forces that have contributed to 
growth in individuals. This person in environment, strengths-based approach is useful in 
uncovering culturally grounded strategies already used in the African American 
community, which allows for culturally appropriate replication of those strategies for the 
benefit of others in the community.  
 For the purposes of this study, culture is defined as “the set of values held by a 
community and its corresponding worldview” (Marsiglia & Kulis, 2009, p. 4). Hruschka 
(2009) further asserts, “Culture has inertia and that culture is to some extent shared”  
(p. 237).  Moreover, risk and resilience vary across ecological and cultural contexts; they 
are related to cultural expectations for normative behavior (Yates & Masten, 2004). Thus,  
cultural influences and norms as seen through resiliency are important in understanding 
diabetes medication adherence in the African American community.   
Primarily, deficit models have been used to research African American people. 
This problem-oriented approach has focused on the weaknesses and deficiencies of 
individuals and groups (Hill, 2007). Recently, the focus has been shifting to examining 
the strengths of African Americans as an alternative lens referred to as “resiliency 
research” (Billingsley & Morrison-Rodriguez, 2007, p. 76; Hill, 2007). Yates and Masten 
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(2004) stress the importance of “promoting competence through positive models of 
intervention and change, in addition to reducing or ameliorating the effects of adversity” 
(p. 522). Resiliency research seeks to identify mechanisms that enhance protection and 
resiliency within a given population (Hill, 2007). Conceptually, members of the African 
American community have used the mechanisms that are uncovered; therefore, the 
researcher simply facilitated the power of the community to be able to spread resilient 
strategies and supports to others who may need them. 
 Yates and Masten (2004) suggest, when identifying patterns associated with 
resilience, there is a need to understand the related concepts of competence, adversity, 
asset, and risk. Competence can be conceptualized as the adaptive use of internal and 
external resources to negotiate challenges in order to achieve positive outcomes  
(Yates & Masten, 2004). Adversity refers to any experience that has the potential to 
disturb healthy functioning and adaptation (Yates & Masten, 2004). Assets are resources 
within a given population that enhance the potential of positive development and 
outcomes; while risks are those factors and conditions that increase the probability of 
unhealthy outcomes within a given population (Yates & Masten, 2004).  
In research with at-risk youth and young adults, resiliency is proposed as an 
important mechanism of protection (Billingsley & Morrison-Rodriguez, 2007; Hill, 2007; 
Rutter, 1987). Rutter (1987) conceptualized resiliency as adaptive or healthy responses to 
stressful circumstances. A concise definition of resilience is, “the ability of individuals or 
families to respond adaptively to factors that are likely to increase stress or negative  
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outcomes” (Hill, 2007, p. 87). Therefore, resilience can be enhanced when responding to 
difficult situations and circumstances. Hill (2007) proposes the four protective 
mechanisms consistent with resilience as follows: 
(1) The reduction of risk impact, including processes that alter the risk, or the 
 person’s response to risk;  
(2) The reduction of negative chain reactions that follow exposure to the 
 threatening effect and contribute to long-term effects of exposure; 
(3) Enhancing self-esteem and self-efficacy, developed through personal 
 relationships, new experiences and task accomplishment; 
(4) Opening up of opportunities or processes that permit the individual to gain 
 access to resources or to complete important transitions. (pp. 76-77) 
 
The resiliency conceptual framework can be used to identify protective 
mechanisms that may enhance resiliency in African Americans with diabetes. Protective 
mechanisms are defined as, “processes at the individual, family, community or societal 
levels that buffer or mediate the adverse consequences of threatening risk factors” (Hill, 
2007, p. 87). Moreover, Rutter and Sroufe (2000) suggest, “mechanisms involved in 
causation might entail dynamic processes operating over time, that indirect chain effects 
might often be present, and that there might be several different routes to the same 
outcome” (p. 268).  
Process-oriented resilience models are powerful because they go beyond the static 
trait model, which simply identifies individual characteristics of resiliency without 
examining the process of how those traits were acquired or how those traits create 
resiliency in people. In addition, a clearer understanding of the causal processes in 
resilient adaptation can be used to create effective practice interventions and policies 
(Miles & Huberman, 1994; Yates & Masten, 2004). 
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 This resiliency framework distinguishes protective mechanisms at several 
ecological levels including individual, family, community, and society (Figure 8). At the 
individual level, the focus is on uncovering the processes associated with internalizing 
positive regard for self, increasing self-efficacy, and promoting internal locus of control 
(Hill, 2007). At the family level, processes that increase support, foster healthy social 
interaction, and strategies that actively encourage and assist African Americans with 
diabetes will be uncovered (Hill, 2007).  At the broader community level, the focus is on 
identifying the role of mediating structures, both formal and informal  
(e.g. church, workplace, friendships, healthcare team, neighborhood). Mediating 
structures can be defined as, “informal or formal groups at the family or community 
levels that offset or buffer the adverse consequences of threatening risk factors”  
(Hill, 2007, p. 87). The society level includes historical influences and socioeconomic 
differences (Walters, 2002).  
 
Figure 8. Ecological Systems Framework 
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Individual Characteristics of Resiliency  
Some common characteristics identified in resilient African Americans include the 
positive values of personal responsibility, respect for others, and high self-esteem 
(Billingsley, 1999; Hill, 2007). In addition, resilient people often have a strong religious 
orientation as expressed by a deep sense of spirituality (Billingsley, 1999; Gallup, 1995). 
People who have a strong internal locus of control are more likely to effectively manage 
diabetes than those whose locus of control is primarily external (Ajzen, 2002). 
Furthermore, Hill (2007) suggests that young people who exhibit strong peer resistance 
are more resilient. This need to resist peer pressure does not stop when a person becomes 
an adult and may be a necessary skill for effectively managing diabetes and taking 
prescription medication. These individual characteristics in conjunction with reciprocity 
or the notion of mutual support contribute to resiliency in African Americans (Boyd-
Franklin, 2003). 
Resilience in Families 
Resilient people are able to exhibit strong social competency in multiple settings 
throughout their lives (Hill, 2007). A primary protective mechanism for resilience is 
effective communication patterns within the family, which transfers to other relationships 
and extends to community interactions (Hill, 2007).  
In addition, ethnic pride, especially as it relates to biculturalism, is associated with 
resilience. Adults who maintain strong identification with their African American roots 
and have the ability to navigate the dominant culture have higher levels of social 
competence than their peers who do not have a dual cultural orientation or biculturalism 
(Boyd-Franklin, 2003; La Fromboise, Coleman, & Gerton, 1993).  
 40 
African Americans have flexibility in their roles within the family, which may 
have the effect of increasing social support (Boyd-Franklin, 2003; Hill, 2007). 
Furthermore, Hill (2007) suggests that Black couples tend to be more willing to share 
household duties than white couples. In addition, this flexibility in roles expands the 
types of support that may be available to African Americans with diabetes as family  
members may be more willing to take on extra responsibilities in order to ease the burden 
of another family member.  
African Americans have a higher proportion of multigenerational households with 
about 12% of African American children living in the same household as their 
grandparent(s) and in some regions of America, from 30% to 70% of African American 
children live with grandparents (National Policy and Resource Center on Women and 
Aging, 1996).  How this living arrangement may affect health and self-management of  
diabetes is unclear.  Can the responsibilities of caring for grandchildren and living within 
a multigenerational family affect social supports in some meaningful ways?   
Community and Societal Protective Mechanisms 
 Hill (2007) suggests that formal and informal groups may serve to decrease 
burden for African American people and families when stressful events occur.  
Boyd-Franklin (2003) identified strengths found in kinship networks, relatives that are in 
close proximity, but not living in the same household. Kinship networks may provide a 
variety of social and economic resources including care for the elderly and disabled, 
food, financial supports, healthcare, and transportation (Hill, 2007).  
 Positive peer influences are a valuable protective mechanism for providing 
enhancement of resiliency and social competence for some African Americans  
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(Hill, 2007). Strong ties with neighbors and friends may allow the transmission of health 
related information, encouragement, and practical supports. In addition to informal 
groups, memberships in formal groups, which include neighborhood groups, community 
centers, churches, health clinics, mental health agencies, and organizations that serve 
elderly populations may be important resources for those who have a chronic illness.  
The Black church has long been a source of strength for African Americans. 
Billingsley and Morrison-Rodriguez (2007) create a picture of the Black church as a 
social institution that has the power to touch all aspects of African American life. In fact, 
Dr. C. Eric London describes the Black church as follows: 
Beyond its purely religious function, as critical as that has been, the Black  church 
 in its historical role as lyceum, conservatory, forum, social service center, 
 political academy, and financial institution, has been and is, for Black America, 
 the mother of our culture, the champion of our freedom, the hallmark of our 
 civilization. (Lincoln, 1986, p. 3)  
 
Billingsley and Morrison-Rodriguez (2007) further assert during times of difficulty, 
“African American people will turn to the church for guidance, support, and leadership” 
(p. 65).  
Using general systems theory as a conceptual framework, Billingsley and 
Morrison-Rodriguez (2007) examined the interaction of the Black family with the Black 
church. Billingsley and Morrison-Rodriguez (2007) suggest that grandmothers form the 
membership base for most Black churches and may be more likely to receive assistance 
and support from the church than other individuals. Historically, the Black church has 
provided social and economic resources to individuals throughout their life course, which 
extends to the elderly and disabled (Hill, 2007). 
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 Billingsley and Morrison-Rodriguez (2007) suggest the Black church is in a 
position to be an “agent of change for protecting the most vulnerable African American 
families” and have a profound influence on the future direction of the Black family  
(p. 58). It is important for social workers and health care providers to understand the 
complexity of African American social systems and how those systems function in order  
to work in a culturally congruent way to improve health outcomes and quality of life for 
African Americans.  
Moreover, large Black churches may have health ministries that allow 
congregants to obtain health information from trusted sources. Health ministries build 
upon the strengths of the African American community by promoting health and wellness 
with a focus on body, mind, and soul (Warren & Charles, 2011). Often, members of the 
Black Nurses Association (BNA) are utilized to assist with the church health ministry. 
The BNA is a non-profit organization that address the health needs of the African 
American community through education and participation in health fairs and provision of 
information on health-related issues in the local area as well as throughout the state 
(Black Nurses Association of the Greater Phoenix Area, 2013). 
Historical Context 
 In addition to community influences of resilience, the historical context for 
African Americans must be considered. African Americans have a unique history of 
institutional slavery and domination by colonialism (Mann, 2001). Social, political, and 
economic struggles have persisted and continue to affect African Americans in modern 
times (Walters, 2002).  Furthermore, Foreman (1999) suggests that a competition exists 
between those Blacks who are educated middle and upper SES and those who are of a 
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lower SES. The power differential between these groups of African Americans certainly 
contributes to their resilience and must be considered as part of the ecological system in 
which the individuals are nested.  
 African Americans have a history of oppression that continues today. Regarding the 
health care of slaves, Collins (1853) states,  
 The slave also knows, that if he is sick, he will be properly attended to, that he 
 may the sooner recover, and resume his duties; that if his children are sick, they too 
 will be taken care of, for the money they are soon to be worth. (p.15) 
 
The health of the plantation owner’s workforce was imperative to his economic success; 
therefore, it profited him to take care of his workers (Andreae, 2009; Collins, 1853). 
However, the manner of care was usually dictated by the plantation owner and depended 
upon the resources available and the perceived worth of the sick slave (Haller, 1972). 
 Larger plantations were more likely to bring in professional medical care, but many 
owners did not consult physicians when Blacks were ill (Haller, 1972). For the most part, 
slaves were at the mercy of their owner to determine what type of medical care would be 
obtained. Principally, the plantation owner, his mistress, or the overseer, became the 
physician (Andreae, 2009; Haller, 1972). 
 Sellers (1994) states, “A slave who became ill meant loss of working time; death, 
an even greater loss” (p. 109). For slaves, a great deal of the health care was provided by 
folk healers, grandmother midwives, lay nurses, and through other social networks such 
as churches (McBride, 2005). Furthermore, grandmothers were an integral, respected part 
of the health care system; they provided a devotion to their patients that was unparalleled 
in the broader community (McBride, 2005). White (1983) suggests that older women 
who provided midwifery were dubbed “doctor women” (p. 252) and were known to have 
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a complex understanding about the proper use of herbs for curing sickness. In treating 
sickness, healers became an instrument of a higher power and exercised control that was 
equally empowering for the healer and the patient (Andreae, 2009).  
 Even so, slaves were often reluctant to report illness to the overseer; they feared 
being accused of malingering (Andreae, 2009). Some slaves complained of sickness to 
avoid work, which contributed to stereotyping slaves as lazy or deceptive  
(Andreae, 2009). Therefore, the revealing of sickness created a dilemma for the slave and 
overseer; genuine sickness needed to be treated to avoid loss of work time or death, but 
allowing a slave to convalesce, resulted in a reduction of the labor force (Andreae, 2009).  
In either case, profits would suffer. 
 This historical view of the treatment of the sick may continue to influence African 
American notions about the proper care of disease in contemporary times. The inertia 
inherent in culture and the inevitable sharing of cultural orientations may persist 
(Hruschka, 2009).  How African Americans view sickness and the steps they take to 
engage in treatment may echo back to these early years in America. There may be a 
lingering perception of suspicion regarding whether someone is truly sick and the person 
who is ill may be perceived to be less valuable than his or her healthy counterparts.  
Historic Gender Roles for African Americans 
 Slavery schooled Black women in self-reliance and self-sufficiency; together they 
firmly resisted domination of masculine authority. Some believe this has contributed to 
the modern day matriarchal Black family. Enslaved women often relied upon the skills of 
slave midwives to assist with birthing; this interdependence permeated other areas of 
their lives, as women depended upon one another for help in raising children and worked 
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together to accomplish tasks (White, 1983, p. 255). Once a female slave had a child, a 
variety of privileges were bestowed upon her.  
 Moreover, the practice of “abroad marriages”, spouses living on different 
plantations, may have intensified female independence and the maternal role, as spouses 
were only able to see one another once or twice a week (White, 1983, p. 255). This 
concept of matrifocality, which emphasizes “the fact that women in their role as mothers 
are the focus of the familial relationships” (White, 1983, p. 256) was central to the Black 
slave family suggesting an inevitable hierarchy of the mother-child relationship over the 
husband-wife relationship. When matrifocality exists, the role of the father is secondary 
to the role of the mother when considering survival of the family unit (White, 1983). In 
summary, female interdependence and cooperation reduced the owner’s leverage over 
African American slaves, which necessitated female self-reliance, encouraged the  
mother-child bond as more sacred than the husband-wife relationship and enabled Black 
families to survive slavery. 
 White (1983) suggests that while African American men and women share a 
common culture, they likely view their role as distinctly different within that shared 
culture. For example, in a society where women form their own groups and associations, 
the women’s roles may complement the men’s, but women exist in an independent 
environment. In addition, contemporary African American women continue a 
matrifocality and see their priority as caretaker of children and other family members.  
Summary of Theoretical Frameworks 
This study sought to understand the strategies and processes associated with 
adherence to diabetes medication(s), including insulin, for African Americans. Using 
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resiliency theory as a lens enabled the exploration of a variety of potential mechanisms 
that may contribute to diabetes management, especially medication adherence, in African 
Americans with Type 2 diabetes. Moreover, the eco-systems conceptual framework 
created a structure for investigating protective mechanisms within the individual, the 
family, the community, and the society (Hill, 2007). When identifying patterns associated 
with resilience, the concepts of competence, adversity, asset, and risk (Yates & Masten, 
2004) directed the formation of questions that guided discussion in both the focus groups 
and individual interviews.  Moreover, the four protective mechanisms associated with 
resilience proposed by Hill (2007) were used as a conceptual framework for creating 
questions to elicit resilient strategies and processes. These protective mechanisms are: 
(1) The reduction of risk impact, including processes that alter the risk, or the 
 person’s response to risk;  
(2) The reduction of negative chain reactions that follow exposure to the 
 threatening effect and contribute to long-term effects of exposure; 
(3) Enhancing self-esteem and self-efficacy, developed through personal 
 relationships, new experiences and task accomplishment; 
(4) Opening up of opportunities or processes that permit the individual to gain 
 access to resources or to complete important transitions. (pp. 76-77) 
 
Moreover, resiliency theory provides a unique lens through which to view the data 
collected. Uncovering resilient strategies, supports, and processes was the focus of the 
analysis.  
Purpose of this Study 
  
 Social determinants of health have been well established and explain much about 
poor health outcomes (Barr, 2008; Marmot & Wilkinson, 2003). Moreover, access to 
health care and the physician-patient relationship contribute to obtaining quality health 
care and necessary medication(s) (Barr, 2008; Luftey & Freese, 2005). However, we 
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know relatively little about cultural factors that are related to medication adherence.  
Improving adherence to diabetes medication(s) has the potential to reduce the prevalence 
of complications associated with poor glucose control in people with diabetes  
(DCCT, 1993) and reduce the cost of health care (Breitscheidel et al., 2010;  
Shenolikar et al., 2006a). 
 Moreover, much is known about reasons for non-adherence to diabetes 
medications (Piette et al., 2011; Rubin, 2005) and psychological insulin resistance 
(Peyrot, et al., 2005; Polonsky et al., 2005); however, little is known about those who 
have managed to overcome the barriers to medication adherence. By uncovering the 
mechanisms used by African Americans with diabetes related to diabetes medication(s) 
adherence, mechanisms may be better understood and strategies to increase medication 
adherence could be extended to those African Americans who are struggling. As the  
strategies will come from within the African American community, cultural congruence 
is assured.   
 Furthermore, public health implications for uncovering mechanisms related to 
diabetes medication adherence have the potential to influence health messages and 
enhance effective communication with African American people with diabetes who need 
medication in order to avoid consequences related to poorly controlled blood sugar. 
Creating positive messages for medication adherence based upon the strengths present in 
the African American community has the potential to reduce the rate of complications 
due to poor glucose management in this population.  
 This study is guided by the broad question, “What mechanisms are associated 
with adherence to diabetes medication(s), including insulin, for African Americans?” 
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This research project has two primary aims: 
  Aim 1: To examine what individual and broader environmental mechanisms 
 are associated with adherence to diabetes medication(s) for adult African 
 Americans with Type 2 diabetes.  
 Aim 2: To identify internal and external factors that enable African Americans 
 with diabetes to go beyond adherence and to develop a broader understanding of 
 the disease and how to manage it.	  
Previous studies have focused on understanding the scope of non-adherence  
(Brunton et al., 2011, Cramer, 2004; Rubin, 2005) and reasons for non-adherence 
(Aikens & Piette, 2009; Piette et al., 2004; Rubin, 2005). The intellectual merit of this  
study is in developing new knowledge about those who take diabetes medication(s) as 
prescribed.  
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Chapter 3 
 
METHODOLOGY 
 
 This qualitative study explored the question, “What mechanisms are associated 
with adherence to diabetes medication(s), including insulin, for African Americans?” By 
focusing on the resilient strategies, supports, and processes employed by African 
Americans with diabetes in regard to medication adherence, the researcher aimed to 
identify culturally compatible strategies and supports for diabetes medication adherence 
that may be extended to others who struggle to take diabetes medication consistently.  
 Many studies have identified barriers to medication adherence in general and in 
diverse populations. Building upon that foundation, this study identified how some 
African Americans with diabetes have successfully overcome those barriers.  
Research Design 
 This exploratory qualitative study conducted four recorded, gendered focus 
groups; two groups had approximately two to five men and two groups had 
approximately two to five women to determine strategies and processes that are used by 
men, women, and both genders. Berg (2009) suggests at least two homogenous focus 
groups are necessary for a rigorous study. The researcher and, when available, an African 
American co-facilitator facilitated focus groups.  
 After analyzing data using content analysis through the theoretical perspective of 
resiliency, in-depth individual interviews were conducted; nine women and eight men 
were recruited for the individual interviews. Stratification will be based on social 
determinants of health to ensure varied representation. Interviews were conducted where 
the participant was the most comfortable (e.g., church, community center, library, etc.).  
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 Furthermore, collection of data ceased when “saturation” was reached; Strauss 
and Corbin (1998) propose that saturation is a “matter of degree” and there is always a 
potential for new ideas to emerge from qualitative sources. However, as a matter of 
practicality and best use of resources, through the iterative process of transcription, 
coding, and analysis, no new themes were emerging from the data. This study had 
twenty-three participants, which is consistent with Creswell’s (1998) proposition of a 
range of five to twenty-five participants and Bertaux (1981) suggest a minimum of fifteen 
participants for a qualitative study.  
Recruitment of Participants  
 African Americans are historically difficult to recruit for research studies; 
methods of recruitment that appeal to white participants are not necessarily effective for 
recruitment of Blacks (Ballard, Nash, Raiford, & Harrell, 1993; Yancey, Ortega, & 
Kumanyika, 2006). Many cite the lack of knowledge about research, mistrust of 
researchers, fear of being exploited, and the abhorrent practices in the Tuskegee Syphilis 
Study as significant barriers to participation (Freimuth, Quinn, Thomas, Cole, Zook & 
Duncan, 2001; Yancey et al., 2006). The Tuskegee Syphilis Study, which intentionally 
chose not to treat syphilis in African American males from 1932-1972, was the longest 
therapeutic clinical study in history and has been pivotal to provide impetus for 
increasing human subjects protections in research. African Americans are most likely to 
cite the Tuskegee study as the research event that creates suspicion about researchers’ 
intentions and creates mistrust of the entire process (El-Sadr & Capps, 1992; Freimuth et 
al., 2001).  
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 Overcoming these understandable barriers to participation requires time on the 
part of the researchers who must answer questions, build trust, and acknowledge the 
atrocities of the past research with people of color (El-Sadr & Capps, 1992; Freimuth et 
al., 2001; Yancey et al., 2006). Even though this study is not clinical research, 
recruitment was challenging; potential participants may not understand the difference 
between social science research and other studies placing all researchers under suspicion. 
Face to face meetings with gatekeepers (e.g. ministers, BNA administrators, housing 
directors) was vital to building trust and having access to participants who meet the 
inclusion criteria. It was imperative to clearly explain the study and how others may 
benefit from the participants’ experiences. Potential participants needed to understand 
their rights and the researcher was committed to taking adequate time to clearly explain 
informed consent. In fact, after participants reviewed the Informed Consent, the 
researcher reviewed the highlights with participants to ensure understanding of their 
rights. 
 Horowitz, Brenner, Lachapelle, Amara, and Arniella (2009) suggest one of the 
strongest strategies for recruiting more people of color for research studies is the 
partnership of academic personnel with the community. Therefore, the researcher spent a 
great deal of time working through community-based organizations such as churches, the 
Black Nurses Association (BNA), and other African American organizations concerned 
with health. Furthermore, the researcher intentionally participated in events hosted by the 
African American community (e.g. health fairs, lectures, celebrations, women’s expos). 
 Moreover, the researcher made appointments with African American leaders to 
answer questions about the research study and obtain “buy in”. These leaders included 
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pastors, respected medical professionals, directors of predominantly Black senior housing 
residences, Black media personnel, and others within the business community. It was 
important to meet the leaders where they were comfortable and allow them to set the 
agenda with freedom to ask whatever questions they wanted and share their concerns 
openly. In a phone call with a prominent African American leader, the researcher 
revealed that she is white and the leader declared, “I don’t care what color you are! If you 
want to help us, you’re all right with me.”  
 Openness and transparency were instrumental to building trust and credibility.  
As appropriate, the researcher provided written materials including those concerning the 
research center and those specific to the study including screening questions, focus group 
and interview questions, flyers, and a 2-page summary of the study. Moreover, leaders 
were offered electronic copies of all materials to forward to others in the community.  
The researcher was especially encouraged whenever she was at an event where 
community members approached her to ask about the progress of the study.  
 Once entrance into the community was granted, attending a variety of events and 
building rapport with individuals before introducing the study was paramount. Often, the 
researcher attended an event, such as a health fair, and provided diabetes-related 
information, which could lead to a discussion about the study. It was not uncommon to 
interact numerous times with a person before the individual disclosed he or she had 
diabetes.  
Theoretical Perspectives in Data Collection 
 From the social constructivist worldview, the goal of research is to seek to 
understand the participant view of the phenomena (Creswell & Clark, 2011) In this 
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particular study, the researcher sought to collect and analyze the shared cultural 
experiences of African Americans with diabetes. Creswell and Clark (2011) suggest 
social constructivism is a result of co-creating the subjective meaning, both socially and 
historically. Therefore, the data was analyzed and description was provided from the 
African American perspective (Creswell & Clark, 2011). To facilitate this process, 
probing questions assisted in constructing shared definitions by the community 
concerning responses to semi-structured questions. Moreover, African American 
community partners vetted the questions and asked to provide further illumination of 
cultural interpretations to increase understanding of concepts expressed by participants. 
 The researcher used the lens of resiliency theory to uncover mechanisms that lead 
to adherence to diabetes medication(s). The findings were shared with culturally 
grounded organizations and community members as a means of confirmability; these 
community partners are invested in the health and well-being of African Americans. 
Thus, the strength inherent in triangulation of data was achieved through focus groups, 
individual interviews, and reviewing findings with culturally grounded community 
members (See Figure 9).  
 
Figure 9. Triangulation of Qualitative Data 
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The resiliency conceptual framework created a structure for investigating 
protective mechanisms within four domains: the individual, the family, the community, 
and the broader society (Hill, 2007). To assist in identifying mechanisms associated with 
resilience, the concepts of competence, adversity, asset, and risk (Yates & Masten, 2004) 
were incorporated into the questions that guided discussion in both the focus groups and 
individual interviews (Appendix C).   
Community-Based Participatory Research Approach 
A Community–Based Participatory Research (CBPR) approach to the research 
study was utilized.  Cornwall and Jewkes (1995) suggest CBPR is not a specific 
methodology, but “the attitudes of researchers, which in turn determine how, by and for 
whom research is conceptualized and conducted [and] the corresponding location of 
power at every stage of the research process” (p. 1667).  Therefore, the researcher views 
CPBR as research that involves the community of interest at every stage of the research 
study and seeks to learn from the community how they perceive the question of interest 
and how the question can best be answered from within the community. 
This study originated from within the African American community.  While 
providing diabetes education in a hospital setting at the community level, the researcher 
had multiple opportunities to interact with African Americans taking prescription 
diabetes medication(s). The struggles and strategies related to adherence to diabetes 
medications were a topic of interest to many Black patients. Currently, the researcher 
provides information and support to African Americans with diabetes through her work 
with the American Diabetes Association’s community outreaches.  Medication adherence 
remains a consistent theme for discussion. Furthermore, the researcher continues to 
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interact with health professionals who are involved in promoting healthier outcomes for 
African Americans with diabetes and they have expressed concern about improving 
medication adherence.  
In this study, having important partners within the African American community 
was invaluable. Moreover, African American community partners vetted the focus group 
questions, strategies for focus group formation, and assisted with strategies for 
recruitment of participants. In addition, presentation of the findings was made to 
community partners as a means of confirmability of these findings. Therefore, medication 
adherence for African Americans with diabetes was based in the community and 
continues to involve the community in the entire research and dissemination process.  
 The researcher is not a member of the African American community and built 
rapport and trust within the community.  Thus, extra care was taken by the researcher to 
be culturally sensitive; she asked probing questions to determine the meaning of an 
answer or concept from the African American perspective. The researcher visited 
communities that expressed interest in partnering in the research project numerous times 
and engaged support of partners within the African American community before 
conducting research. Efforts were made to build positive relationships with members of 
the African American community who have a stake in the research. Sharing findings with 
participants, culturally-grounded organizations, and community partners was done, as 
appropriate, taking care to achieve accessibility both physically and intellectually to 
community partners as was relevant to their needs and concerns (Minkler, 2004).  
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The Role of the Researcher 
 The role of the researcher in interviews and focus groups was one of facilitator 
and instrument (Creswell & Clark, 2011). Morgan and Krueger (1993) suggest competent 
group leadership can alleviate pressures of social status by emphasizing the goal of 
finding out as much as possible about participants’ experiences and feelings on a given 
topic. Moreover, the facilitator/interviewer sought to create an open and accepting 
atmosphere in which each person had the freedom to share her or his point of view. 
Furthermore, while the researcher has extensive personal experience in managing 
diabetes, she does not assume that her experience is relevant for other people with 
diabetes.  
 The researcher is aware that the insider perspective in being a person with 
diabetes coupled with an outsider perspective of being white in a Black community poses 
both strengths and challenges. Moreover, gender differences created potential challenges. 
For example, when interviewing men, the outsider perspective was salient, as men were 
sometimes reticent to discuss this personal topic with a woman who was not known to 
them.  
 The decision to divulge the researcher’s diabetes diagnosis was one made on an 
individual basis, as it could create additional barriers to information gathering or rapport, 
depending upon the individual being interviewed. For example, one man was not 
informed about the researcher’s diabetes diagnosis at the onset of the interview and was 
guarded in his answers until the researcher shared this information with him; the 
interview proceeded with increased rapport and more detailed sharing from that point 
forward.  However, the contrary was also observed, as informants would assume the 
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researcher already understood a particular concept or strategy because the researcher 
shared the diabetes diagnosis.  
 As a person with diabetes, the researcher was able to understand the difficulties of 
managing diabetes and probe for examples; however, she had to bracket her own 
experience in order to hear and understand the experiences of others. The researcher took 
care not to share her opinions, either verbally or non-verbally, with participants. While 
conducting the focus groups, the researcher intentionally engaged in bracketing to allow 
members of the focus group to answer questions according to their own definitions, 
sharing their experience without imposing the researcher’s views (Creswell & Clark, 
2011).   
 Moreover, it was important for the researcher to engage in reflexivity to consider 
how her ethnicity, gender, perspective, and personal experience of living with diabetes 
could influence the research and interpretation (Padgett, 2008). She engaged in 
documenting observations and feelings shortly after focus groups and interviews as a 
means of reflexivity and increasing self-awareness.  
Human Subjects’ Protection 
 
 All researchers involved in the study must verify completion of human subjects 
training within the past three years.  The researcher received approval from Arizona State 
University’s Internal Review Board (IRB) before conducting research (Appendix A). In 
addition, the researcher went through the process to be an Adjunct Research Associate 
(ARA) at Maricopa Integrated Health System (MIHS) and obtained a separate IRB 
approval from them (Appendix G). The primary mission of the IRB is to protect human  
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subjects; therefore, this process further reduced the possibility of harm for research 
participants.  
 The research study participants included adults who self-identified as African 
American, are diagnosed with Type 2 diabetes, and are adherent with their diabetes 
medication(s). Participation in focus groups and individual interviews was voluntary and 
the process of information letters or informed consent was thoroughly explained to all 
people who agree to participate in focus groups and interviews recruited through MIHS 
(Appendix H and I) and through other means (Appendix E and F). If the participant did 
not wish to be audio recorded, the researchers took detailed notes instead. Participants 
could decide not to participate at any point without penalty. Participants received a gift 
bag worth approximately $25 donated by a local pharmacy chain.  
	   The researcher honored confidentiality regarding all information shared in both 
focus groups and interviews. With focus groups, there is no assumption of 
confidentiality, as the researcher could not force others who are in the focus group to 
maintain confidentiality. However, with individual interviews, the researcher took 
reasonable precautions to protect the identity of the participant and maintain 
confidentiality regarding content. There were minimal risks to the participants as they 
were free to share whatever they were comfortable sharing; however, it is always possible 
that some may feel a degree of discomfort when sharing a particularly personal story.  
Sampling  
 The qualitative research design collected data through three gendered focus 
groups with adults who self-identify as African American or Black. Additional inclusion 
criteria included (1) diagnosed with Type 2 diabetes; (2) currently on insulin therapy; and 
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(3) adherent to their medication(s) as assessed by four questions in the Simplified 
Medication Adherence Questionnaire (SMAQ) (Knobel et al., 2002;  
Moritsky et al., 1986).  
 The decision to use only those who are taking insulin limited the pool of potential 
participants as only 26% of those with diabetes are prescribed insulin (CDC, 2014); 
however, this decision allowed the richness of understanding the process of adherence to 
both OHAs and transitioning to insulin therapy.  Diabetes is progressive; therefore, some 
people with diabetes who were able to obtain adequate glucose control with OHAs may 
require insulin over time (ADA, 2014).  
 Moreover, social determinants are related to health disparities; therefore, 
participants were asked about highest education level, category of income, and insurance 
status (Barr, 2008; WHO, 2010). This information was used to stratify sampling for 
individual interviews to represent a wider variety of income levels, educational 
attainment, and access to health care for participants.  
 Participants were recruited through gatekeepers who are well acquainted with the 
African American community. Flyers were distributed at community events and places 
that may attract the population of interest, as well as through email lists held by various 
organizations. In addition, the recruiter attended a number of community events  
(e.g. health fairs, bingo games, church services, women’s expos) to recruit participants.  
A total of 35 people screened as eligible for the study and 23 agreed to participate. 
Primarily, participants were recruited from area Black churches (43%) and a healthcare 
center (30%) (Table 1). Only one woman contacted the recruiter as a result of receiving 
an email about the study; the remaining participants had contact with either a healthcare 
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worker, trusted acquaintance, or the researcher before being screened and participating in 
the study.  
Table 1. Recruitment of Participants 
How/where recruited Women Men All 
Church 6 4 10 
Healthcare center 4 3 7 
Friend referral 2 2 4 
Media email 1 0 1 
Community event 0 1 1 
Total 13 10 23 
  
The researcher conducted the screening in three ways when contacted by an interested 
person: 1) in person; 2) over the telephone; or 3) by emailing a screening form. Once 
someone was determined to be eligible for inclusion, contact information was obtained 
and the person was invited to be a part of the focus group. If the person was unable to 
attend the focus group or preferred an individual interview, he or she was scheduled to 
participate in an interview at their convenience. Participants could not participate in both 
the focus group and the individual interviews. 
 The researcher sought variation on the demographics known to be associated with 
health disparities including education level, income, and access to healthcare. Sites for 
data collection were chosen based upon convenience for participants (Table 2).  
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Table 2. Focus Groups and Interviews Sites 
Site Women Men All 
Individual Interviews 
Church 0 1 1 
Community Center 1 1 2 
Home 2 1 3 
Public Library 2 3 5 
Medical Facility 2 0 2 
Office/Work 1 1 2 
Focus Groups 
Church Weekend Day 2 2 4 
Church Weekday Evening 2 0 2 
 
Data Gathering Methods 
Focus Groups 
 Data collection was conducted from August 2013 through September 2014. The 
focus groups included one men’s group and two women’s groups of two participants 
each. All focus groups were conducted at churches.  
 Focus groups do not carry the assumption of confidentiality, as the researcher 
cannot control what participants may share with others after the focus group discussion 
concludes and this was made clear in the informed consent (Berg, 2009). Informed 
consents were reviewed and given to all participants (Appendix E and Appendix I). In 
addition, a short questionnaire asking about length of time since diabetes diagnosis, 
insurance coverage, transportation to medical appointments, educational level, 
categorical income, and basic demographic information (e.g. gender, age) was 
administered prior to the focus group (Appendix B). The researcher provided light 
refreshments and participants recruited after gift bags were donated received them; 
otherwise, no compensation was provided.  
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  “Focus groups may be best conceptualized as a research site, not a research 
instrument—a place where we can observe the processes of social interaction” 
(Hollander, 2004, p. 631). Krueger and Casey (2000) suggest, “The intent of focus groups 
is to promote self-disclosure among participants. We want to know what people really 
think and feel” (p. 8). Moreover, Hollander (2004) suggests a focus group is a specific 
social context in which members develop interpersonal relationships, which affect 
presentation of self; thus, gendering was an avenue to create a more comfortable setting 
for openness for participants. Furthermore, community partners suggested there may be 
differences in protective mechanisms, processes, or strategies used by men versus 
women; therefore, three gendered focus groups were conducted - one for men and two for 
women.  
The focus group interviews were semi-structured with questions created using 
resiliency theory and an ecological perspective as a guide (Appendix C), remaining broad 
and general, allowing for variation in response and preventing leading of the informants 
(Creswell & Clark, 2011). The minimal structure of the questions allowed for the 
flexibility to explore unexpected responses, personal stories, and lines of discussion. 
Open-ended questions generated discussion and sharing of stories about the informants’ 
experiences with diabetes. Responses were repeated and summarized periodically to help 
participants to decide if there is anything missing from the discussion. 
 The researcher utilized focus groups to explore participants’ experiences in an 
interactive format (Lambert & Loiselle, 2008). Moreover, focus groups were particularly 
useful at uncovering macro level data, while individual interviews better illuminated 
more proximal, micro level data (Lambert & Loiselle, 2008). The primary goal of the 
 63 
focus groups was to use interaction data resulting from discussion among participants to 
enhance the richness of data about aspects of the phenomenon that may be otherwise less 
accessible (Lambert & Loiselle, 2008). Focus group interactions served to accentuate 
participants’ similarities and differences and provide information about the range of 
perspectives and experiences (Berg, 2009; Lambert & Loiselle, 2008). 
 Focus groups tend to be high in external validity as compared with other methods 
as they can mirror the typical conversations of participants (Hollander, 2004). Therefore, 
when forming focus groups, context was an important consideration. Understanding who 
has power and how that power may affect the discussion were imperative for optimal 
participation. The 90-minute focus groups drew upon the synergy of members, as 
participants responded to the comments of others in the group in addition to questions 
from the researcher (Berg, 2009).   
 The researcher reflected on Stevens (1996) analytical questions used to identify 
the nature of group interactions. These include: “How closely did the group adhere to the 
issues presented for discussion? Why, how, and when were related issues brought up? 
What statements seemed to evoke conflict?” (p. 172). These questions were discussed 
and answers were documented as part of the reflexive de-briefing process by the 
facilitator and co-facilitator. 
 The focus groups were viewed as a “site for analyzing the collaborative 
construction of meaning” (Hollander, 2004, p. 632). A social constructionist perspective 
suggests that people do not have stable underlying attitudes and opinions; rather, cultural 
norms and beliefs are constructed through the process of social interaction (Creswell & 
Clark, 2011). In this view, issues related to conformity, groupthink, and social 
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desirability do not obscure the data; instead, they become an integral part of the data 
because they are important elements of interaction within the African American 
community (Hollander, 2004). 
Individual Interviews 
 Participants in focus groups were not considered for individual interviews. 
Recruitment for individual interviews used the same inclusion criteria used for the focus 
groups.  Participants obtained through MIHS were provided with informed consent 
signed by both the participant and the researcher (Appendix H). Information letters per 
ASU IRB approval were reviewed and given to all other participants (Appendix F).  The 
same questionnaire requesting personal information related to demographics and caring 
for diabetes was administered (Appendix B). The semi-structured interviews were 
conducted in quiet, private spaces. The settings included a room at a library, the 
participant’s home, community centers, an office at MIHS, and the participant’s place of 
work; it was important that the participant was in an environment that was comfortable 
for him or her. The interview elicited in-depth experiences from the participant and the 
interview lasted approximately one hour. A similar recruitment strategy was used and 
participants recruited after gift bags from a retail pharmacy were donated received them.   
 Focus groups and individual interviews were independent data collection 
methods; however, combining the data gathered provided corresponding views of the 
phenomenon of interest and enhanced description of the mechanisms that lead to 
adherence  (Lambert & Loiselle, 2008). Integration of focus group and interview data 
involved an iterative process of uncovering data convergence and divergence  
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(Lambert & Loiselle, 2008). As themes emerged from the analysis of the focus group 
data, interview data was integrated into the overall analysis, producing a more complete 
picture.  
 There are two primary rationales for the combination of focus groups and 
individual interviews: (1) practical reasons, which provide alternative formats for 
gathering information to accommodate participants and (2) an integrated use, which 
strives to achieve data completeness and confirmation of findings (Lambert & Loiselle, 
2008). Integration of focus group and individual interview data provided value through 
an iterative process whereby an initial model informed the guided exploration of group 
accounts and individual data further illuminated broad conceptualization of the 
phenomenon (Lambert & Loiselle, 2008). After analysis, the preliminary findings were 
shared with culturally-grounded community partners. Moreover, the convergence of core 
concepts of the phenomenon across focus groups, individual interviews, and vetting 
findings with community partners served to enhance the trustworthiness of findings 
(Lambert & Loiselle, 2008).  
Content Analysis 
 As little is known about diabetes medication adherence in African Americans 
with diabetes, the theoretical lens of resiliency, guided content analysis.  In addition, the 
study sought to understand cultural influences related to diabetes medication adherence 
and diabetes management; therefore the analysis utilized a social constructivist 
perspective. An assumption of social constructivism is that there is no one reality; various 
degrees of subjective interpretations can be applied to the same content  
(Creswell & Clark, 2011; Graneheim & Lundman, 2003; Miles & Huberman, 1994). 
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Moreover, it was important to understand diabetes medication adherence from the 
particular perspectives of the individuals who are experiencing this phenomena  
(Creswell & Clark, 2011).  
 A comprehensive literature review informed potential mechanisms associated 
with medication adherence. Then, content analysis of the focus groups and interviews 
examined language patterns used, as well as the particular contexts in which 
communication occurred (Berg, 2009).  Furthermore, content analysis provided a coding 
and interpreting process, a detailed system of examining and interpreting data with the 
aim of identifying common patterns, themes, biases, and both manifest and latent 
meaning (Berg, 2009). Conventional content analysis involved the coding of categories 
derived inductively from the data for the purpose of generating resiliency based 
connections to the data (Berg, 2009).  
 The content analysis interpretive approach focused on both manifest content and 
latent content (Graneheim & Lundman, 2003). Manifest content refers to the more 
obvious, visible aspects of interpretation, whereas latent content involves interpreting the 
underlying meaning (Berg, 2009; Graneheim & Lundman, 2003;  
Miles & Huberman, 1994). Latent content analysis allowed for a deeper level of 
abstraction, a participant view of the phenomena going beyond the exact wording to 
interpreting what the informant intended to convey (Berg, 2009;  
Miles & Huberman, 1994). Moreover, a minimum of three independent examples to 
document the researchers’ interpretations served as confirmability of latent meaning 
(Berg, 2009).    
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Process of Data Analysis 
 The volume of data generated by this study necessitated the use of technology to 
assist in organization and interpretation. MAXQDA software was utilized to assist in the 
organization and coding of the focus group and interview data. Weitzman and Miles 
(1995) state, “There is no computer program that will ‘analyze’ your data…Computers 
don’t analyze data; people do” (p.10). MAXQDA software provided an organizational 
tool with the capacity to assist the researcher in coding, retrieving, and connecting data  
(Berg, 2009).   
 The value of deductive reasoning based on the theoretical perspective of 
resiliency, ecological systems, and culture must be acknowledged; however, the 
researcher primarily employed an inductive approach to the data, allowing the 
presentation of the African American perspective to emerge from the data, while still 
facilitating the grounding of categories to the data (Berg, 2009).  
 Open coding, an inductive method of coding, served to open inquiry (Berg, 2009). 
Strauss (1987) suggests four primary guidelines when conducting open coding:  
 (1) ask the data a specific and consistent set of questions; (2) analyze the data 
 minutely; (3) frequently interrupt the coding to write a theoretical note; and (4) 
 never assume the analytic relevance of any traditional variable such as age, sex, 
 social class, and so forth until the data show it to be relevant. (p. 30) 
 
Furthermore, Berg (2009) suggests viewing coding as a funnel; the process begins with a 
broad statement, and progressively narrows the statement with substantiated rationale 
until the small end of the funnel presents a refined conclusion. The ecological perspective 
provided a broad framework for coding, as the individual, family and friends, healthcare 
providers, and society became spheres for thinking about the content.  
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 The researcher engaged in data reduction and interpretation by listening to the 
recordings and reading the voluminous data collected in the focus groups and interviews 
multiple times, while taking apart the data in order to create a consolidated picture of the 
phenomena (Creswell, 1994). Moreover, the researcher focused on the research questions 
to avoid time spent on other questions of interest for future study. The process of content 
analysis is depicted in Figure 10. The units of analysis for this study were focus group 
transcripts and individual interview transcripts, field notes, and researcher memoing. Unit 
of analysis refers to the specific objects being studied (Graneheim & Lundman, 2003); in 
this case, each transcript became a separate unit of analysis.  
 
Figure 10. The Process of Content Analysis 
 From the unit of analysis a meaning unit, the assemblage of words, phrases or 
statements related to each other through a common content and context was derived 
(Graneheim & Lundman, 2003).  A code refers to the label given to a given meaning unit 
(Graneheim & Lundman, 2003). Coffey and Atkinson (1996) suggest, “codes are tools to 
think with” that allow the data to be thought about in novel ways; however, meaning will 
be kept in context in order to preserve fidelity in interpretation (p. 32). Codes were 
Unit of Analysis  
(Focus groups & 
interviews) 
Meaning Units  
(Coded related 
statements) 
Condensation  
(Core concepts 
abbreviated)  
Categories  
(Answers “What?”) 
Content Areas  
(Focus on issue of 
interest) 
Themes  
(Answers “How?”) 
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derived from literature. For example, support was coded according to who the informant 
identified as the one supporting the individual in medication adherence (e.g. spouse, 
friend, God, healthcare provider). 
 The next step in the analysis process included condensation, which is 
conceptualized as abbreviating while still maintaining the core concept  
(Graneheim & Lundman, 2003). The process of grouping condensed units under logical 
headings or abstraction includes the creation of codes, categories, and themes 
(Graneheim & Lundman, 2003). Open coding of categories was central to content 
analysis; a category is a cluster that shares commonality with other members of the same 
group (Graneheim & Lundman, 2003). Krippendorff (1980) suggests a category is used 
to answer the question of “What?” Categories were exhaustive and mutually exclusive 
meaning that no data was eliminated that was related to the category and no data was 
excluded simply because of an absence of an appropriate category (Berg, 2009; 
Krippendorff, 1980). The category provided a thread to connect the codes and was an 
expression of manifest content; categories were further divided into sub-categories 
(Graneheim & Lundman, 2003). Axial coding, which related categories with concepts, 
occurred after open coding and consisted of rigorous coding within one category  
(Strauss, 1987). 
 The specific domains are referred to as content areas since there was a focus on a 
particular issue of interest (Graneheim & Lundman, 2003). Content areas are portions of 
the text grounded in theoretical assumptions in existing literature or a section of text that 
addresses an uncovered topic (e.g. support). Finally, a theme refers to threads of meaning 
that recur in the content areas (Graneheim & Lundman, 2003). The theme answers the 
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question, “How?” (Graneheim & Lundman, 2003). Themes were expressions of latent  
content as they were examining the underlying meaning; themes were further divided into 
sub-themes, as necessary (Graneheim & Lundman, 2003). Themes may be gendered; for 
example, support was very different by gender, as “nagging” was interpreted as care and 
love to many men and it was interpreted as criticism to many women.  
 Moreover, representative quotes from participants were observed to cluster 
according to similar characteristics (e.g. gender, illness perception, support) through an 
iterative process  (Wachholz & Stuhr, 1999).  In addition, a procedure for identifying 
common classes to distinguish among and between persons was used. The categories 
were essential to ascertain whether certain demographic characteristics (e.g., gender, age, 
education level) were related to patterns observed in the data (Berg, 2009).  
Psychotherapy research refers to this process as qualitative cluster analysis (Wachholz & 
Stuhr, 1999).  This clustering was used to detect emerging typologies, which provided 
ways of identifying multiple pathways to medication adherence and the identification of 
four distinct typologies with at least three people in each group.  
Data Interpretation  
 The research question was central in the process of data interpretation, which 
entailed the development of ideas related to the data through the theoretical lens of 
resiliency (Berg, 2009). The goal was to illuminate and clarify how the perspectives of 
participants were related to the broader literature on medication adherence in African 
Americans. Berg (2009) suggests content analysis is a “passport to listening to the words 
of the text and understanding better the perspective(s) of the producer of these words”  
(p. 343). The process of data collection, data interpretation, data analysis, and writing the 
 71 
results were conducted simultaneously (Creswell, 1994). Negative case analysis was 
utilized to verify a given hypothesis (Berg, 2009). This strategy involved intentionally 
seeking to disconfirm a given hypothesis by exploring examples that challenge the 
hypothesis (Berg, 2009). For example, if the Black church were hypothesized to be an 
asset to resiliency, and evidence to the contrary (e.g. little or no support was identified by 
participants) then this would disconfirm the hypothesis.   
 The data were presented in matrices, visual displays of information that 
represented the data in a spatial format (Creswell, 1994; Miles & Huberman, 1984).  
The matrices display categories by participants and demographic characteristics. In 
addition, relationships between data were demonstrated in narrative and visual formats. 
This enabled clustering of themes, categories, and demographic similarities to be 
observed, as commonality within gendered groups were identified; thus, the fur emerging 
typologies became evident. 
Trustworthiness 
 Qualitative research uses the terms credibility, dependability, and transferability 
to describe aspects of trustworthiness. Credibility refers to assurance of how faithful the 
researcher(s) have been in the process of data analysis (Graneheim & Lundman, 2003). 
Credibility begins long before data has been collected; the researcher made decisions 
about the appropriate theoretical lens, selection of participants, recruitment protocols, and 
ethics in carrying out the research design, which all contribute to the credibility of the 
study (Berg, 2009; Creswell & Clark, 2011). Choosing diverse participants who had a 
unique perspective and could provide rich information about the phenomena under 
investigation was imperative to credibility.  
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 Moreover, credibility was derived from how well the categories and themes cover 
the data in that no relevant data were excluded as well as determining similarities and 
differences between categories (Berg, 2009; Graneheim & Lundman, 2003). The 
researcher created an audit trail that clearly delineated how decisions were made 
concerning categories and disagreements between coding (Creswell, 1994). 
Representative quotations from a minimum of three distinct participants were used to 
support the category or theme (Berg, 2009). The integration of the data collected from 
both focus groups and individual interviews served as a productive strategy to better 
understand the phenomenon and characteristics associated with resiliency in medication 
adherence. Since multiple realities exist for individuals, perfect agreement on category  
and thematic choices was not the goal; rather the goal was to create a consistent process 
used to label and sort data (Berg, 2009; Graneheim & Lundman, 2003).   
 Participants and other members of the African American community were asked 
to review the findings as a means of confirmability, or the degree that the findings can be 
corroborated by others within the cultural community (Berg, 2009; Graneheim & 
Lundman, 2003). This is consistent with a CBPR approach, which encourages engaging 
the community in the research at every level including sharing with the community what 
strategies and supports have been uncovered through the research process. Discussions 
concerning initial findings were held with individuals and pairs within the community to 
determine if the researcher was interpreting the data correctly. The cultural community 
partners often asked probing questions of the data. For example, one partner asked how 
long participants had been diagnosed with diabetes in order to better understand how time 
impacted the acceptance of the diagnosis and medication adherence. Moreover, 
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community cultural partners vetted the emerging typologies and were invited to provide 
descriptive names for these typologies. 
 Trustworthiness also includes the aspect of transferability, or the degree that the 
research can be extended or transferred to similar communities  
(Graneheim & Lundman, 2003). A detailed description of the sample, including the 
demographics of interest, was necessary to determine for whom the findings are relevant 
in order to assess transferability. Choosing appropriate quotations from the text that 
represent the cultural and contextual characteristics of the sample enhanced 
transferability (Graneheim & Lundman, 2003). Ultimately, the reader will decide if the 
results are applicable to broader populations outside of African Americans living in the 
Southwest. 
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Chapter 4 
RESULTS 
 This study is guided by the broad research question, “What mechanisms are 
associated with adherence to diabetes medication(s), including insulin, for African 
Americans?” This research question is operationalized through two primary aims: 
  Aim 1: To examine what individual and broader environmental mechanisms 
 are associated with adherence to diabetes medication(s) for adult African 
 Americans with Type 2 diabetes.  
 Aim 2: To identify internal and external factors that enable African Americans 
 with diabetes to go beyond adherence and to develop a broader understanding of 
 the disease and how to manage it. 
Rutter and Sroufe (2000) suggest, “mechanisms involved in causation might 
entail dynamic processes operating over time, that indirect chain effects might often be 
present, and that there might be several different routes to the same outcome” (p. 268). 
As much as possible, a discussion of context and process will be included to provide a 
deeper understanding of the findings from the focus groups and interviews.  
Participant Demographics  
 Twenty-three people participated in focus groups and interviews. There were 17 
participants in individual interviews and six participants in gendered focus groups. The 
sample was diverse in demographics including age (36-80 years), income, education, and 
marital status with men being more likely to be married than women. Furthermore, 
diabetes-related information confirms the majority of informants (83%) participated in 
DSME at least once. There was variation in insurance coverage with most participants 
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having AHCCCS (8), Commercial (7), or Medicare (6).  Other demographics of the 
sample varied considerably by gender.   
 There were a total of thirteen female participants; nine participated in individual 
interviews and two women were in each of two focus groups (Table 3).  The mean age 
was 59.35 with a range of 36-79 years. Five women were married. Most participants 
completed college (8).  Most women in the study had family income of $50,000 or less 
(11).   
 
Table 3. Female Participant Demographics 
*Participa
nt **Age 
Highest Education 
Completed 
Family Income 
Category Marital Status 
Gina 36 College >$75,000 Married 
Julia 45 High School <$25,000 Single 
Carrie 53 College $25,000-$50,000 Single 
Laura 56 High School >$25,000 Married 
Marie 60 High School >$25,000 Single 
Vanessa 62 College $25,000-$50,000 Married 
Alice 64 College $25,000-$50,000 Single 
Lucy 70 <High School <$25,000 Single 
Annie 79 College <$25,000 Single 
Focus Group Participants 
Renee 43 High School <$25,000 Single 
Jeannie 77 College $50,000-$75,000 Married 
     
Monica 55 College <$25,000 Single 
Gloria 64 College $25,000-$50,000 Married 
*Pseudonyms were given to protect confidentiality 
**Age at time of interview/focus group 
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 There were a total of ten male participants; eight participated in individual 
interviews and two men were in the focus group (Table 4).  The mean age was 
approximately 58.9 with a range of 38-80 years. Most men were married and half of 
participants completed college.  Half of participants had a family income of $50,000 or 
less.  
Table 4. Male Participant Demographics 
*Participant **Age 
Highest Education 
Completed 
Family Income 
Category Marital Status 
Bret 52 College $50,00-$75,000 Married 
Anthony 55 High School <$25,000 Single 
Fred 72 High School $50,00-$75,000 Married 
Greg 40-50 College No answer Married 
Denzel 55 College <$25,000 Single 
Andrew 57 <High School <$25,000 Single 
Harry 60 College >$75,000 Married 
Charlie 80 High School $25,000-$50,000 Married 
Focus Group Participants 
Jack 38 High School <$25,000 Married 
Ernie 61 College >$75,000 Single 
*Pseudonyms were given to protect confidentiality 
**Age at time of interview/focus group 
 
 Female participants reported mean time since diagnosis of diabetes as 19.5 years 
with a range of 5-35 years (Table 5). Moreover, women were diagnosed with diabetes at 
an average of 41.4 years old; most were between 33-54 years old at diagnosis. The 
majority of women reported no diabetes-related complications. Furthermore, the majority 
of women participated in a diabetes self-management education program (DSME) at 
some point since diagnosis. One woman, Alice, had no insurance coverage. Four women 
were on Arizona Health Care Cost Containment System (AHCCCS), which is Arizona’s 
Medicaid program. Four women received commercial medical insurance through their 
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employer and four women were on Medicare. Female participants overwhelmingly chose 
to get prescriptions filled at the pharmacy; the exceptions were Vanessa whose husband 
took care of ordering medication for her and had it delivered by mail and Gina who got  
most prescriptions filled at a retail pharmacy and one medication through a mail order 
pharmacy.  
Table 5. Female Participant Diabetes-related Information 
*Name 
Age at 
diagnosis 
Years 
of diabetes 
Medication 
Type DSME Complications Insurance 
Prescription 
Acquisition 
Gina 30 6 Insulin & OHA Yes No Commercial Both** 
Julia 38 7 Insulin & OHA No Yes AHCCCS Pharmacy 
Carrie 48 5 Insulin & OHA No Yes AHCCCS Pharmacy 
Laura 21 35 Insulin only Yes No AHCCCS Pharmacy 
Marie 38 22 Insulin only Yes Yes AHCCCS Pharmacy 
Vanessa 50 12 Insulin & OHA Yes No Commercial Mail Order 
Alice 42 22 Insulin & OHA Yes No None  Pharmacy 
Lucy 54 16 Insulin only Yes Yes Medicare Pharmacy 
Annie 53 26 Insulin only Yes No Medicare Pharmacy 
Focus Group Participants 
Renee 24 19 Insulin & OHA Yes Yes Medicare Pharmacy 
Jeannie 72 5 Insulin & OHA Yes No Medicare Pharmacy 
        
Monica 33 22 Insulin & OHA Yes No Commercial Pharmacy 
Gloria 35 29 Insulin & OHA Yes Yes Commercial Pharmacy 
*Pseudonyms were given to protect confidentiality 
DSME=Diabetes Self-Management Education 
AHCCCS= Arizona Health Care Cost Containment System 
**Both=Retail pharmacy and mail order  
 
 Male participants reported mean time since diabetes diagnosis as 15.4 years with 
a range of 2-26 years (Table 6). Moreover, age at which men were diagnosed was an 
average of 43.6 years old; range of 32-57 years old at diagnosis. Participants were evenly 
divided in the type of diabetes medication they took; half took insulin only and the other 
half took both insulin and OHAs.  Most men reported no diabetes-related complications 
and the majority of men participated in DSME one or more times since diagnosis. Four 
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men received care through AHCCCS, three men received commercial medical insurance 
through their employer, two men received healthcare benefits through Medicare, and one 
man received military health benefits through Tricare. Prescription acquisition was 
primarily through pharmacies, with three men using the mail order option. 
Table 6. Male Participant Diabetes-related Information 
*Name 
Age at 
diagnosi
s 
Years 
of diabetes 
Medication 
Type DSME Complications Insurance 
Prescription 
Acquisition 
Bret 38 14 Insulin only Yes No Commercial Pharmacy 
Anthony 32 23 Insulin only No Yes AHCCCS Pharmacy 
Fred 57 15 Insulin only Yes No Medicare Pharmacy 
Greg 26-36 14 Insulin & OHA No Yes Commercial Pharmacy 
Denzel 38 17 Insulin & OHA Yes Yes AHCCCS Pharmacy 
Andrew 55 2 Insulin & OHA Yes No AHCCCS Pharmacy 
Harry 45 15 Insulin & OHA Yes No Tricare Mail Order 
Charlie 54 26 Insulin only Yes No Medicare Mail Order 
Focus Group Participants 
Jack 35 3 Insulin & OHA No No AHCCCS Mail Order 
Ernie 46 15 Insulin only Yes No Commercial Pharmacy 
*Pseudonyms were given to protect confidentiality 
DSME=Diabetes Self-Management Education 
 
Categories and Themes 
 Furthermore, it is important to note that all participants were screened based upon 
adherence to diabetes medication and not necessarily adherent in all areas of diabetes 
self-management (e.g. diet, activity, blood glucose monitoring). In fact, very few 
participants reported being adherent with all facets of diabetes self-management. Many 
admitted to having difficulty eating a healthy diet and many reported not engaging in 
enough physical activity. Concerning consistency in taking her medication, Vanessa 
summarizes the thoughts of those who take their diabetes medication and struggle with 
changing lifestyle habits, “At least I'm doing one thing right!”  
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 Ecological systems and resiliency lenses provided a theoretical framework for 
viewing data to examine individual and broader mechanisms associated with diabetes 
medication adherence in this population. Data were approached by open coding meaning 
units that were condensed and categorized and working toward more specific themes 
(Table 7). Condensation revealed the broad areas discussed while further investigation 
saw emerging categories and themes within these condensed areas.  
Table 7. Categories and Themes Derived from Data 
Illness Perception • Sense of stigmatization within community 
• Acceptance of diagnosis 
• Awareness of seriousness of diabetes 
• Conceptualization of diabetes  
• Personal locus of control and empowerment 
  
Support • Family and friends 
• God 
• HCPs  
• Insurance 
  
Process of Medication 
Adherence 
1. Seeing a HCP 
2. HCP writes prescription 
3. Pharmacy fills prescription 
4. Pick up prescription 
5. Understand dosing instructions 
6. Follow dosing instructions 
7. Overcome fears and side effects 
8. Repeat process when new prescription needed 
  
 The major themes discussed will include illness perception, support, and the 
process of medication adherence. Illness perception will include stigmatization, 
acceptance of diabetes diagnosis and awareness of the seriousness of diabetes. Major  
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sources of support included family and friends, God, HCPs, and insurance. Furthermore,  
four gendered emerging typologies were identified, which may further illuminate major 
themes. 
“Diabetes is One of those Stigmas” (Harry) 
 People who do not have diabetes often do not perceive diabetes to be a 
stigmatized condition; however, many of the people with diabetes in this study reported 
feeling judgment, shame, and unwanted interference in their lives. A seminal author in 
the conceptualization of stigma, Goffman (1963) defines stigma as an "attribute that is 
deeply discrediting and that reduces the bearer from a whole and usual person to a tainted 
discounted one" (p. 3). Link and Phelan (2001) further describe stigma as the “occurrence 
of its components –labeling, stereotyping, separation, status loss- and further indicate that 
for stigmatization to occur, power must be exercised” (p. 363). Furthermore, many 
researchers suggest that stigmatization is capable of affecting the health and well-being of 
those who are stigmatized (Bock, 2012; Link & Phelan, 2001; Schabert, Browne, Mosely, 
& Speight, 2013). Bock (2012) suggests, “Stigmatizing storylines occur when 
stereotypical categories overdetermined individual identities” (p. 158). This can be heard 
in informant Jeannie’s comment, “Just don't drop me into that pot with everybody, you 
know.” She expressed determination to be treated as an individual and not stereotypically 
labeled as an obese diabetic.  
 A major challenge in recruitment for this study was the perception of diabetes-
related stigmatization in the African American community. Church health minsters, 
Black nurses, and others invested in the health of African Americans seldom knew 
someone who had diabetes, let alone someone who was taking insulin, which alludes to 
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the reluctance to discuss the prevalent diagnosis. Furthermore, many people in the 
community (e.g. church members, African American healthcare workers) were hesitant to 
invite people they knew had diabetes to participate because “I don’t want to get in their 
business.”  Discussions with HCPs about potential patients to participate in the research 
study often resulted in resistance.  For example, one primary care physician declared, 
“There aren’t any patients who are adherent.”  Prolonged engagement with an 
organization or group was necessary in order to build adequate rapport and trust enabling 
people with diabetes to feel safe volunteering to be screened for the study.  
 On one occasion, a Black woman in her 80s, who was well known to the 
researcher, approached and whispered, “I have diabetes if that will help.” She was not 
taking insulin; thus, she was not eligible for the study. On two occasions, the researcher 
presented the study to a professional organization concerned with African American 
health. Upon the conclusion of each presentation, several members of the group 
approached the researcher and declared, “I like your study. I just wish I knew someone 
with diabetes.”  
 Moreover, when asking community members about why an African American 
may not want to reveal he or she has diabetes, the common reply was related to revealing 
a “weakness” or “vulnerability”, and not wanting to be a “burden” or “looked down on”. 
These responses from the larger community suggest a loss of status associated with a 
diagnosis of diabetes. This sense of weakness associated with diabetes was salient, 
particularly for some women in the study. Another community partner expressed concern 
about the stigmatization of a medical diagnosis in the African American community, 
“When are we going to start talking about our medical conditions?”  
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 Many participants discussed telling their mothers about being diagnosed with 
diabetes and hearing for the first time about a family history of diabetes. Ernie discussed 
finding out his mother had diabetes, “I never knew, because I don't think she became a 
diabetic until she was about the age I am now, about 62 years old.” In talking about his 
own diagnosis, Ernie discovered a family history of diabetes, “And my grandmother, she 
[mother] told me, was a diabetic also, and I said, ‘I didn't know that.’” Julia discovered a 
family history of diabetes at a family gathering about a year after she was diagnosed, “I 
started hearing that everybody else had diabetes. I didn't know.”  She recalled the extent 
to which her family was diagnosed with diabetes, “My mom, and I have a cousin who's 
diabetic and her brother.” Vanessa recalled, “I know I started talking to Momma when I 
found out about it [diabetes] and maybe that's when I found out. I don't know that much 
about my family history.”  
 For most participants this discovery was a shock and they determined to tell their 
children about the extensive family history of diabetes. For example, Vanessa engaged in 
regular conversations about diabetes with her children. “We talk openly about it, and 
because I want my kids and the rest of my family to know that, sure, heredity plays a lot, 
but environmental factors I think weigh even heavier.” 
 Some informants were highly aware of obesity-related stigma, which often 
extended to a diagnosis of diabetes, suggesting that the judgment they experienced may 
be related to their size and their diabetes diagnosis. One women’s focus group discussed 
the impact of weight on how people, including medical professionals, treated them. 
Renee revealed: 
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It bugs me that they can look at me and tell [she has diabetes], because — I guess 
that's because the doctor who initially told me that's what she did, and it's like, 
what are you basing it on, you know?  I was downright offended! Well, you know 
what it was, and I'll be very honest with you. Because she said, when she was 
explaining it to me, she was saying because of my weight. 
 
When asked if medical professionals label or judge based on size, Jeannie added, “That's 
what I'm seeing now.  That is the way society works.”  Furthermore regarding negatively 
stereotyping those who are obese, Jeannie stated, “Then they [medical professionals] 
drop us all into the same pot, and that's what I'm getting from what she's [Renee] saying, 
you know.  Just don't drop me into that pot with everybody, you know.”  
 Even participants like Harry who were open and willing to talk about diabetes 
with others were keenly aware of the stigmatization of diabetes,  
There's nothing to be embarrassed about to being a diabetic.  Because I think in 
the African-American culture there are some stigmas to certain things, and, 
believe it or not, diabetes is one of those stigmas, and I don't know why, but it is. 
 
He goes on to posit why talking about diabetes is taboo within the African American 
community,  
I really don't know, because what diabetes is, I mean, it's not, you know, it's not 
one of those, I don't know, it's not an STD or anything like that.  You know what 
I'm saying? So it's just something that, you know, it's something that happens, so I 
just don't understand why folks don't like to talk about being diabetic.  I just don't 
— obviously I'm not one of those. 
 
 Charlie alludes to the stigma present in the African American community and his 
desire to be more open about talking with others, especially his family, about diabetes, 
“Well, the family, the children, all the kids know [about his diabetes diagnosis].  It never 
was something we were ashamed of.  It's a black man's disease.”  Charlie has been open 
with his family about his diabetes and encourages his sons to get checked.  
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 Gina suggested another reason for people being hesitant to divulge a diabetes 
diagnosis, “But I just think it's, like, the whole diabetes police coming out again and, like, 
monitoring you.” For her, this is not an issue; she viewed the additional attention as 
people caring about her.  
“I have to accept in order to live” (Alice) 
 From the very beginning, some informants accepted the diagnosis of diabetes and 
were adherent to medication, “I have no problems at all accepting my diabetes, because 
it's something I have to accept in order to live” (Alice, diagnosed 22 years ago). Bret 
summarized his attitude this way; “The whole is simply this for me.  I found out that I 
have Type 2 diabetes.  They gave me medication.  They said I must take it on a daily 
basis. I'm going to take this medication every day.” 
 Moreover, Bret understood the need to manage diabetes from watching other 
African Americans not take diabetes seriously,  
I understand that in my culture that many have diabetes, and they don't take it 
seriously.  I took it seriously from standpoint that they [physician] said, ‘Hey, this 
disease can cause you to go blind, heart attack, and it's a silent killer.’ You may 
not even know that you have it.  When you find out about it, it's too late. 
 
Bret engaged in prevention by having a physical twice a year. He believed this practice 
helped him to be diagnosed early and prevent complications from poor glucose control. 
Moreover, he quickly learned about diabetes self- management, “So I had to educate 
myself and get educated about diabetes.  So I read everything that I could possibly read 
about it, then I took control of my diet.” 
 Others reported denial and, thus, non-adherence to their medications after 
diagnosis.  “So I was in denial at first.  I don't have it [diabetes]” (Julia, diagnosed 7 years 
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ago).  In fact, Julia did not tell anyone except her mother about her diagnosis for about a 
year stating, “Why should I talk about it [diabetes]? I don’t got that, you know?” Julia’s 
initial blood test revealed an extremely high blood sugar of about 350 mg/dL; normal 
blood sugar would be below 100 mg/dL. She was given a prescription for oral 
hyperglycemic medication, “I didn't take it, because I was, I don't — this is not for me.”  
She explained, “I got it filled, but I didn't feel bad.  I felt fine, so I'm like what are they 
talking about?  I don't have no, you know, but then when I started getting, learning more 
about it.” After about a year, Julia discovered that many of her relatives have diabetes 
and some have experienced serious consequences from not adequately controlling blood 
sugar. She decided to tell them she has diabetes as well. At this point, she began to take 
her medication regularly, “I have to. I have to.”  
 Renee (diagnosed 19 years ago) was initially in denial, “I figured that it [diabetes] 
would go away.  I did.  I figured it would go away, because I'm Renee, you know.” Renee 
was forced to tell people about the diagnosis; however, she struggled with accepting the 
diagnosis stating it took her 6 months to a year to accept she had diabetes.  
I really didn't take it seriously when they first gave me the medication, because, 
like I said, they were giving me 2 mg of Amaryl, and I'm like, so you want me to 
take this little itty bitty little pill and cut it in half?  Darn diabetes! Leave me 
alone.  Why are you messing with me, you know? 
 
Moreover, she minimized the seriousness of the diagnosis, “I thought, you know, it was 
as if to say taking just half of a teeny tiny pill it can't be that serious. I didn't think my 
condition was as serious, you know.” Through a process of learning more about diabetes, 
she accepted the diagnosis and now states, “Now it's just old hat to me.” 
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 Jack was diagnosed with diabetes three years ago and initially struggled with 
taking diabetes medication. He had a desire to go “back to being normal without having 
to live my life to take a pill every day or to get a shot every day.” He goes on to reflect, 
“It [taking medication] used to be a downer, like, okay now I've got to take that.  I've got 
to get up and take this medication.” He still hopes to “beat it [diabetes]” and not have to  
take any medication to control his blood sugar, but is resigned that diabetes medication is 
necessary for him to be healthy at this point in time.    
 Other informants were adherent with their medication from the beginning. “I'm 
one of these people that believes what the doctor says … and if they say that I need the 
pills or the shot or whatever, I take it religiously” (Vanessa). Harry grasped the diagnosis 
of diabetes from the very beginning, “I've got to accept it and find out what do I need to 
do to control it now.  This is going to be a lifelong thing for me now, so I have to learn 
how to live my life having diabetes.”  
 The transition from taking OHAs to including insulin therapy presented additional 
challenges to medication adherence for many participants. For example, when Bret 
reflected on the conversation with his doctor about needing to take insulin, he recalled, 
“That was a rough conversation between me and my doctor.” Bret remembered the 
physician informed him that, “You're going to now be on Lantus [long-acting insulin], 
and you're going to have to stick yourself 20 units at night.” He shook his head in 
disbelief and stated, “I heard what she said. I don't think I comprehended what she said.” 
He clarified the need for insulin shots, “Is there anything else that you might have or 
something else that you can prescribe, because you're talking about literally poking me?” 
His doctor of fifteen years confirmed the need for insulin and suggested he try it for three 
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months. She confirmed the necessity of this treatment by telling Bret, “This is going to 
help you live.” Bret learned how to administer the pen injections before leaving the office 
and confirmed, “It [insulin] has helped me. Much better than I did when I was taking the 
pills.” 
 Denzel equated initiating insulin therapy with a terminal illness,  
 
It's almost like the doctor telling you, ‘We're going to have to send you to the 
hospice.’  This is that serious, you know, being on insulin.  And I thought, okay, 
they say you're on insulin the rest of your life. 
 
 Greg was somewhat fatalistic, “guaranteed the disease is going to progress.” Greg 
fears that if he does not take his diabetes medication, “You might develop new 
symptoms.” He goes on to state he fears even worse, “or indications, signs of the disease 
progressing.  So it may not be discernible to you immediately, but over time, if you do 
nothing, you're going to degrade.  Your condition is going to degrade.” 
 While some participants readily accepted the diabetes diagnosis, others were 
initially in denial and, therefore, did not see a need for taking their medication. The 
process of acceptance often involved an understanding of their family medical history 
concerning diabetes. Ultimately, acceptance of the diagnosis was instrumental for all 
informants when it came to taking their diabetes medication consistently.  Alice 
discussed her understanding of diabetes: 
You can't get rid of that [diabetes], and see, they tell you that.  They say once 
you're a diabetic, you are always a diabetic.  When you face that reality when 
someone tell you that you are a diabetic, you say, “Oh my God.  For the rest of 
my life I've got to be a diabetic?”  I've got to take medication. 
 
Alice confirms her need for diabetes medication, “You also look at the lab work and that 
helps you know that your meds are helping.” 
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Healthcare Providers: Pharmacists 
  
 While support from others (HCPs, family, friends) varied according to gender and 
personal preference, participants consistently reported the value of their pharmacist in 
diabetes medication adherence. When informants were asked how they obtain their 
medications, the vast majority stated they go to the pharmacy (83%) every month to pick 
up their prescriptions versus those who utilize mail order pharmacy services (17%). The 
sense from those who preferred to go to the local pharmacy was one of choosing control 
and engagement over convenience cited by mail order pharmacy proponents.  
 When asked if they have the option for mail order pharmacy, many people said 
they do have that option; however, their preference was to go to the pharmacy on a 
monthly basis anyway. The reasons for this choice fell into the following categories:  
1) they get refill reminders; 2) they have a beneficial professional relationship with their 
pharmacist; 3) it is part of their routine; 4) problem solving is easier in person; and 5) 
they could obtain free diabetes information. 
 Many participants were grateful for the automated reminders to get refills of their 
medication. This process was made a bit easier for them when they received a reminder 
notification and could call the pharmacy to order their medication.  
 Patients felt they benefitted from a relationship with their pharmacy personnel. 
For example, Ernie stated,  
Everybody in that dadgum store knows me… and if I go to another city — this 
has happened more than once — the pharmacy in the other city may not fill the 
prescription, and then I'll have them call my pharmacy, and they'll say, oh yeah, 
fill his prescription.  
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 Monica saw a benefit in a relationship with her pharmacist, “the pharmacist 
knows me, I just establish a rapport with them [pharmacy personnel], and I haven't had a 
problem.” Several informants spoke glowingly about their pharmacist. Carrie declared, “I 
love my pharmacist.  Lou's my guy!” Anthony looks forward to seeing his pharmacist, 
“I'm in a habit.  I'd just rather go down there and pick it [prescription] up, because I get a 
chance to see him [pharmacist] and talk to him and, you know.” Others spoke about 
obtaining specific information from their pharmacist that helped them take their 
medication or prevented a problem. For example, Carrie credits her pharmacist with 
preventing a serious drug interaction,  
He's, like, “you taking too many medications that will have an adverse reaction to 
this medication. So I'm going to call your doctor and let them know that I don't 
know why they prescribed this, but they need to prescribe something else, because 
you can't take this.”  So he really knows me.  He has my history since, like I said, 
since I've been diagnosed.  
 
Gloria related a similar encounter with her pharmacist, “He [pharmacist] says, ‘you 
know, it's not likely, but we don't want to push it, but based upon what you're taking, this 
medication is known to cause seizures.”  I was so grateful!”  
 Routine was cited as a reason to go to the pharmacy to obtain prescriptions even if 
they had a mail order option. Many people seemed to adopt the “if it is not broken, do not 
fix it” mentality. Anthony stated he had a mail order option, but he preferred to obtain his 
prescriptions from pharmacy across town, “I don't have no problems with them 
[pharmacy across town].”  
 Gina got most of her prescription medication from her local pharmacy, but 
obtained one through mail order. When asked why she does not get all of her 
prescriptions in one place, she replied, “So it's close, and I have to go there anyway to 
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pick up my son's prescription.” She simply never considered transferring all of her 
prescriptions to one source. 
 Others told stories about how their prescription medications were not correct and 
it was possible to fix the error in a timely manner when they were at the pharmacy; they 
could not imagine the difficulty if a mail order pharmacy were involved. Renee believed 
she can prevent mistakes with prescription refills by reconciling the order with the list on 
her phone before leaving the pharmacy, “well they [pharmacy personnel] bring it to me, 
and before they ring it up I go and check my list against what they have.”  
 Annie kept a spreadsheet of what medications cost and where she can purchase 
them for the least amount of out-of-pocket cost and shopped for lower prices at different 
pharmacies, “So I started getting it [one of her diabetes medications] at Store A, because 
if I get it at the regular drug store it's more expensive than at Store A.”  
 Many people enjoyed picking up the free health-related magazines and other 
written information while picking up their prescriptions. In addition to this form of 
information gathering, a few were even more assertive and posed questions to their 
pharmacist about diabetes management. For example, Carrie learned about the danger of 
getting scar tissue associated with giving her insulin shots in the same place from her 
pharmacist, “He said, don’t do it [insulin shot] in the same spot every day.  Alternate.   
Do it in your hips, stomach, arm, then go down, arm, stomach, hip, then go back again, 
hips…” Her doctor confirmed this information two months later.   
 Those who favored the mail order pharmacy cited the convenience of not having 
to be involved in the process of medication acquisition. Typically, the HCP called in the 
prescription and the mail order pharmacy took it from there; patients received their 
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medication in a few days. Insulin arrived in a cooler and no one in the study had a 
problem with getting tainted insulin. Harry believed obtaining his diabetes medication 
through mail order has helped him to be adherent, “Because before I started doing the 
mail order, I would have to go to the pharmacy, and sometimes I would forget and then 
I'd run out.”  
  While perception of stigma and acceptance of the diabetes diagnosis were 
common among all participants, other perceptions varied according to gender.  For 
example conceptualization of diabetes and, thus, orientation toward self-management 
differed according to gender and other demographic factors that clustered within 
emerging typologies.  Furthermore, support from others changed according to personal 
preferences and perceptions and personal definitions of support. For example, preferences 
and expectations for HCPs and the ensuing relationship with various HCPs differed 
according to gender and typology and were seen to be on a continuum from compliant to 
somewhat resistant at times. The explorations of these emerging typologies provides an 
avenue for discovering variations in mechanisms that result in medication adherence, as 
there are several paths to diabetes medication adherence. 
Gender: Emerging Typologies for Black Females 
 For Black women there were two distinct emerging typologies (Table 8). The 
“Alpha” females were mostly college-educated women who viewed themselves as 
“independent,” “strong,” and “self-sufficient.”   When Alpha women were asked about 
who helps them with their diabetes, many appeared confused by the question.  The first 
answer was usually, “my doctor” and, if pressed, some offered God as a support. These 
women had high expectations for their HCPs and told stories about being highly assertive 
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in their medical care. It was not unusual for Alpha women to talk about a doctor who was 
not “invested in my health” getting “fired.”  
 In contrast, “Networking” women had a support system that extended beyond 
HCPs and God to friends, family, and co-workers. These optimistic women welcomed 
the support of others and found it relatively easy to talk about their diabetes with other 
people. Their focus was on creating an increasing support system with healthcare 
professionals and others who could help them to manage diabetes and learn more. 
Table 8. Emerging Typologies for Diabetes Medication Adherent African American 
Women  
Alpha Women 
 Characteristic Representative Quote 
 
 
Alice 
Annie 
Carrie 
Gloria 
Renee 
Diabetes is a vulnerability or 
weakness 
Identify as strong, self-sufficient, 
independent 
Primarily college educated 
Low social support for diabetes 
management 
High expectations for HCPs 
“invested in my health” 
God is an important support 
“This is my healthcare, not theirs [doctors]. I have to 
be here, so you're not going to play with my 
healthcare!”  
“I get all my questions answered.” 
“We [sister and her] know something about it 
[diabetes], so why discuss it?”   
“I just don't want to talk about it [diabetes].  Bring it 
up for what?” 
 “I've learned that no one else can help you when you 
get into your own physical, emotional thing.” 
“What can man do to help me out?” 
“I'm a very religious person, and I go to God, you 
know, when I have really serious problems.” 
Networking Women 
Gina 
Lucy 
Marie 
Monica 
Vanessa 
 
Diabetes is a part of their lives 
Optimistic, amiable, focused on 
building rapport with others 
Feel “cared for” by their HCPs 
Extended support system (HCPs, 
God, friends, family, co-
workers) 
“Diabetes doesn't have me.” 
“I thank the Lord that He has doctors.” 
“I just establish a rapport, not only with my doctors, 
but with the pharmacist.” 
“I'm like an open book.  Anybody that wants to 
know.” 
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Alpha Women: “What can man do to help me?”   
 These strong, independent women were primarily single; the Alpha woman who 
was married described her relationship with her husband as somewhat distant. When 
speaking about diabetes, Alpha women expressed a sense of being invaded by an 
unwanted intruder. Carrie felt betrayed by her once healthy body, “How could my body 
reject my insulin?  What the heck?  So now, you talk about betrayal.  That was a big 
betrayal.” She goes on to state that she always took good care of this “vessel”, “Never did 
drugs.  Don't drink alcohol.  Always exercised.  I'm, like, and this is what you do? … 
I mean, what was the reward?  Oh.  Hey.  Guess what?  I'm not going to produce any 
insulin for you.”   
 Many Alpha women were keenly aware of someone they know who experienced 
severe complications or someone who died as a result of diabetes-related complications. 
Alice shared her understanding about what could happen if she does not take her 
medication, “Because if you don't take your pills you will die, because you will go into a 
stroke.  Your sugar go up so high, you stroke, heart attack, I mean, why go through those 
changes if you don't have to?” Carrie discussed the importance of taking her diabetes 
medication, “I know that I have to do it [take medication].  I have to do it, or I could end 
up like my brother.” Sadly, Carrie’s brother died at a young age from diabetes-related 
complications.  
 These women had stories about poor relationships with HCPs; thus, had strong 
opinions about what a good relationship with a physician entailed. Their expectations for 
HCPs included being “invested in my health.” In fact, many Alpha women were 
extremely meticulous in their record keeping and prepared for their doctor visits; many 
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Alpha women brought in detailed blood sugar logbooks, which included food diaries. 
Annie kept an Excel spreadsheet with complete records of when she purchased her 
medications, cost, and which pharmacy.   
 Alpha woman, Alice, only relied on her doctor and God for support and states, 
“Well, he's [her doctor] concerned, you know, you ask questions.  You're not afraid to ask 
questions.” In fact after Alice’s husband passed away, she made her doctor aware of her 
tight financial situation: 
As soon as the insurance stopped ... I went to the doc and I said, doc, I don't have 
any more insurance, and he tries and says, “Well, can't you go through AHCCCS 
[Medicaid] or something?”  I make too much money. 
Alice’s doctor agreed to see her every six months and charge her $30 for a 30-minute 
office visit. In addition, he provided samples when she could not afford her medication.  
 Alpha women expressed they were able to get the information they needed about 
diabetes and often provided a long list of places they get reliable information about 
diabetes (e.g. online resources, books, pamphlets, HCPs). Alpha women reported a 
variety of HCPs had been helpful in providing information to assist in diabetes self-
management. Renee recalled a medical assistant, who was particularly helpful,  
Before she left, she gave me a book - calorie and carb counting book.  It has food 
named in the book and how many carbs in one serving is and so on and so forth. 
That was very helpful, and I have two of them as a matter of fact.  They're 
extremely, extremely helpful.  
 
 In addition, Alpha women sought a doctor with excellent communication skills. 
Annie stated succinctly what many Alpha women expected from their physician, “she 
[physician] would listen to me, which, you know, sometimes doctors don't always listen 
to you.” Alice elaborated on what she expected from her physician, “You're not afraid to 
ask questions.” In fact, Jeannie brought a list of questions to her appointments. She 
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smiled as she related the story, “I had all of my stuff wrote down there…. he [doctor] 
said, ‘Jeannie, give me that paper’…. And he goes down my paper and then he started 
answering my questions.” Carrie said succinctly, a good doctor visit is one in which “I 
get all my questions answered.” Carrie further asserted, “I have to be here [doctor’s 
office], so you're [physician] not going to play with my healthcare!” Gloria stated what is 
important to many patients is communication outside of the exam room, “I'll call and 
leave a message.  He [doctor] calls me back.”  
 After a discussion of HCP support with women, the researcher prompted, “Who 
else?” Often baffled Alpha women searched for another answer and several women 
offered God as an additional support. Alice expressed her strong preference for speaking 
with God about her diabetes in this way, “Because what human, what can man do to help 
me out?  Nothing.  Nothing.” Furthermore, Alice explained,  
He'll [God] give me a spiritual understanding, and I think that He will allow me to 
understand what's happening. He will give you knowledge. God does talk to all of 
us.  They don't realize it, but that little mind in the back of your head - what do 
you think that is?  You? …. I’m a very religious person, and I go to God, you 
know, when I have really serious problems. 
 
 Some Alpha and Networking women saw God as supportive in their diabetes 
management and articulated the process of building an intimate relationship with God 
over time. For example, Vanessa, a Networking woman, spent a great deal of time 
reconstructing her path to resilience as she recounted a multitude of hardships 
experienced since childhood. These difficulties included homelessness, poverty, teen 
pregnancy, an abusive marriage, the death of her beloved father, and incarceration of her 
sons. It was shortly after her father passed that she was diagnosed with diabetes and she 
declared: 
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And all the pain! And I've grown to learn the Word of God — God does not waste 
pain, so I don't care what the source of pain is that I go through when I do 
something stupid and bring it on myself or whether it comes from some other. He 
doesn't waste the pain; He uses it to mature us. And then I used to be such a big  
crybaby, and it's just so comforting to know that He collects my tears.  They're 
valuable to Him. 
 
 Beyond healthcare providers and God, Alpha women did not provide anyone else 
they perceived as supportive or anyone else they talked with about diabetes. Some Alpha 
women reported family or friends who went to diabetes education classes with them, but 
did not see this as supportive of them personally. Rather, the women perceived attending 
the classes to be supportive of another family member or a way to criticize them later if 
they did not follow the guidelines suggested at the classes.  
 Even Alpha women who stated they had friends and family members with 
diabetes did not talk with them about diabetes. For example, Alice has a sister with 
diabetes and when asked if she talked with her sister about their shared condition, she 
was unsure about why she would do that, “We know something about it, so why discuss 
it?  You know what I'm saying?  Sometimes it can be depressing.”  
Networking Women: “I say that I have diabetes, diabetes doesn't have me” 
 Diabetes was represented differently by Networking women, “I say that I have 
diabetes, diabetes doesn't have me, and I don't even really call it diabetes.  I tell people I 
have di-a-bitties.”  For Monica, this assertion gave her power over a serious illness; she 
diminished its power by renaming it and laughing about it. Gina chose to look on the 
bright side of having a diabetes diagnosis, “there's positives in it, I mean you know now 
why your body's been doing what it's been doing.  So all you have to do is just take the 
actions and you'll get a good result.“ 
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 Networking women were adept at connecting with people and constructing a 
support system that included a wide range of people. Two of these women (Lucy and 
Marie) were unable to drive, which forced them to find supportive people to meet their 
practical needs. Women in this group were naturally amiable and optimistic; they talked 
easily about their struggles with diabetes, but primarily focused on what was going well.  
 Furthermore, Networking women would elaborate on how their doctor and other 
HCPs made them feel valued and cared for: 
I never had a doctor that made me feel like I wasn't the most important person in 
there, and the relationships that I've had with my doctors has always — they'll ask 
me about my children.  They'll ask me about my work.  It's just they think — I 
communicate with them.  They communicate with me, you know, he [doctor] 
cares. (Vanessa) 
 Gina has been seeing the same physician for about fourteen years and reported a 
good relationship with him. “So he's pretty comfortable, like, you know, really telling me 
off about how he feels how I'm acting. It bothers me, but it's, like, I know it's because he 
cares.” At one time, Gina did not have insurance and her doctor tried to help her to be 
able to continue to take her diabetes medication, “he'll try to give me as many samples as 
possible.” Now that she has insurance, the cost is not a barrier. 
 Julia recently began to see the “education doctor,” a diabetes educator, every three 
months. The diabetes educator helped her understand, “The pills sometimes stop 
working,” which eased her transition to insulin therapy. 
 Two Networking women had assistance in obtaining their medication. Vanessa’s 
husband took on the responsibility of ordering her medication through a mail order  
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pharmacy. In fact he was so responsible for this task that she felt a bit guilty that she had  
no idea what the process looked like, “He takes care of everything.  It's terrible he takes 
care of it.”   
 Networking women felt differently than the Alpha women concerning social 
support. Gina, a 36-year-old college educated woman reported she has a number of 
people who were supportive. Her family and sorority sisters all knew about her diabetes 
and she smiled when recounting their concern and care for her. “So I do a lot of social 
activities.  I think, that's probably the one thing, like, I don't think being diabetic has, like, 
impacted my social life.” In addition, she felt there was no reason not to talk with people 
about her diabetes.  
 Another Networking woman (Marie) who survived a recent six-year prison 
sentence and living in a homeless shelter while being confined to a wheelchair 
successfully reached out for social support in her current residence and neighborhood 
pharmacy.  
 Finally, Monica, an extremely optimistic 55-year-old woman who lived alone 
smiled as she told the researcher her oldest son said, “Mom, you're the healthiest diabetic 
that I know.”  In addition, Monica’s younger brother, who also has diabetes, moved 
closer to “make sure that we were okay, and he checks on me.” She goes on to say. “My 
coworkers, past and present were all aware that I had diabetes.” Moreover, she had close 
friends that “know that I am diabetic.”  She has received support and encouragement 
from all of these people over the years.  
 Vanessa provided an example of the Networking woman in the HCP relationship. 
“I'm one of these people that believes what the doctor says … and if they say that I need 
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the pills or the shot or whatever, I take it religiously.” Vanessa is a nurse and listened to 
her doctors, relying on their expertise.  She generally trusted physicians, “doctor's are 
practicing medicine... they’re making their best educated guess that they can make” and 
acknowledges the patient’s role in her healthcare as “it's really the patient's responsibility, 
the majority of it is to take better care of yourself and don't put all of that on the doctor.” 
 A caring relationship with their HCP was important to Networking women. 
Networking woman, Monica, missed the exemplary doctor she had before moving to the 
Southwest, “God's honest truth.  If I had the money, I would fly back…. for my doctor's 
appointments if I had the money.”  She goes on to say that even though he was busy, he 
took time with her and remembered “stuff that you don't even remember was wrong with 
you” making her feel he cared. Other Networking women agreed that they wanted their 
physician to spend adequate time with them; they felt there is no shortcut to 
comprehensive assessment and building rapport.  
Gender: Emerging Typologies for Black Men 
 Overall, Black men were remarkably different from women in their perception of 
support in managing their diabetes. When men were asked, “Who helps you with your 
diabetes?”, they would smile broadly and produce a litany of supporters from HCPs, God, 
family members both male and female (e.g. uncles, brothers, sons, wives, sisters, 
daughters, mothers, mothers-in-law), co-workers, and friends. Bret stated with a laugh, “I 
have a lot of help, a lot of support!” This was in stark contrast to Black Alpha women 
who were hard pressed to identify support other than HCPs and God. 
 However, two emerging typologies for Black men included “Warriors” and 
“Trustees” (Table 9). Warriors were highly educated men; three Warriors had military 
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backgrounds and two Warriors were currently in management positions at work. These 
men were advocates for diabetes self-management education as power and sought 
information that helped them attack the enemy. They attended at least one series of 
diabetes education classes; many went back for “tune ups” over time. 
 Trustees were responsible only for information and medical advice given to them; 
these men were less likely to seek out additional support from family or friends.  
Moreover, they seldom sought information on diabetes self-management and preferred to 
rely upon their HCPs to provide necessary information or referrals. Trustees were less 
assertive in their relationship with their HCPs reporting, “ I do what they [physicians] tell 
me” which tended toward compliance rather than adherence in the strictest definition. 
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Table 9. Emerging Typologies for Diabetes Medication Adherent African American 
Men  
Warrior Men 
 Characteristics Representative Quotes 
 
Bret 
Charlie 
Denzel 
Ernie 
Fred 
Harry 
Jack 
 
Diabetes is the enemy: 
“insidious”, “sneaky disease”, 
“silent killer” 
In “attack” mode   
Military and leadership 
backgrounds 
Heavy reliance upon routines 
and regimens 
Primarily college educated 
Broad arsenal of weaponry 
(HCPs, God, DSME, being 
proactive, social support, etc.) 
Appreciate HCPs who are 
“direct” and “strict” 
“When the doctor told me about it [diabetes], I mean, I 
wanted to attack it head-on.” 
 “I take my pills on time in the morning and the evening.  
It's a routine to me now.” 
“I may be not able to reverse what happens, so, you 
know, if I can prevent it, then yeah.” 
“She [doctor] told me exactly what she wanted me to do, 
and when she assigned me a diabetic class I went.” 
“I've got a list of things that I want to ask her [nurse 
practitioner] when I go to see her.” 
 “I can't do this alone. I know that there has to be 
Somebody helping me.” 
“The more you learn about the disease the better off 
you're going to be.” 
“I have a couple of friends that are supportive that know I 
have diabetes.  I don't try to hide it.” 
“I must do everything regimented.”   
Trustee Men 
 
Andrew 
Anthony 
Gregg 
 
Compliant relationship with 
HCPs  
Participate in DSME if doctor 
recommends it 
Desire little social support 
“I do what they [doctors] tell me” 
 “When I do what I'm instructed to do [by his physician], 
it works out.” 
“She's [doctor] looking out for my best interest.” 
“Diabetes is just for me, I'll just take care of it.” 
 
 
 
 
Warrior Men: “I wanted to attack it head-on”   
  Warriors had a unique conceptualization of diabetes. Fred discussed how he 
characterizes diabetes, “I've always been told it's called a sneaky disease.  It's called the 
quiet disease.  It slips up on you before you know it, and I'd say that's a true thing.” Harry 
concurred and feared complacency in his diabetes care, “You know, to me diabetes is one 
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of those silent killers.” Bret agreed, “medication you can control it, but it's [diabetes] the 
silent killer, and you can't control that.”  Denzel related an impactful conversation with a 
friend who was a nurse. He asked her what word she would use to describe diabetes, 
“And she paused, and she said insidious.  And it is.  It really is.  I just thought that's a 
very interesting answer.  Insidious.” The word resonated with him because “you don’t 
feel any different.”  
 Many Warriors used language that alluded to “fighting” diabetes; there was a 
sense of being in competition or at war with the disease. Harry provided context for his 
adversity to diabetes, “When the doctor told me about it [diabetes], I mean, I wanted to 
attack it head-on.” Jack talked about the difficulties his aunt and uncle had with 
complications from diabetes; this motivated him to win the battle, “I go, yeah, I'm going 
to beat this.” Ernie summarized what many believed about the war on diabetes; “I know 
that I could have bad results if I don't take my medicine.” 
 Denzel was a Warrior man who had a long period of time in which he was losing 
the battle to diabetes. For two years, Denzel was laid off from his job and did not have 
insurance to assist with buying insulin. Denzel described what was happening when he 
was losing the battle against diabetes: 
I was losing my muscles and my body was feeding off of the fat, because it 
wasn’t getting the nutrition that I was eating because of the diabetes.  My muscles 
— I started losing muscle tissue.  My body was feeding off of itself… I didn't feel 
right.  I didn't feel good every day for weeks, for days I didn't feel well. 
 
Denzel has lived with diabetes for 17 years and philosophized about what made him 
decide to be more engaged in his diabetes management,  
I don't know if most people think about this, but I guess there are a lot of people 
that are planners and there are people who wait for the disaster to hit before they 
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have prepared for it, and maybe I was the kind of person that was waiting for the 
disaster to hit. Because for me I felt, well, I didn’t feel that much different. I didn't 
quite understand what diabetes was all about then and even up until now.  Well, 
actually I should say even up until about two years ago, but it was a gradual — I 
was gradually beginning to learn more and more about it. 
 
For the past two years, Denzel has been able to receive medical care through AHCCCS 
and reflected upon the consequences of not managing diabetes for many years. 
I came to a point where it was a void I'd fallen into, where I had no power.  I had 
no money to maintain care that was needed to the point where I lost a lot in that 
period.  I had a lot of nerve damage that took place.  I didn't see or feel it at the 
time. 
 
 Currently, his orientation toward diabetes was one of actively fighting the enemy 
to maintain his health. “I'm learning a little bit at a time how what this diabetes thing's 
about.  It's insidious.  It sneaks up on you.  You don't know how bad things are until you 
start getting to a point of no return.” 
 Warrior men had a wide range of weapons or tools available to fight diabetes. For 
many men, spirituality was part of their arsenal. When asked about how his relationship 
with God encouraged him, Harry stated, “It encourages me, because, again, I don't think 
He's done with me yet, and so even though I have diabetes … I may be able to touch 
someone else who has diabetes that I can encourage them that may be going in a different 
direction.” Charlie discussed his view on God’s involvement in his health, “Well, you 
might, you might say that I know that I can't do this alone.  I know that there has to be 
somebody helping me.”  
 Bret saw his relationship with God as a means for mental toughness. “My 
relationship with Jesus Christ gives me peace that surpasses all understanding.  It keeps 
my heart and my mind.” Furthermore, Bret believed joy was imperative when fighting, 
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“Even when you go through the worst of times and the best of times all at the same time 
if you have some joy. And I had some joy when I got the news about the diabetes.” That 
deep abiding joy carried him through managing diabetes even when it was necessary to 
begin insulin therapy, “I didn't lose my joy, because now I have to stick myself.  I have to 
learn how to do this. And understand it's for my betterment.” Bret asserted his faith 
“doesn't make it [managing diabetes] any less challenging.” He conviction was that faith 
in God made handling diabetes easier because “I have a belief system that I won't let go 
of, and no matter what the situation is, I know that I win in the end.” 
 In addition to spiritual tools, Warrior men believed in the power of knowledge 
about diabetes. For example, Bret worked with his HCP to learn more about his disease 
and stated, “And if they [HCPs] have only given me part of the tools, I'll have something 
to work with, and I'll educate myself the rest of the way and figure out the rest.” He 
discussed friends who lost limbs from poor diabetes management and stated with 
conviction, “I'm not going to do that.  I'm not going down that road. If someone gives me 
the tools to work with, trust me, I'm going to work with the tools.” Bret saw diabetes 
management as his personal fight for health, “The wars that you do have that are yours, 
pick your battles, and know that, hey, I may lose the battle, but I'm going to win the war.” 
 Denzel participated in three DSME classes in three different cities. “And they 
were all very different. I mean the information was the same, but there were different 
angles, like different angles at which to attack diabetes.” He advocated for DSME and 
stated, “I tell people whenever I run into someone who's about to take the class, I say take 
the class. You will benefit greatly from doing that.” 
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 Warrior men joked about being “nagged” by many people, but when asked how 
they felt about being nagged, they would say the supporter was showing his or her love 
and laugh heartily. Furthermore, married Warriors often attributed their ability to take 
their medication regularly, along with other aspects of diabetes self-management, to their 
spouse. For example, Jack smiled as he stated, “The main reason I take my medicine…. 
because she [wife] is always on me about it.” When Denzel’s ex wife reminded him to 
take his medication, he felt “that was really nice or sweet of her to ask and show that she 
had some concern.”   
 Moreover, Jack identified his brother as an important supporter, “He calls me 
every once in a while to make sure I'm doing what I'm supposed to be doing…he works 
at the hospital, and he's like, ‘Don't be one of those guys.’ So he helps.”   
 Warrior men were very open to talking about diabetes with others. Denzel 
summed up the feelings of many Warrior men, “I didn't see any reason why not to talk 
about it.” In contrast to Alpha female, Alice, not understanding why she might talk about 
diabetes with her sister, Harry talked regularly with his brother who has diabetes.  
So we talk about that kind of stuff.  And he [brother] says,  ‘I was on this one 
medication that worked for me, or did you hear the report about this medication?  
You may want to talk to your doctor.’ You know, this is the kind of thing him and 
I talk about.  
 
Bret and his mother-in-law were both diagnosed with diabetes at about the same time and 
took the same medication. She would call every morning to ask him, “Have you taken 
your medicine?” Bret replied, “I've taken mine, but have you taken yours?”  
 Warriors generally agreed upon the qualities common among the doctors with 
which they had a good relationship. Honest and direct communication from the physician 
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was highly valued, “I need you [doctor] to tell me what's going on” (Jack). In fact, Bret 
traveled forty-five minutes for visits with his trusted physician and declared, “The 
distance is worth the difference.”  
 Many Warrior men articulated daily rituals and routines that helped them 
remember to take medication. Bret called himself “anal” and believed routine is 
imperative for his diabetes management, “So I must do everything regimented. And I 
don't want to be outside of my routine, because if I'm outside of my routine, now I'm 
going to forget something.”  
 Ultimately, Warrior men took personal responsibility for their own health, 
“Nobody's going to hold your hand.  Nobody's going to walk you through this.  This is 
something you must do” (Bret).  His optimistic attitude is summed up, “When a person 
finds out that they have diabetes, it's not the end of the world.  It's the beginning of a new 
life.”  
Trustee Men: “I do what they tell me” 
 Trustees accepted the diagnosis of diabetes and took it seriously. Greg’s mother 
had a history of diabetes and experienced diabetes-related complications, “For decades 
prior it [diabetes] was a term as bad as cancer, if not worse, in my mind.”  From watching 
his mother’s health decline, Greg described his characterization of diabetes, “I knew it 
was a dangerous, treacherous, ugly disease, and I respected it in that way, and when I 
heard the term diabetes I respected it right away.”  
 Trustees were generally content to allow the doctor to make health decisions with 
little interaction from them. For example, Greg, an educated Black man between 40 and 
50 years old exemplified a compliant relationship with his physician. Greg described a 
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poor relationship with the doctor he had been seeing for more than three years, “There's 
no eye contact.  They're either on the computer or on their notepad.  Here's a prescription.  
Here's a refill.  On your way.”  The office policy was to make appointments with the 
physician at least four weeks in advance.  Greg’s response was, “I stopped making 
appointments with her.” Instead, he was seeing three different physician assistants (PA) 
in the same office. In fact, he referred to the physician with disdain as the “prescriber”.  
In order to obtain a prescription for his diabetes medication, he was forced to see a PA 
monthly; the office policy does not allow prescriptions to be called in without a doctor 
visit and Greg never asked if he could see the doctor less often.  
 Greg discussed a disagreement with his doctor about insulin dosing, “So she took 
me from 20 units to 14 in one swoop, in one change.” He elaborated, “It [A1C] was good 
at 20.  ‘I'm going to reduce you.’ Isn't that a significant, very significant drop?  ‘Yeah.  I 
want to try it.  I want to see if it works, how you're doing at 14.’  Okay.  I'll follow your 
orders.” Greg vehemently disagreed with lowering his insulin dosage; he believed that his 
A1C was in a healthy range and it was a mistake to lower the dose. However, when asked 
how much insulin he took each night, he took the dose recommended by his physician 
and declared, “That way it’s on her, not on me!” Greg explained this statement,  
They [physicians] will be the first to say, ‘You didn't follow my orders.  You 
didn't follow my instructions.  You didn't do X, Y, Z.  This is why you're in the 
position you're in, because you didn't follow doctor's orders.  You didn't take the 
prescription as prescribed.  You didn't.  So therefore, it's your fault.’  
 
By following the doctor’s orders, if something goes wrong, Greg can say, “I did exactly 
what you told me to do.”  
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 It was apparent that obeying authority was important to Greg; he could not 
imagine “challenging” his doctor by discussing the dosage or taking the amount that 
seemed best to him. Greg continued to obtain healthcare through this office because he 
does not have “enough time to take care of my personal business.”    
 Greg had not asked the physician for a prescription that lasts longer than a month, 
even though he was clearly upset at having to go to the doctor and the pharmacy every 
month. A year ago, Greg decided he preferred to see the physician assistant in the office 
and demoted the physician to “prescriber” in light of his unvoiced disagreement with the 
medication dosing decisions made by the physician. Gregg has not asked questions or 
challenged medical decisions from any of his physicians, as he felt he would be perceived 
as “whining” or “complaining.”  
 Trustee men were not interested in acquiring social support. Andrew summed up 
the feelings of the other Trustee men, “Diabetes is just for me, I'll just take care of it.” 
When family or friends reminded them to take medication, it was not particularly 
bothersome, but Trustee men felt no one else should be concerned. Greg chose not to talk 
about diabetes with his family because, “I don't have to dump everything on her [wife].” 
He explained, “So when I'm sick, I have diabetes, diabetic complications, and you don't 
and never have, it's going to be hard for you to relate so I minimize the harder-to-relate 
conversations.”   
Community Response to Gender Specific Emerging Typologies 
 Community partners were asked to provide feedback, either individually or in 
small groups, at various phases of the data analysis. In discussions with African 
American community members concerning the typologies, the disparity in support for 
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Alpha women with diabetes was palpable. Typically, African American men were in 
disbelief; the men were certain all African American women socialized regularly and 
thought this equated to adequate support. However, African American women had a very 
different response and would nod in agreement with the notion of low support and 
feelings of isolation for some Black women with diabetes. The notion of feeling 
somewhat alone when going through a difficulty of any kind resonated with them. 
Furthermore, Black women would begin to naturally advocate for their sisters with 
diabetes, trying to help the African American men to understand the isolation many 
women feel. One older African American woman who has worked to reduce health 
disparities for nearly two decades was moved to tears declaring, “I thought we were past 
that.”  Another African American woman who worked in public health shook her head 
and stated, “Those are my people! That [isolation] is so unhealthy. We know those who 
have higher social support have reduced depression and better outcomes.”  One man who 
had extensive experience with Black men’s health stated, “It’s like she shuts down 
resources around her” when speaking about the Alpha woman.  
 Community partners viewed Networking women as having a healthier attitude 
towards diabetes management. African American women smiled when reviewing the 
Networking profile and talked easily about the benefits of creating a support system. One 
female community partner discussed whether these women were connectors rather than 
networkers. The difference to her was whether their focus was on connecting to others 
regardless of personal benefit or whether the networking primarily benefitted their own 
health and well-being. She decided that Networking women were creating an 
environment to support their own health and as an aside, improving the lives of others.  
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 While most community partner African American women easily pictured Trustee 
men, many were unfamiliar with Warrior men. After consideration, the women were able 
to picture these men in their community stating that they do not work much with adherent 
clients; therefore, Warrior men were not as common in their practice situations. However, 
both male and female community partners knew Black men who, in general, “attacked” 
problems and depicted this approach to adversity.  
 Community partners more easily understood Trustee men. Community partners 
related to the sense of the doctor as more knowledgeable and, therefore more trusted to 
make medical decisions than the patient. However, the concern was whether all 
physicians deserved that high level of trust. Community members questioned turning 
over important health decisions and well-being to one person. Moreover, several 
community partners asked about the race of the physicians. When told that participants 
primarily had white HCPs and did not express a preference for an African American 
HCP, one woman stated, “In Arizona, there aren’t many Black doctors, so they don’t 
really have a choice.” In fact, if participants had a preference, they were more likely to 
choose a HCP of the same sex.  
 A community partner with extensive experience in Black men’s health issues 
suggested the Trustee men might be empowered by having “talking points” to discuss 
with their physicians. He was further troubled by the short time period of doctor 
appointments and asked, “Is this enough time to get information?” He believed 
physicians must understand the power differential and the potential to influence Trustee 
men.  
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 Perception of stigma and acceptance of the diabetes diagnosis were common 
among all participants. Certainly acceptance of the diabetes diagnosis was instrumental in 
diabetes medication adherence and precludes initiation of consistently taking medication. 
In order to engage in the laborious process of obtaining and taking medication as agreed 
upon between the HCP and patient, he or she must see a need for the medication.  
 However, conceptualization of diabetes and orientation toward self-management 
differed according to gender and other demographic factors that clustered within four 
emerging typologies.  Furthermore, support from others, including HCPs, differed 
according to gender and typology. Thus, the challenges experienced for each person were 
different; the manner in which each person engaged in the process of medication 
adherence and solved the challenges inherent in this process were unique as well. The 
value in exploring this process of medication adherence is in the differentiation of the 
steps and, therefore, the potential pitfalls, at each phase of the process. The resilient 
people in this research study were not daunted by the challenges; they found creative 
ways to overcome adversity and risk at each stage. 
The Process of Medication Adherence Model  
 
 The data revealed a multi-step process of medication adherence with potential 
obstacles at each step that may have to be overcome (Figure 11). Participants described 
the process of acquiring their prescriptions and the strategies they used to overcome 
common hurdles in remaining adherent. Each point represents a necessary step in the 
process of medication adherence. Moreover, the patient must successfully navigate 
through the process to achieve consistent medication adherence. There is potential for  
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adversity and risk at each stage of the process where patients must have the assets and 
competence to overcome any barriers to be able to consistently take their diabetes 
medication. 
 
Figure 11. The Process of Medication Adherence 
 
Step 1: See a Healthcare Provider 
 
 The initial step in diabetes medication adherence involves seeing a healthcare 
provider to obtain an accurate diagnosis and develop a plan for treatment. Participants in 
this study discussed various roadblocks to seeing a healthcare provider including 
difficulty in making an appointment in a timely manner, transportation, work-related 
obstacles, office policies, and paying for the visit. Their strategies for successfully 
overcoming barriers may be helpful to others who are struggling with this initial step.  
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 Come to the appointment. A few of the participants did not drive (Marie, Lucy, 
and Andrew); thus, finding reliable transportation to appointments could be a problem 
from time to time. Marie and Andrew had AHCCCS coverage, which included rides to 
medical appointments, but not to the pharmacy. This was a great advantage to both of 
them and they were very satisfied with this benefit. Lucy had Medicare coverage and 
relied on public transportation and her daughters for transportation to her appointments. 
All three participants were able to get to their doctor appointments with consistency.  
 Other participants were concerned about missing work for an appointment and 
those who were currently employed scheduled their appointments around their work 
schedule. For example, Monica routinely asked for the first appointment of the day with 
her physician. In order to be able to get this coveted time slot, she built rapport with the 
office staff, and made her follow up appointments at the end of her current visit.  This 
strategy required prioritizing her doctor appointments, but allowed her to limit missed 
work time.  
 Pay for the visit. With the exception of Alice who did not have insurance 
coverage to assist with medical costs, participants did not feel copays for doctor visits 
were burdensome. Alice was able to be open with her physician about her financial 
situation and brokered a reasonable compromise in payment of $30 for her regular office 
visits. 
Step 2: Healthcare Provider Writes Prescription 
 Prepare for the visit. Participants generally felt that if they provided good 
information to their physician, HCPs would make better decisions. It was important to 
know how the current medication was working in order to know if any changes should be 
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made. Toward this end, participants had a multitude of strategies for getting the most 
from the short time they had to meet with their HCP (Table 10). 
Table 10. Participant Strategies for Preparing for a Doctor Visit 
• Write down questions for HCP ahead of time 
• Prioritize those questions 
• Tell the doctor if you need a refill on a prescription 
• Bring a completed blood sugar log book 
• Provide a food diary 
• Bring in bottles of all prescription medications 
• Keep a brief medical history in a purse or wallet 
• Keep a list of current prescription medication in a purse or wallet 
• Get blood drawn 3-4 days ahead of time  
 
 Seventy-seven year old Jeannie shared her strategies to get what she needed from 
her doctor visit,  
I write down my questions before I go [to the doctor]. Before I started doing that, 
I would go in and, you know, sometimes, my talking sometimes gets kind of 
spacey like.  I'm still trying to come up with that next question, and they will be 
gone.  
 
Renee concurred with this strategy, “I did the list with my primary care and I find that she 
paid more attention to me.” Renee found a list was particularly helpful when she could 
not communicate her thoughts clearly, “I just handed it to her [doctor] and let her see it, 
and she did address what I had.” Charlie used the same strategy with success, “I've got a 
list of things that I want to ask her [doctor] when I go to see her.” Carrie went a step 
further and prioritized her three most pressing topics for conversation with her HCP, “If 
you can't deal with the rest of them, I'll come back, but don't rush me.” 
 Annie was a meticulous record keeper and provided an updated copy of her 3-
page medical history to her physician to revise or add to on the day of the visit. “So every 
 115 
then I keep one in my wallet just in case of an emergency.  Everything is there that they  
need to know.” Many participants brought a logbook with blood sugar readings and a 
food diary to doctor visits. 
 While many participants kept an updated list of prescription medication with 
them, Carrie found updating a list of medications to be unreliable for her because 
prescription medications changed so often. She saw a number of specialists and each one 
may prescribe a medication to treat or prevent conditions. Instead, she brought a bag of 
current medications with her wherever she went to be certain all doctors were aware of 
all prescription medications (Figure 12).  
 
Figure 12. Carrie’s Medication and Supplies  
 Several participants expressed they wanted to review current lab work with their 
HCP at each visit; therefore, they did what Harry did, “I get my blood drawn three or four 
days before [doctor appointment].”  
 Participants believed all of this prior preparation allowed the patient and 
physician to discuss the current treatment and decide what kind of medication is needed 
and whether any changes to dosage or strength needed to be made. After the information 
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is synthesized, the HCP wrote a prescription and handed it to the patient or faxed/called 
one in to the pharmacy. This could be either a mail order or local pharmacy, depending 
upon the preference of the patient and the insurance provision.  
 Writing the prescription correctly. Some participants discussed the mismatch 
between the prescription and the number of doses of the medication needed for the time 
period. For example, Gina discussed a problem with having enough Victoza, “I think 
sometimes it comes down to, like, how the doctor writes the scripts.” She elaborated, 
“there's the instructions, and then there is the quantity.” She discussed that she had 
instructions on how much and how often to take the medication, but not enough of the 
medication to follow the written directions. Her solution was, “So I have to read the 
prescription to see if it matches.” This way she could catch any errors before she left the 
doctor’s office.  
 Mail order. For mail order pharmacy users, the process from the HCP calling in 
the prescription to having it delivered was very simple. For example, Jack set an alarm on 
his cell phone to remind him every three months to order his medication, which he 
received by mail order. Jack stated the simplicity of the mail order process as, “Just call 
the doctor, he sends the order [to the mail order pharmacy]. And then he will send it off, 
and they'll [mail order pharmacy] send me some more.” Jack added that it took two to 
three weeks for the refill process to be completed, “because then they've got to call me 
and verify that you want it.” This process took minimal effort on the part of the patient. 
Ernie also enjoyed the simplicity of using a mail order pharmacy, “you just put in your 
[prescription] number, and they tell you you'll get it within seven to ten days, and they're 
usually pretty punctual.”  
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Step 3: Pharmacy Fills Prescription 
 HCP fails to call in prescription. While the hand off from the doctor to the 
pharmacy could pose problems, few participants expressed difficulty with the pharmacy 
receiving the prescription. However, this may be because most preferred to take the 
written prescription directly to the pharmacy rather than rely upon the physician’s office. 
Those who used a mail order pharmacy could not recall a time when the prescription was 
not received by their pharmacy. 
 Patient takes prescription to pharmacy. Many participants chose a pharmacy in 
their neighborhood or close to their place of employment. Several participants used a 
pharmacy within a grocery chain. This enabled them to run other errands while waiting 
for the prescription to be filled. Transportation challenges were minimized with this 
strategy; however, those who relied on public transportation often found it difficult to get 
to the pharmacy to drop off and pick up prescriptions in a timely manner.  
 Those who utilized public transportation solved this problem. Marie chose a 
pharmacy within two blocks of her home and used her wheelchair to travel to and from 
several times a month. Lucy had her physician call in the prescription instead of making 
the trip to drop off the prescription. Andrew used public transportation and waited for the 
pharmacist to fill the prescription rather than make another trip.  
Step 4: Pick Up Prescription   
 Monthly task. Participants did not expressed feeling burdened by picking up their 
prescriptions from the pharmacy.  Lucy, who does not drive, called the pharmacy every 
month to order her medications and then informed one of her two adult daughters that 
they have three days to pick up the prescription and deliver it to her house before she ran 
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out of medication. For many local pharmacy users, picking up their prescriptions had 
become part of their monthly tasks. Ernie reordered and picked up his insulin, “Usually 
when I'm down to the last 3 cartridges I will call them [pharmacy].”  
 Jeannie described her process for knowing when it is time to get her medication 
from the pharmacy, “And when I get down, I fill that pillbox up, and I probably have 3 or 
4 more days left, and that's when I think I should order.” If she did not follow her self-
imposed rule, she realized, “I’m not going to have any medication, so that's when I take 
myself to the pharmacy and sit there until they refill it.” She viewed having to wait 20-30 
minutes for the refill as “punishment” for not ordering medication when she knew she 
was low. 
 Pharmacy reminders. Many participants spoke about pharmacy-based reminders 
to get refills of their medication. These reminders came in the form of automated phone 
calls, text messages, or emails. Renee described her pharmacy’s refill reminder, “They 
[pharmacy] automatically fill it [prescription] every month and then they let me know 
when it’s ready.”  
 Correcting prescription errors. Renee reported a number of times when her 
pharmacy did not provide the proper drug or left out one of her prescriptions. She had a 
strategy for making certain she had everything she needed before she left the pharmacy, 
“well they [pharmacy personnel] bring it to me, and before they ring it up I go and check 
my list against what they have.” Renee kept her list on her cell phone to ensure it is 
always with her.  
 Gina had a problem with a prescription for her glucometer test strips and had to 
speak with the pharmacist about correcting the number of strips she received. She 
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believed correcting this error would have been much more complicated if she had a mail 
order pharmacy, “Just talking to the pharmacist is way easier than talking to someone 
over the phone at a mail order pharmacy to get the whole thing figured out.” 
 Paying for the prescription. Most participants had insurance and were able to 
cover the cost of co-pays. Greg asserted a frustration shared by many participants, “And 
then when my insurance changes, the pharmacy changes.” As a result of this change of 
insurance and concurrently a change in pharmacy, the loss of the relationship with their 
pharmacist and familiarity of the routine that was working were challenges to overcome.  
  Furthermore, many informants told stories about challenges with cost in the past 
that affected their ability to be adherent to their medication. Moreover, a few discussed 
the challenges of falling into the “donut hole” with Medicare when prescription payments 
were the sole responsibility of the patient.  
  Alice had no insurance and paid out of pocket costs of approximately $200 a 
month for her diabetes medication and supplies.  She went without other things (e.g. new 
clothes, meat) in order to pay for her medication. “That's my life!  My life is my health, 
really.  People don't realize that until you get sick. You can't even put a price on health.  
You really can't.  I don't know how people think they can, but you can't.” 
 Jeannie decided that she would delay retirement until she was eligible for 
Medicare; she knew she could not afford health insurance and would not be able to pay 
for her diabetes care without insurance. Jeannie’s husband falls into the donut hole 
around August of each year and she declared, “We run for the border.” She clarified, “We 
go into Mexico. More affordable.” 
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 Renee was unable to afford her insulin when she first came to Arizona. Her 
strategy was “I'm going to take a little less of that [insulin].” She soon realized that she 
needed the full dose of her insulin and was able to obtain Medicare coverage as a part of 
her disability package to assist with the cost. Vanessa stated when finances were tight, 
she always prioritized insulin, but would sometimes have a week when she could not 
refill her OHAs. 
 When Denzel could not afford more syringes, he reused them to save money.  
And so I had maybe five needles left or something, and I had two weeks — I had 
two bottles of insulin left. Before I was able to get the money to buy the syringes I 
had to double up, triple up on these syringes. 
 
Moreover, he recalled times when he could not find the few dollars necessary for the co-
pays for his medication and it would be quite stressful.  
 Charlie discussed the difference in having Veteran’s Administration (VA) 
benefits. “Since I've got the VA, there's no cost, but prior to getting the VA, it was, it 
was, it was a burden.  It was a burden.” He encouraged those who are eligible for VA 
benefits to use it,  “If a person is VA eligible, he should seek the medical supply from the 
VA, because it would save him a tremendous amount of money.”  
 Even though Annie had insurance, she paid $300 to $400 a month for her diabetes 
medication and supplies. Annie decided to talk with her doctor about her inability to 
afford the medication she was prescribed. She called the pharmacy because “the last time 
I had it filled for 90 days it was $70.  Now it's $2100” and the pharmacy responded, “It's 
because you're in the donut hole.” Annie explained the “donut hole” as,  
Well, you have a limited amount of money to cover your drugs for the year and if 
you use them all up in the first 6 months then you in the donut hole, so you're 
responsible from then on.  That means you pay full price for the medicines. 
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Annie reaches the donut hole in May of each year and had to stop taking medication for a 
time due to cost. To remain adherent to her diabetes medication, she obtained samples 
from her physician when she could not afford her medication.   
Step 5: Understanding Dosing Directions 
 Confusion about taking diabetes medication. Sometimes directions for using 
insulin were extremely vague. Julia’s doctor gave her rapid-acting insulin with these 
instructions, “He said, here, just take a little bit of it [insulin].  Just be careful with it.” 
Subsequently, Julia had some scary hypoglycemic episodes and stopped taking rapid-
acting insulin. Ernie’s endocrinologist was similarly unclear about how much insulin to 
take after Ernie reported persistent high blood sugar after initiating insulin therapy, “He 
[endocrinologist] said, ‘just try using more insulin.’” Ernie researched diabetes self-
management for himself and stated, “I just became very, very strict about watching what 
I ate, exercising and so it's exercise and diet, and then I got my number [blood sugar] 
from 400 down to 100.” 
 Participants expressed times of confusion over what the directions indicated and 
what they were told by their HCPs. For example, Annie told about a time in which her 
doctor was helping her to increase her long-acting insulin safely, “They [physician] had 
me taking Levemir [long-acting insulin], and they kept telling me just keep increasing it 
every 4 days by 2, every 2 days I think it is by 4 points until I got it under 140 in the 
morning?”   
 Several participants were unsure about whether insulin needed to be refrigerated 
or not. Jack was confused about what he was told, “It says don't refrigerate it.  In the 
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refrigerator to keep it, but once you — before you use it has to be room temperature or 
something like that.” Gloria experienced conflicting information about the refrigeration 
of insulin from her HCPs, “So with the Humalog…what my endocrinologist told me was 
the Humalog could be at room temperature.” However, when she talked with the 
pharmacist, “Pharmacist says, ‘No.  We give it to you out of the refrigerator, why 
wouldn't you keep it chilled?’” She sighed in frustration. 
 A number of participants took time to read the information that came with their 
medication before they left the pharmacy. This strategy helped them to make certain they 
understood what to do when they got home. Most participants considered the written 
directions to be the definitive resource for resolving conflicting instructions.  
Step 6: Follow Dosing Directions 
 Remembering to take medication. Setting up the home environment for success 
was integral to taking prescription diabetes medication on time and consistently. This 
included keeping medication and supplies in a central spot and connecting taking 
medication to other established habits.  
 Many participants kept their medication in a central location (e.g. bedside, 
bathroom, kitchen counter) as a matter of convenience. Julia took her medication first 
thing in the morning and before bedtime. She had a system, “So it's [medication] by my 
bed, and I have, this little thing with my insulin and my needles and my pills is in this 
little green basket, and that's what I use to remind me to take it.” Furthermore, she kept 
bottled water and extra insulin in a small refrigerator by her bed.  
 Lucy kept a zippered lunch bag of her medication and supplies on the kitchen 
table with her dosing instructions for insulin stapled to the lid (Figure 13). This helped 
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her to remember to test her blood sugar and take her medications regularly. Furthermore, 
if she went on a trip, she just zipped the bag closed and packed it in her suitcase. Denzel 
had a similar system. He kept all of his “tools of the trade” (e.g. syringes, lancets, 
glucometer, pillboxes) in a cloth tote bag in the dining room.  In addition, he used 
pillboxes to organize his medication. Weekly, he filled two sets of pillboxes; one was for 
morning medicine and one was for medication to be taken in the evening.  
 
Figure 13. Lucy’s Bag of Medications and Supplies  
 Charlie developed an innovative system for knowing which medication to take in 
the morning and which to take in the evening.  
I've got a medicine cabinet.  It's got three shelves in it, one, two, three, and I take, 
let's see, four shelves, four shelves in it, three partitions, four shelves.  I've got 
medicine I take in the daytime. Okay, now I say the medicine I that I take in the 
daytime, that's medicine that's standing up.  That's when I'm standing up.  I'm 
upright.  I got them one, two, three standing up from top to bottom this-a-way. 
Now the medicine I take at night is when I'm lying down.  Now they run on the 
shelf this way (on their side). I know it's crazy, but it works for me. 
 
 Furthermore, many participants connected taking their medication with another 
activity that was already a part of their established daily routine. For example, when 
Ernie was first trying to remember to take his diabetes medication,  
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I started putting it in those pill cases, so I just leave a pill case on the counter, so 
when you come in in the morning, and you want to go in the refrigerator the pill 
case is right there. Like, oh yeah, that's my medicine I need to take.  
 
Others, like Charlie, naturally connected taking their medication to meal times, “twice a 
day and before breakfast and before dinner.” Most participants were keenly aware of the 
time to take their medication. Therefore, the clock or a television show became a 
reminder to them. Harry explains, “It's just that I kind of know at 9 o'clock I want to do it 
[take diabetes medication], so when I look over [at the clock], I say, oh yeah. It's kind of 
become a regimen for me.” 
 Those that had a longer history of taking diabetes medication felt it was just a part 
of their everyday routine. In addition to his shot of insulin at bedtime, Fred stated, “I’ve 
been doing it [taking diabetes medication] for years at the same dosage, too.  I take it in 
the morning.  I take it in the evening.  I take about eight pills in the morning and six pills 
in the evening.” 
 Having medication with you. While Carrie had a plastic bag with all of her 
medication that she carried in her tote bag everywhere she went (Figure 12), most 
participants took time to think through their daily schedule and decided if they needed to 
bring their medication with them or not. For example, Gina had a system,   
I figured out this is the best direction for me.  I used to carry a big pill bottle… 
with lots of pills in it.  Now I only carry the dose for the day.  Every morning, I 
just cut two pills in half and have that with me. 
 
 If insulin was needed while away from home, most felt comfortable not 
refrigerating it as long as they kept the insulin in a temperate environment (e.g. desk 
drawer, purse, shirt pocket).  Pills were often tucked into a purse, pocket, backpack, or 
briefcase in their original bottle. Charlie got a little help from his wife, “If I'm going out 
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to a restaurant, won’t eat at home, I'll put my insulin in a pen and put it in my wife's purse 
since I don't have a purse.” Some people habitually carried a small pillbox or sandwich 
bag with a few pills. On occasion, participants were out and unable to take their 
medication on time; most were comfortable with taking the missed dose as soon as they 
returned home, “better late than never.”  
Step 7: Overcome Fears of Taking Medication and Side Effects 
 Fear of needles. Not all participants had an aversion to needles. Marie stated, 
“Well, shots don't bother me.  I'm not scary of shots and stuff like that, it just something I 
didn't do it so much.” Vanessa was motivated to feel better, “I'm not afraid of shots.  I 
just wanted to feel better. I was willing to take the insulin, because I wanted it [blood 
sugar] to be controlled better.” Vanessa later discussed her experience with 
immunizations, injection pain medication for dental procedures, and labor stating, “I've 
grown up to love shots.  To take away the pain, because I have a low pain threshold, so 
taking insulin shots didn't bother me.” When she had gestational diabetes, Monica was 
not troubled by the thought of taking insulin injections, 
When I first had to take insulin, I was protecting me and my baby.  I was carrying 
my baby, so that didn't bother me.  I saw that the insulin helped my father.  I saw 
that the insulin helped my sister.  I was never resistant to taking insulin, because I 
saw the benefits. 
 
When asked about taking insulin shots, Denzel shook his head, “The needle, the syringe, 
the needle I use for diabetes?  No. That's not a problem. Most of the time you don't, you 
don't feel the sting, if there is a sting.” 
 However, Harry’s feelings about needles were representative of many 
participants. “We are not friends.  At all.”  He was able to overcome his fear of taking 
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shots by thinking about what could happen if he did not take his insulin. “And so, yeah, 
and then some folks that I know that they have had, you know, amputations because of 
diabetes and things like that.” Some participants expressed a preference for an insulin pen 
as opposed to the syringe and vial method of administering insulin. Harry was surprised 
that insulin injections with a pen were not as painful as he thought, “…the pen is just, to 
me, it's a little different… you can do it yourself, and it's just, boom.” While Bret was not 
happy about “sticking” himself, he was a paramedic at one point in his life and needed to 
inject patients on occasion, “It's no problem for me to stick somebody, It's not going to 
hurt me, I mean, this is something to help them live.” He applied this reasoning to his 
own situation,  
So I had to get that wrapped around my mind, that this was going to help me.  It 
was going to be faster.  It would be easier at some point. For when I get over my 
fear of having to poke myself with a needle that I don't feel comfortable with for 
my own self. 
 
He summed up his experience with injections, “It's not as bad as you think it is.” 
 Alice discussed her feelings about having to give herself the first insulin injection, 
“It was frightening. I just cried and cried and cried, and I'd even ask my husband help me 
out.  Give me my shot.  He said, ‘Are you kidding?’  He's afraid of needles too.  Anyway, 
so I had to learn.” 
 Gloria shuddered when she stated, “And what I finally found out, too, about the 
shots, it just, it just hurt.” Andrew was similarly succinct in his thoughts about insulin 
therapy, “I don't like needles.  I didn't like it too much, but I had to do it.” When asked 
why he had to take insulin, he stated simply, “Because it [uncontrolled diabetes] can 
cause you know, coma, diabetic coma, paralyzed, you can get a stroke or whatever.   
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Different things can happen that's very serious.” His fear of long-term complications 
outweighed his fear of the short-term discomfort of the injection. 
 Some participants were periodically overwhelmed by their fear of needles and 
would ask a loved one to help out. Julia relied upon her boyfriend to administer the 
injection during these times, “Because sometimes when I just don't want to do it.  
Sometimes I don't want to stick myself… I say, here honey, stick me.” 
 Carrie gave herself insulin injections for about five years and still struggles,  
Even right now to this day, and it's been five years, almost five years.  And I 
alternate points, but I'm still, like, every time I'm hesitant.  I'm like, oh my God, I 
hate doing this.  Why do I have to do this?  Okay.  Take a deep breath.  All right.  
And go.  Okay.  Wait.  Okay.  I'll do it in a minute.  Wait, wait, wait. 
 
Carrie believed her athletic training helped her to do many of the tasks necessary for 
diabetes management. The discipline and self-regulation she learned as a young athlete 
prepared her to do things that are beneficial, but are not easy. 
 After several years of increasing OHAs and increased difficulty controlling blood 
sugar for more than about six months, Greg started on insulin therapy. “The transition to 
insulin went well.  Besides the shots.  I have a problem with the shots in my stomach.  
Still to this day.” He overcame his distress of giving himself insulin injections because he 
felt so much better, “But as far as how I felt physically, the insulin was a huge 
improvement.  A huge improvement.” In spite of his disdain for giving himself injections, 
Greg recommended starting insulin therapy, if needed, “The doctor, if they know 
anything about treating diabetes, they say, ‘you're ready for insulin, or you're an excellent 
candidate for insulin.’  Do it.  That would be validated.” 
  
 128 
 Anthony was particularly fearful of taking insulin. He watched both of his parents 
take insulin injections for years and remembered hoping he would never need insulin.  “I 
knew that they [parents] had to do it [take insulin shots], you know, because they wanted 
to live a long time.  My mother died at 75, and my father died at 79.” Anthony attributed 
their long life to “They did what they supposed to be doing.”   
 Gina discussed her concern about “shot etiquette” and the proper way and place to 
administer injections when around others, “No one ever tells you about shot etiquette, 
like, do you do it at the table?  Do you do it at your desk, you know?” Moreover she was 
unsure about the proprieties of glucose testing in public, “should you poke your finger 
around people or should you not do it around people, you know?” When asked about her 
practices concerning shot etiquette, she stated, “they're probably going to freak out about, 
like, blood than anything else, you know what I mean? “ She just made sure she had an 
alcohol wipe handy to clean up quickly after blood sugar testing. For administering shots, 
she decided, “So I can do it through my clothes, which is, like, no big deal.”   
 Weight gain from diabetes medication. Sixty-four year old Gloria articulated 
her struggle with a common concern for participants about insulin therapy,  
The issue for me is that diabetes — insulin is a growth hormone, and I'm like do I 
need to be bigger?  I don't think so.  But do I want to live?  Yes.  I want to live to 
105 and die in childbirth.  I am not going to be able to do that until I get the 
diabetes under control. 
 
Monica also believed that insulin contributed to weight gain, “I too struggle with the big 
gut.  I can't stand it! I believe that it's there because of the insulin.” However, Monica 
discussed other factors involved with her size. Ultimately, she valued her health and 
believed taking insulin will keep her healthy even if she carries extra weight. 
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 Greg gained “overall, 45-50 pounds” as a side effect from one OHA. He 
accommodated the weight gain by having his clothing altered. However, he continued to 
be concerned about the weight gain because it made the diabetes “not only harder to 
control, but it's worse for managing diabetes overall.” His physician told him, “You need 
to start exercising and losing weight.” His doctor added another medication used to treat 
high cholesterol, which had the added side effect of chronic muscle pain. Greg related the 
triple barrier to working out as, “So fatigue, muscle pain and weight gain.” Eventually, 
while on the OHA, Greg was able to lose 40 pounds through diet and exercise. His A1C 
improved for about six months and then began to increase.  
Gastrointestinal problems. Carrie’s pharmacist was her primary source of support and 
information about diabetes medication. 
When I first got diagnosed with diabetes, I was asking him [pharmacist] about the 
metformin, and he was telling me, ‘Well some people can tolerate it and some 
people can't. And I couldn't for a long time.  It made me so sick to my stomach. 
  
She had difficulty with eating and taking her insulin, “If I took it [metformin], I couldn't 
eat.  Then when I didn't eat I couldn't take my insulin, but then I had to take my insulin 
even if I didn't eat, which made me, oh God.” Carrie sought support from her trusted 
pharmacist and he told her, “You have diabetes.  This is what it's [metformin] going to do 
to you, I mean, but you have to take it.  There's nothing else you can do.” Carrie pushed 
through and the side effects dissipated.  
 Julia talked about unwanted side effects from her diabetes pills, “It [Glucophage] 
started giving me diarrhea, and they say, well, you've got to keep continuing to take it.” 
Julia talked with her doctor and her doctor encouraged her to stay on Glucophage. “So I'd 
been taking it [Glucophage] all these years, and all of a sudden, every blue moon I get 
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diarrhea.  Sometimes — one time I pooped on myself.” She continued to be plagued by 
diarrhea, “It would go away and come back.  Yeah.  And so she [doctor] took me off, and 
I haven't — I'm good now.”  
 Having a discussion with a trusted HCP about unwanted side effects from 
medication either encouraged the patient to persevere or to decide on an alternative 
course of treatment. Gina was taking an OHA that caused her to have diarrhea; she spoke 
with her doctor about the problem and “he ended up switching me to Januvia, Januvia-
metformin combo.  And that helped.” 
 Higher blood sugar. Often when patients initiated insulin therapy, HCPs 
prescribed a lower dose than may be therapeutic to prevent hypoglycemia. Annie was not 
aware of this practice and she was not sure that insulin was helping her to gain better 
control of her blood sugar, “But then she [physician] was the one who put me on the 
Levemir [long-acting insulin] and stuff, and that's when I thought that my blood sugar 
started to go up rather than down.” Annie pointed out entries in her logbook “Because if 
you notice they started going up.” Annie persisted and the physician adjusted her daily 
dose of insulin incrementally; she improved her blood sugar control over time.  
 Ernie had a similar experience, “I took the insulin, went back to see him 
[endocrinologist] for a follow up in 2 weeks.  My numbers were 450!” In addition to 
working with his endocrinologist to adjust the insulin dosage, Ernie engaged in learning 
about insulin therapy through the Internet and diabetes education classes to gain better 
control of his blood sugar.  
 Hypoglycemia. Some participants discussed severe hypoglycemic episodes from 
having too much insulin in their system.  Marie was hospitalized several times due to 
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severe hypoglycemia. Charlie related a time when he took his insulin and went to get 
sandwiches, “I just blacked out somewhere between picking up lunch and getting home.” 
Charlie now checks his blood sugar before driving and keeps “something really sweet 
that I can get into me quickly to make sure that it doesn't reach that point where it's 
[blood sugar] down in the 40s.” Furthermore, Charlie checks his blood sugar before 
bedtime and eats a snack if necessary, “a couple graham crackers or maybe half a cup of 
glass of milk or something like that to make sure that I don't run down low during the 
night.”  
 Participants who discussed episodes of severe hypoglycemia reported taking 
preventative measures to avoid this problem in the future. Among those strategies were 
eating a snack, testing blood sugar more often, becoming aware of the symptoms 
preceding hypoglycemic episodes, and waiting to take insulin until food is available.  
Step 8: Repeat Process When New Prescription or Refill is Needed 
 Most participants had refills on their prescriptions for at least three months and 
used this as a reminder to make an appointment with their physician within the next 
month.  “And then when I get down to that last refill, that tells me when it's time to go to 
the doctor” (Bret). 
 A retail pharmacy or mail order pharmacy may solicit prescription renewal from 
the physician as a service to the patient. However, some participants’ HCPs would not 
refill a prescription without seeing the patient every month; these patients felt unduly 
burdened by monthly doctor appointments in order to remain consistent with their 
diabetes medication.  
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Summary of Findings 
 
 Important individual and broader environmental mechanisms are associated with 
adherence to diabetes medication(s) for African Americans with Type 2 diabetes. Both 
internal and external factors that enable African Americans with diabetes to adhere to 
diabetes medication were identified. Furthermore, these resilient participants were able to 
go beyond medication adherence to develop a broader understanding of the disease and 
how to manage it. 
 Many participants and community members were well aware of the stigmatization 
in the African American community associated with having diabetes. While some 
informants made a conscious decision to not share their diagnosis with others as a means 
of avoiding judgment and unwanted attention, many participants were open about their 
diagnosis. Those who were more open believed there was nothing to be ashamed about 
and thought discussion of diabetes allowed them to be more informed and created a safer 
environment.  Their motivation for sharing with family members was twofold; they 
understood that genetics played a part in diabetes and wanted to be a positive example for 
their family.  
 Moreover, participants accepted the diagnosis of diabetes and understood the 
potential ramifications of not engaging in adequate diabetes self-management, including 
medication adherence. Participants often told stories about loved ones who suffered dire 
consequences as a result of poor diabetes management, which provided caution about the 
need to be vigilant about their own diabetes management. In addition, informants 
believed taking care of diabetes now would allow them to be healthier in the long term.   
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 The healthcare team included physicians and a variety of other members (e.g. 
diabetes educators, nutritionists, physician assistants). However, one of the more salient 
members of the healthcare team was the pharmacist. The majority of participants 
obtained their prescription medication through a local pharmacy as opposed to through 
mail order. Many participants had tremendous respect and trust in their neighborhood 
pharmacist. The reasons for this choice were as follows: 1) they get refill reminders; 2) 
they have a beneficial professional relationship with their pharmacist; 3) it is part of their 
routine; 4) problem solving is easier in person; and 5) they could obtain reliable diabetes 
information. Those who chose a mail order pharmacy cited the convenience and believed 
the simplicity of this process helped them to more easily obtain diabetes medication.  
 Four emerging gendered typologies were noted: 1) Alpha women; 2) Networking 
women; 3) Warrior men; and 4) Trustee men. It is important to remember that all of these 
typologies were associated with diabetes medication adherence; there is not one way to 
be successful at taking diabetes medication.  
 Alpha females were more likely to be keenly aware of stigmatization; therefore, 
they were less likely to talk with others about their diabetes. However, they were 
interested in learning about diabetes management and engaged in diabetes self-
management education in their own and in groups. Alpha women were strong 
independent women who viewed diabetes as a weakness or vulnerability. They had high 
expectations for their HCPs and were highly assertive in their relationship with HCPs. 
These women were likely to discuss their relationship with God as personal and 
supportive, believing God provided guidance and help when they need it.  
 Networking women acknowledged the stigma related to diabetes, but were open 
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about talking about diabetes with others because they valued the support of family, 
friends and co-workers in addition to their HCPs and God. Their support network was 
ever-increasing and judgment from others was of little concern to them. Their optimistic 
orientation toward caring for their diabetes transferred to their relationship with their 
HCPs; these women generally felt cared for by their healthcare team. For many 
Networking women, God was a partner in life and that included diabetes management. 
 Warrior men were educated men who viewed diabetes as the enemy; they were at 
war and welcomed any addition to their arsenal. Therefore, these men had a large support 
system, which included their healthcare team, family, friends, co-workers, educational 
resources, and a relationship with God. Knowledge was power and these men often went 
to diabetes education classes more than once after diagnosis. Warrior men appreciated a 
HCP who was direct and clear about what needed to be done to win the fight against 
diabetes. Warrior men favored a consistent regimen when engaging in diabetes self-
management; they were extremely disciplined, rarely wavering from prescribed routines.  
 Trustee men described a compliant relationship with HCPs, believing the doctor 
knows best. These men would do whatever the HCP recommended without question, 
even if they disagreed with the treatment plan. They seldom engaged in discussions with 
HCPs or others about diabetes management. They did not want much social support and 
quietly took care of themselves.  
 The process of medication adherence model aids in understanding internal and 
external factors that enable African Americans with diabetes to engage in medication 
adherence. Furthermore, these resilient participants were able to overcome common 
barriers and pitfalls to achieve diabetes medication adherence on a consistent basis. 
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Participants often had routines to support diabetes medication adherence, which included 
preparation for HCP appointments, convenience of pharmacy location and relationship 
with pharmacist, rituals around taking medication, and strategies for overcoming fears 
and side effects. These resilient people were able to creatively problem solve points of 
potential adversity and develop solutions that allowed them to persevere and consistently 
take their diabetes medication.  
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Chapter 5 
 
DISCUSSION 
 
 This study explored the broad question, “What mechanisms are associated with 
adherence to diabetes medication(s), including insulin, for African Americans?” More 
specifically, this research project had two primary aims: 
  Aim 1: To explore what individual and broader environmental mechanisms 
 are associated with adherence to diabetes medication(s) for adult African 
 Americans with Type 2 diabetes.  
 Aim 2: To identify internal and external factors that enable African Americans 
 with diabetes to go beyond adherence and to develop a broader understanding of 
 the disease and how to manage it. 
Resiliency is an important mechanism of protection characterized as an adaptive 
response to stressful circumstances (Billingsley & Morrison-Rodriguez, 2007; Hill, 2007; 
Rutter, 1987). Resnicow and Page (2008) suggest, “Change is usually conceptualized as 
rational and a deterministic process in which individuals obtain information, consider 
pros and cons, make a behavioral decision, and then plan a course of action” (p. 1382). 
Many assume this process is under the conscious control of the person making the 
change; however, this may not necessarily be the case. Internal and external forces 
influence people without their conscious assent. Resnicow and Page (2008) further assert, 
“It is not so much a planned decision, but something that arrives beyond cognition” (p. 
1382). Moreover, Rutter and Sroufe (2000) suggest, “mechanisms involved in causation 
might entail dynamic processes operating over time, that indirect chain effects might 
often be present, and that there might be several different routes to the same outcome”  
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(p. 268). Certainly there is no one-size-fits-all formula to diabetes medication adherence; 
participants each shared their own pathway to adherence. Thus, the value of this research 
is in increasing our awareness of the shared processes involved in diabetes medication 
adherence and pursuing a deeper understanding of examining how participants arrived at 
the decision(s) required to be adherent.  
 The themes elicited from this study: 1) illness perception and empowerment; 2) 
salient formal and informal support; and 3) strategies for navigating the process of 
medication adherence suggest a number of mechanisms that were associated with 
medication adherence and can be extended to others. The participants in this study were 
all on insulin and adherent with their medication as measured by the SMAQ. In short, 
their acceptance of the diabetes diagnosis, beliefs about diabetes, self-efficacy, personal 
locus of control, and the importance of taking their diabetes medication as recommended 
supported the decisions to be medication adherent. The discussion chapter will place the 
findings of the present study in the context of the existing literature reviewed and 
summarized in the first two chapters. The implications section will discuss how to utilize 
this valuable information to improve the lives of others who struggle with diabetes 
medication adherence.  
Discussion of Findings 
 Resiliency theory provided the lens through which the data was interpreted and 
eco-systems theory provided the framework for viewing resiliency. Thus, resiliency was 
observed at the individual, family and friends, community (e.g. healthcare providers, co-
workers, church relationships), and society levels (e.g. historical context, policies, health 
insurance). Moreover, resiliency theory allowed for a focus on strategies and mechanisms 
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that promote diabetes medication adherence. This perspective is innovative in that prior 
studies have taken a problem-oriented focus concerning medication adherence, focusing 
on barriers rather than overcoming those barriers. When identifying patterns associated 
with resilience, there is a need to understand the related concepts of competence, 
adversity, asset, and risk (Yates & Masten, 2004). Participants were faced with adversity 
and risk (diabetes management) and responded with competence (adherence to 
medication) by exerting their assets (successful problem-solving strategies). Many 
participants stated they had no choice but to take their medication, but certainly there are 
people with diabetes making the choice not to manage diabetes every day. The lens of 
resiliency allows the researcher to explore the participants’ responses to adversity, with 
the intention of disseminating those resilient strategies to the larger community. 
 Key findings related to resiliency and individual mechanisms consistent with 
diabetes medication adherence include (1) participants’ negotiation of diabetes 
stigmatization; (2) acceptance of the diabetes diagnosis; (3) high level of self-efficacy as 
evidenced by their expressed confidence in their ability to engage in self-care behaviors 
(including medication adherence) necessary to control blood glucose; (4) understanding 
of the ramifications of diabetes self-management; and (5) garnering support from both 
formal and informal resources.  
 Participants were motivated to avoid poor outcomes and debilitating 
consequences associated with failure to adequately control blood glucose (e.g. 
progression of disease, amputations, blindness); however, they were equally likely to cite 
their desire to increase well-being and improve their health as motivation to engage in 
medication adherence. Furthermore, participants had a deep understanding of the value of 
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all aspects of diabetes self-management (e.g. medication adherence, healthy diet, 
adequate activity, glucose monitoring, regular doctor visits) today leading to an improved 
quality of life in the future. The strategies used to improve their diabetes self-
management varied, suggesting there is more than one pathway to managing diabetes and 
approaches to diabetes self-management need to be developed by the patient in 
conjunction with HCPs.   
Stigmatization of Diabetes 
 Many participants were unaware that there was a familial history of diabetes until 
they were diagnosed and chose to talk with a family member, usually their mother.  Julia 
and Vanessa were excellent examples of how learning about genetic factors and the 
extent of diabetes in their families led to medication adherence. Kirkman et al. (2015) 
suggest patients who were newly diagnosed with diabetes were significantly less likely to 
be adherent to diabetes medication. This may be, in part, because they are in denial and 
have not accepted the diagnosis of diabetes; therefore, acceptance of the diagnosis is of 
primary importance for diabetes self-management.  
 Once the family history of diabetes was disclosed, this set in motion a cavalcade 
of potential support from other family members. Moreover, many participants were 
committed to breaking the silence and openly discussed diabetes prevalence and 
prevention with their own children. Link and Phelan (2001) suggest an examination of 
stigma should extend to incorporating how "people artfully dodge or constructively 
challenge stigmatizing processes" (p. 387). The resilient people in this study were, in 
essence, choosing not to participate in the acknowledged diabetes-related stigma present  
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in the African American community and breaking the silence by challenging stigmatizing 
processes (Link & Phelan, 2001). 
 The stigmatization of diabetes may have its roots in slavery and the treatment of 
sick slaves. Plantation owners viewed African Americans as property and, therefore, were 
compelled to care for the sick (Andreae, 2009; Collins, 1853). However, resources 
allocated to care for sick slaves were dependent upon the perceived worth of the worker 
in terms of productivity (Haller, 1972; Sellers, 1994). Sick slaves faced a conundrum; 
they were forced to reveal their weakness (being sick) at the risk of being negatively 
labeled as malingering or deceptive (Andreae, 2009). Furthermore, if slaves were 
chronically ill, the owner may devalue their worth and sell or trade them for a healthier 
worker (Andreae, 2009). This historical view of sickness may persist to modern times 
without conscious assent by African Americans. Thus, the perception of diabetes as a 
weakness or burden that must not be revealed continues. Moreover, in every sense of the 
word, stigmatization is seen as an "attribute that is deeply discrediting and that reduces 
the bearer from a whole and usual person to a tainted discounted one"  
(Goffman, 1963, p. 3) in the narratives of many participants, particularly Alpha women. 
Many participants chose to eschew stigmatization either by keeping their diagnosis 
private or telling others to increase support. Furthermore, participants empowered 
themselves through knowledge to engage in diabetes self-management. 
Knowledge Empowerment and Diabetes Medication Adherence 
 The second aim of this study was to identify internal and external factors that 
enable African Americans with diabetes to go beyond adherence and to develop a broader 
understanding of the disease and how to manage it. The development of this broader 
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understanding of diabetes was interwoven in the interviews and focus groups. Many 
participants comprehensively discussed diabetes self-management, which suggested they 
possessed a deep understanding of their condition and the various means necessary to 
fully engage in self-management (e.g. diet, activity, glucose monitoring, regular HCP 
visits).   
 Psychosocial barriers consistently related to diabetes self-management and 
resiliency were self-efficacy, locus of control, and social support (King et al., 2010; 
Sarkar, Fisher, & Schillinger, 2006). Ajzen (2002) asserts that self-efficacy focuses 
primarily with the person’s assessment of the relative ease or difficulty of performing a 
given behavior, whereas locus of control measures the extent to which a behavior is 
under the control of the individual versus an external agency. Furthermore, Bandura 
(1977) proposed that the confidence patients have in their ability to competently perform 
a given health behavior will determine which behaviors they will adopt. Thus, high self-
efficacy is consistently associated with improved health outcomes (Krichbaum, Aarestad, 
& Buethe, 2003; Sarkar et al., 2006).  
 The assets of self-efficacy and internal locus of control are consistent with a 
resiliency perspective and were invaluable for participants in this study. While the 
questions targeted medication adherence, many participants discussed related issues that 
suggested they possessed a deep understanding of their condition and the various means 
necessary to competently engage in self-management (e.g. diet, activity, glucose 
monitoring, regular HCP visits). For these participants, knowledge was foundational to 
knowing what activities were most important to adequately manage blood sugar; 
therefore, the vast majority of participants attended DSME classes at least once (83%).  
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 “Diabetes self-management education (DSME) is the ongoing process of 
facilitating the knowledge, skill, and ability necessary for diabetes self-care”  
(Funnell et al., 2011, p. 1). Participation in DSME classes is known to significantly 
improve adherence to medical treatment and is associated with lower A1C (Brunisholz et 
al., 2014). Furthermore, for every dollar spent on DSME, a savings of up to $8.76 can be 
realized (Klonoff & Schwartz, 2000). Li et al. (2014) found extremely low participation 
in DSME, defined as attendance in one class, during the first year after a diabetes 
diagnoses (6.8%). The findings from Li et al. (2014) are not consistent with standards of 
care (ADA, 2014), which suggest DSME should be received by patients upon initial 
diagnosis of diabetes and whenever needed to increase self-efficacy. For example, when 
patients are initiated onto insulin therapy, DSME can assist in this transition by providing 
a specific understanding of the side effects of insulin and guidelines for safe utilization.  
 Furthermore, ADA (2014) suggests DSME must provide care for psychosocial 
issues to optimize positive outcomes. Participants in this study were very likely to utilize 
DSME as a cost effective intervention and many informants attributed their success with 
diabetes self-management to participation in DSME. Best practices would suggest 
patients with diabetes need to be provided with a prescription for DSME and prompted to 
take advantage of this important resource that stresses developing individual strategies to 
adequately address psychosocial concerns and personal action-centered strategies to 
engage in lifestyle and behavior changes to effectively mange diabetes  
(Funnell et al., 2011; Haas et al., 2013). 
 Many participants cited foundational knowledge was obtained from attending 
DSME classes; however, these resilient participants often sought information through a 
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variety of resources including HCPs (e.g. physicians, pharmacists, nutritionists, certified 
diabetes educators) and through other resources (e.g. Internet, brochures, books). In 
addition, some had strong connections with friends and family with diabetes.  
Support 
 While type and degree of social support varied for participants, all participants 
saw the need for support in learning about diabetes and adequately managing it. On one 
end of the continuum, the Alpha women and Trustee men were content to have a limited 
support system with the primary support of HCPs and maybe the inclusion of spirituality; 
Networking women and Warrior men were intentionally widening their support system to 
include an array of friends, family, and other resources, albeit for different reasons. 
 Family and friends. Alpha women self-identified as strong, self-sufficient, 
independent African American women. This disposition of being the one who cares for 
others may create a barrier to identifying and accepting support, even the same type of 
support they would give to those they love. For example, Alpha females perceived 
“nagging” had a negative connotation. Furthermore, these women perceived attempts at 
supportive behaviors by others (e.g. attending diabetes education classes, reminding them 
to take medication, invitations to exercise) as judgmental and not supportive for them.  
 Conversely, “nagging” did not bother Black men; in fact, they perceived it as 
evidence that someone loved and cared for them. However, Trustee men were less likely 
to see a need to increase support from others and were more likely to manage diabetes 
with only assistance from HCPs. Warrior men perceived social support, even nagging, in 
many forms as another tool in their kit to fight diabetes. Similarly, Networking women 
welcomed support from others.  
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 Thus, for African Americans, supportive behavior may be conceptualized very 
differently according to gender. This difference in perception may be related to 
traditional roles; African American women have often functioned in the caregiver role in 
addition to financially supporting the family (Tang et al., 2008; White, 1983).  
 Tang et al. (2008) utilized the symbolic interaction theory (Blumer, 1969) as the 
framework for understanding individual behavior in the context of subjective experience 
in the social exchange. For example, an individual’s perception and thus, the 
interpretation of social support have an effect on how a given interaction is received. This 
framework is useful in understanding gender differences in social support in the African 
American participants. Consistent with these findings, Tang et al. (2008) found African 
American men in their study reported more social support and diabetes-care related social 
support than their female counterparts. Moreover, the men were more satisfied with the 
quality of the support and perceived support as more positive compared to the women.   
 The second Diabetes Attitudes, Wishes, and Needs (DAWN2) was a global 
survey that sought to better understand the experiences of people with diabetes and their 
families with the aim of improving diabetes self-management through psychosocial 
mechanisms (Kovacs Burns et al., 2013; Nicolucci et al., 2013). Furthermore, Peyrot et 
al. (2014) specifically examined U.S. data to understand ethnic differences in 
psychosocial attitudes among non-Hispanic whites, African Americans, Hispanic 
Americans, and Chinese Americans. Overall, a higher perception of social support, a 
larger diabetes-related support network, and a sense of availability of support were 
associated with improved psychological outcomes for all people with diabetes. However, 
Peyrot et al. (2014) found salient differences in social support; African Americans and 
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Hispanic Americans reported having larger support networks. But, minority groups 
reported more diabetes-related family arguments than non-Hispanic whites. Peyrot et al. 
(2014) hypothesized more frequent family arguments may be related to increased 
interaction with family members in minority groups.   
 Thus, the social worker, as part of the healthcare team, can be a catalyst for 
reshaping the patient’s view of social support, helping the person with diabetes to 
appraise various types of behaviors perceived as constructive and caring versus those that 
feel negative or critical. It may be beneficial for African American people with diabetes 
to understand the potential benefits of increased social support and learn how to clearly 
communicate their needs and wants when it comes to diabetes-related support. Moreover, 
the social worker is uniquely trained to integrate caregivers (spouses, other family and 
friends) into the support network and teach them to effectively communicate support, 
which may assist the person with diabetes to better engage in diabetes self-care, including 
medication adherence. Furthermore, social workers can assess and integrate additional 
salient support as identified by the person with diabetes, which may include spirituality.  
 Spiritual support. Many participants expressed the value of spirituality and 
support received from their personal relationship with God. Some participants, like 
Vanessa, articulated a long history of spiritual support when facing other challenges 
throughout her life course. Others simply acknowledged a general sense that God was 
watching out for them. The range of personal spiritual connection was observed and the 
absence of acknowledging institutional support from the Church was salient. Therefore, 
while the Church, as an institution, may contribute to a personal spirituality, participants 
did not specifically attribute diabetes-related support to their church. A few participants 
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discussed the presence of health programming (health fairs, educational events), but did 
not perceive a personal need for those types of events.  
 This does not mean the Church is irrelevant in assisting people with diabetes in 
medication adherence and broader aspects of diabetes self-management. To the contrary, 
the Black Church has a vital role in encouraging congregants and the larger community to 
care for their bodies as the “temple of the Holy Spirit” (I Corinthians 6:19 New King 
James Version) and to highlight the benefits of “bear one another’s burdens” (Galatians 
6:2) to increase social support. Historically, the Black church is the center of African 
American life (Billingsley & Morrison-Rodriguez, 2007; Hill, 2007) and has been 
concerned with holistic health (Warren & Charles, 2011); many Black churches prioritize 
health as an integral part of their ministry and outreach to the larger community. The 
Church can be a catalyst for change by openly discussing diabetes management, reducing 
stigma, highlighting individuals who are managing diabetes well, and fostering support 
for all people with diabetes.   
 Faith-based health interventions, which target prevention and treatment of Type 2 
diabetes in African Americans, have been shown to improve health outcomes  
(Collins-McNeil et al., 2012; Johnson et al., 2014). Moreover, there are culturally 
compatible resources available for African American churches to initiate DSME classes. 
For example, Project POWER is a faith-based program designed to provide Black 
churches with activities throughout the year to increase awareness and improve the health 
of those living with diabetes and their families (ADA, 2014). There are six modules 
facilitated by Project POWER ambassadors, lay members of the church, designed to 
empower African Americans to learn more about diabetes prevention and management. 
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Consistent implementation of these types of programs can support the mission of the 
Church and improve health outcomes for the African American community.  
Practice Implications 
 The process of diabetes medication adherence is complex and rife with obstacles 
that patients must overcome successfully in order to maintain medication adherence. A 
salient finding from this research is an identification of the multistep process of diabetes 
medication adherence and the hurdles present for participants. Moreover, the role of 
healthcare professionals in adherence to diabetes medication is evolving; the role of the 
patient is increasing and physicians must partner with other HCPs to achieve optimal 
results. Evidence-based interventions are providing HCPs with a myriad of options to 
increase diabetes medication adherence in the context of team-based healthcare.   
The Process of Medication Adherence 
 Sustaining medication adherence is not a simple task. Participants described an 
eight-step process of medication adherence that must be successfully navigated in order 
to maintain adherence. Participants provided strategies used to solve common barriers in 
this process. HCPs can widely distribute these strategies to those who find themselves 
stuck at one or more points in this process. Moreover, the process can provide a road map 
for patients and HCPs to discuss and identify and resolve the point(s) of challenge for 
patients. 
 Several salient strategies can be extended to those who struggle with adherence.  
For example, one strategy involved scheduling appointments well ahead of time to reduce 
lost work time and ensure renewing a prescription in a timely manner. This simple idea  
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can be implemented in conjunction with the HCP staff to assist in making timely 
appointments and facilitate ongoing care and medication adherence.  
 Pharmacists were an integral part of the successful medication adherence equation 
(Brennan, 2012; Grant, Devita, Singer, & Meigs, 2003; Jacobson, 2014; Kalsekar, 
Sheean, & Peak, 2007; Krass Taylor, Smith & Armor, 2005; Mazroui et al., 2009; 
Odegard, Goo, Hummel, Williams & Gray, 2005; Phumipamorn, Pongwecharak, 
Soorapan, & Pattharachayakul, 2008). In addition to refilling prescriptions, study 
participants utilized this resource for additional information and support. Improving 
communication among all HCPs will provide a safety net for the patient and timely 
renewal of prescriptions leading to increased medication adherence. Furthermore, the 
utilization of pharmacies as a center for education has tremendous potential. It may be an 
innovative place for social workers to partner to increase adherence. Social workers could 
communicate with patients to better understand whether non-adherence is intentional or 
unintentional; thus, tailoring an intervention and offering resources to fit the patients’ 
needs.  
 Moreover, participants described various ways of setting up the home 
environment for success including clustering medication and supplies in a central area 
and attaching taking medication to an already existing behavior (e.g. meals, brushing 
teeth, time of day).  Participants were particularly adept at overcoming their fear of 
needles and challenges concerning unwanted side effects. The strategies used by these 
participants are generally accessible for other patients and can be distributed to those who 
struggle with medication adherence due to apprehension and unwanted side effects. 
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The Role of Healthcare Professionals in Medication Adherence 
 The practice of medicine is evolving at a rapid pace and includes an examination 
of past processes and roles, which may not be serving the patient in modern times. 
Andersson, Garfield, Eliasson, Jackson, and Raynor (2014) reviewed 103 publications 
that included randomized control trial (RCT) interventions to improve medication 
adherence in diverse populations. Moreover, the RCT interventions had to include a 
defined role in intervention delivery for pharmacists and/or physicians. Pharmacists 
typically assumed the role of patient educator and made medication treatment 
recommendations. Of these interventions, 66% led to improved medication adherence, 
while 73% led to improved clinical outcomes (e.g. lower A1C). Andersson et al. (2014) 
recommend HCPs receive specific training in developing a concordant approach with 
patients where a treatment plan meets identified needs of the patients, thus, increasing 
adherence. Moreover, Andersson et al. (2014) suggest non-adherence to a medication 
prescribed by a HCP may be an appropriate informed decision by the patient. 
 Patient–physician roles in medical decision-making. Participants in this study 
used a number of different ways of relating to their HCPs. It is important to note that 
many patients had high expectations for their HCPs and clearly communicated when they 
had questions or problems concerning their medication. The patients in this study can be 
located at various points on the shared decision-making continuum in their own decision-
making process with their HCPs. Moreover, they provided important insights into the 
value of patient-centered care and factors related to a trusting relationship with HCPs 
(e.g. listening, answering questions, spending adequate time). Peyrot et al. (2014) found 
African Americans were more likely to report experiencing patient-centered care than 
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their white counterparts. Furthermore, Peyrot et al. (2014) found a strong association 
between patient-centered care and diabetes empowerment; thus, people with diabetes  
who were engaging in patient-centered care were significantly more likely to experience 
diabetes self-care empowerment.   
 A salient finding in the physician-patient relationship was the lack of guilt 
participants expressed about transitioning to insulin. Their HCPs were able to help them 
understand the need for a different treatment (insulin) to supplement or replace their 
OHAs. This respectful, non-judgmental strategy made the need for insulin a natural part 
of the progression of diabetes rather than a failure on the part of the patient. While many 
participants immediately accepted advice from their doctor to begin insulin therapy, 
several participants stated it took some time for them to be ready to initiate insulin 
therapy. Regardless of the initial response, patients were included in this decision and 
their views were respected. 
 Makoul and Clayman (2006) suggest that decision-making runs along a 
continuum; at one extreme is the healthcare professional unilaterally making the decision 
without patient input and at the other extreme is the patient making medical decisions 
without consulting the HCP (Figure 14). Makoul and Clayman (2006) suggest better 
outcomes are related to shared decision-making, which lies somewhere in the center of 
the continuum. 
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Figure 14. Integrative Model of Shared Decision Making in Medical Encounters 
Source: Makoul & Clayman (2006, p. 307) 
 
 While there was variation in the study participants’ expectation for participation 
in the medical decision-making, ideally, the concordance approach to patient care would 
be implemented to elicit various opinions resulting in a decision agreed upon by both 
patient and physician (Horne et al., 2005). This approach insists that healthcare team 
members reach beyond simply asking patients if there are any questions to making 
certain the patient understands his or her options and can articulate what he or she would 
like to do. Epstein and Street (2011) suggest “helping patients to be more active in 
consultations changes centuries of physician-dominated dialogues to those that engage 
patients as active participants” (p. 101). Furthermore, Epstein and Street (2011) suggest 
understanding the specific proximal outcomes of patient-centered care that might 
contribute to improving adherence and self-care is essential. It is imperative that patients 
take part in the decision-making process and that may take some persistence and 
coaching on the part of the healthcare team.  This may be particularly important for 
Trustee men who described passivity and compliance in their relationship with their 
physicians.    
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 Pharmacists’ role in adherence. A salient finding was the study participants’ 
value of the pharmacist as an integral part of their healthcare team. Many informants in 
this study reported feeling comfortable asking questions of their pharmacist and 
expressed appreciation for information gained through these interactions. Furthermore, 
informants who went to the pharmacy on a monthly basis were likely to pick up 
educational materials in the form of brochures and free magazines while obtaining their 
prescription medication. Increasing the role of the pharmacist in improving medication 
adherence is consistent with findings from this study. 
 According to the 2013 Boehringer Ingelheim Pharmacy Satisfaction Pulse Survey, 
which included 5,455 patients diagnosed Type 2 diabetes, nearly 20% of patients filled 
prescriptions more than 50 times in the past year (Jacobson, 2014). Moreover, 76% of 
patients were very comfortable discussing Type 2 diabetes with their pharmacist and 85% 
considered the role of their pharmacist to be important in their overall health (Jacobson, 
2014). Furthermore, 52% of people with diabetes were more interested in receiving 
written information about their medical condition and general health topics than were 
other pharmacy patients (42%). This is consistent with participants in this study that often 
asked questions of their pharmacist about their medication and diabetes management in 
general. Moreover, many participants looked forward to obtaining free magazines and 
pamphlets from the pharmacy that provided reliable information about diabetes self-
management.  
 In 2012, 24% of American diabetes patients utilized mail order pharmacies as 
their primary resource for obtaining prescription medications (Jacobson, 2014). 
Furthermore, Jacobson (2014) reported that people with diabetes were significantly more 
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likely (66%) to exercise their option for a 90-day medication refill compared to other 
patients (48%). People in this study who showed a preference for mail order pharmacies 
felt obtaining their medication without interruption and with as little effort on their part as 
possible was integral to their ability to be medication adherent. HCPs may want to 
explore a mail order pharmacy as an option for those who have difficulty remembering to 
reorder or experience challenges in obtaining their medication (e.g. transportation 
barriers, no delivery by pharmacy in town).  
 Pharmacists have an opportunity to increase their role in the health of their 
patients and play a pivotal role in promoting medication knowledge and adherence. For 
example, many pharmacies currently offer helpful services to their patients such as free 
diabetes screening, medication refill reminders, diabetes education classes, information 
about insurance coverage, and money saving programs (Jacobson, 2014). Moreover, 
Brennan (2012) evaluated a pharmacy-based intervention aimed at improving diabetes 
patients’ adherence rates. This large study included an intervention group with 5,123 
patients with diabetes and a control group of 24,124 matched patients with diabetes. The 
intervention involved both mail order and retail pharmacists who were provided with 
information on patients’ adherence to medication (Brennan, 2012). When pharmacists 
used this adherence information to encourage patients, diabetes patients’ medication 
adherence rates were increased by 2.1%, compared to the control group (Brennan, 2012).  
 Moreover, patients who received counseling in the retail setting benefitted more 
than those who received phone calls from pharmacists based in mail-order pharmacies, 
suggesting face-to-face interaction between the pharmacist and patient contributed to the 
increase in adherence (Brennan, 2012). Furthermore, the pharmacy-based interventions 
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were cost-effective; the return on investment was about $3 for every $1 spent on the 
intervention (Brennan, 2012).    
 Due to the promising findings regarding pharmacist led interventions in 
conjunction with the positive regard study participants reported for their pharmacists, 
expanding the role and scope of practice for pharmacists may lead to increased 
medication adherence. Pharmacists can assist patients with Type 2 diabetes improve 
adherence to antihyperglycemic medications (Omran, Guirguis, & Simpson, 2012) and 
increase patient knowledge (Grant et al., 2003; Kalsekar et al., 2007; Krass et al., 2005; 
Mazroui et al., 2009; Odegard et al., 2005; Phumipamorn et al., 2008). Moreover, 
pharmacist-led interventions not only improved medication adherence rates, but some 
also demonstrated lower A1C as compared to the control group (Mazroui et al., 2009; 
Odegard et al., 2005; Phumipamorn et al., 2008).  
 Patient education was the most common strategy used in pharmacist-led 
interventions (Grant et al. 2003; Kalsekar et al., 2007; Krass et al., 2005;  
Mazroui et al., 2009; Odegard et al., 2005; Phumipamorn et al., 2008). The educational 
component focused on improving the patient’s knowledge and understanding of various 
diabetes medications through a discussion of the expected benefits and potential side 
effects. Beyond an increased understanding of diabetes medication, education included 
increasing knowledge and awareness of other aspects of diabetes including risk for 
complications and healthy lifestyle changes (Omran et al., 2012). These educational 
components were delivered through face-to-face meetings between the pharmacist and 
patient and some involved supplementation with written information  
(Mazroui et al., 2009; Odegard et al., 2005; Phumipamorn et al., 2008).    
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 Team-based health care. The participants in this study relied upon HCPs to 
assist in improving their health and described high expectations for these interactions. 
Alpha women wanted an “investment” in their health; Networking women wanted 
“caring” physicians; Warrior men needed “direct” communication; and Trustees relied 
heavily upon HCP expertise. These ideas are not mutually exclusive; in fact, it is possible 
to train HCPs and other members of the healthcare team to be invested experts with  
communication styles that are both direct and caring. Participants in the research study 
benefitted from a team-based approach to their care, which included a variety of HCPs.   
 Primary care physicians are in short supply (Phillips, Bazemore & Peterson, 
2014); therefore, the time is right for the advancement of an integrated team approach to 
patient care. To best serve patients in the future, it is necessary to innovate the healthcare 
delivery system to be truly patient-centered.  
 Healthcare models, such as Iora, are on the cutting edge of innovation in 
healthcare delivery (Fernandopulle, 2013; Landman, Aannestad, Smoldt, & Cortese, 
2014). Iora reinvented the model for healthcare by eliminating the fee for service billing 
and focusing on a team-based approach utilizing health coaches (Fernandopulle, 2014; 
Landman et al., 2014). Social workers are perfectly suited for the health coach role, 
which includes patient advocacy, assisting with behavior change, and support. In fact, the 
Iora approach requires a social worker as a vital component of the healthcare team. In 
pilot testing, this model has demonstrated improvement in patient experience, health 
outcomes, and lower healthcare costs (Fernandopulle, 2013).  
 Patient needs and challenges are comprehensively assessed using the eco-systems 
model. The strengths of patients are weighed and interventions to improve health are 
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discussed as a team, which includes the patient; the health coach supports the patient in 
carrying out the agreed upon plan (Fernandopulle, 2013). Increasing patient support can 
include more frequent visits with a health coach or social worker, activities with other 
Iora community members, and individualized solutions to medication adherence 
struggles.  
 The findings from this study have potential to impact the training of the next 
generation of HCPs. In our current culture of healthcare reform we need innovative 
notions concerning how to define and achieve patient-centered care, which improves 
outcomes and reduces costs is invaluable.  
Interventions to Improve Medication Adherence 
 The patients in this study believed medication adherence was crucial in 
preventing or eliminating diabetes-related complications. Some participants reported 
times in the past when they intentionally decided not to take their medication due to 
denial or fear of needles; others were in circumstances in which affording the medication 
was the issue and they were unintentionally non-adherent.   
 The findings from this study stress the importance of interventions tailored to 
individual needs. Moreover, practitioners must distinguish between intentional non-
adherence and unintentional non-adherence; there is a difference in intervention when a 
patient lacks motivation to take medication as opposed to one who is experiencing 
barriers to taking medication. Furthermore, it is crucial to address an individual’s specific 
situation in order to improve adherence (Clifford, Garfield, Eliasson, & Barber, 2010).  
 Modifying patient beliefs about diabetes medication is a promising avenue for 
improving diabetes medication adherence. Broadbent, Donkin, and Stroh (2011) found 
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patients hold specific beliefs about diabetes management and the relative importance of 
diet, exercise, and medication adherence concerning outcomes and perception of risk for 
diabetes-related complications. Patients ranked medication as the most important aspect 
of diabetes management; moreover, they rated medication adherence as more important 
than either diet or exercise (Broadbent et al., 2011).  
 Segal, Leach, May, and Turnbull (2013) suggested that in addition to medical 
management, access to psychosocial care is required if clinical targets for diabetes 
management are to be met; this is especially true for underserved populations.  
Wailoo (2006) suggests the experiences of disease by African Americans are 
"designating hidden invisible taints. . . and thereby reinforcing broader prejudices and 
policies" contributing to health disparities in America (p. 533). Thus, policies that may 
contribute to disparities in prevention and outcomes of diabetes need to be honestly  
assessed for discrimination. 
 Social workers can be a valuable part of healthcare teams, as they possess 
distinctive training in culturally appropriate psychosocial care: relationship skills useful 
in improving communication with other healthcare professionals and significant others; 
effective behavioral change and coping skills; and expertise in understanding how 
ecological systems influence people with diabetes (DeCoster, 2001;  
Karls & O’Keefe, 2008; Segal et al., 2013; Snoek et al., 2011). Social workers can make 
substantial contributions to the creation and teaching of DSME classes; furthermore, they 
can communicate the need for culturally appropriate psychosocial components of care in 
addition to foundational knowledge (DeCoster, 2001). In fact, social workers’ behavioral 
science training that includes instruction in behavior modification, coping skills, and both 
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stress and time management is a perfect companion to the traditional biological and self-
management skills training in many DSME programs (DeCoster, 2001).    
 Furthermore, assisting patients with chronic conditions requires a more complex 
approach beyond basic information. Haynes, Ackloo, Sahota, McDonald, and Yao (2008) 
suggest interventions delivered by HCPs such as nurses and pharmacists were worthy of 
future research. Patients need to understand potential side effects and implications of 
long-term treatment. In addition to information, reminders via texting, telephone follow 
up, and additional supervision may help patients to develop habits that lead to long-term 
adherence (Haynes et al., 2008).  Furthermore, Haynes et al. (2008) suggest some patients 
may benefit from individual counseling, family therapy, or crisis counseling, which could 
be expertly provided by social workers. 
 Overcoming barriers to adherence. An enhanced understanding of barriers to 
adherence has led to the development of the AIDES method (Table 11). This approach 
incorporates information gathered from 153 studies of medication adherence 
interventions (Horne et al., 2005). In particular, social workers and diabetes educators can 
be trained to assess patient needs concerning medication adherence using the AIDES 
method. This method provides a unified forum for identifying challenges for patients and 
working with them to create a plan that leads to improved medication adherence. The 
data from the informants in this research study can be used to create a menu of options to 
assist with problem solving at each juncture. 
 
 
 
 159 
Table 11. The AIDES Method for Improving Adherence to Medications 
A Assessment: Assess all medications 
I Individualization: Individualize the regimen 
D Documentation: Provide written communication 
E Education: Provide accurate and continuing education tailored to the needs of the 
individual 
S Supervision: Provide continuing supervision of the regimen 
Source: Horne et al. (2005), p. 384  
 
 The social worker can target individual, familial, or broader aspects of the 
environment by utilizing the AIDES method. Social workers trained in health education 
and behavioral changes have the opportunity to address diabetes self-management from a 
fresh perspective. Social workers can assist patients in creating a self-management plan  
that leads to acceptance of their condition and increases self-efficacy, key elements 
related to adherence.  
 Motivational interviewing. Participants described the process of diabetes 
medication adherence, which included self-awareness resulting in lasting behavioral 
change. Resnicow and Page (2008) suggest “mini-epiphanies” may be a catalyst for 
behavior change (pp. 1382-1383). One tool that shows promise in promoting these 
epiphanies and engagement in patient-centered care is motivational interviewing (MI). 
MI began as an evidence-based approach in addiction and recovery models in the 1980s 
(DiClemente & Prochaska, 1998). The stages of change characteristics are in Figure 15. 
This approach acknowledges gaps between knowledge and behavior choices  
(Christie & Channon, 2014; DiClemente & Prochaska, 1998). In fact, this approach 
extends permission to make no change at all if that is the choice a person wishes to make 
at a given time.  
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 In addition to other HCPs, social workers are poised to utilize MI to engage 
patients in healthy lifestyle adaptations and empowerment. The MI trained practitioner 
guides the conversation, providing a listening ear that intentionally explores dissonance 
and stresses exploring the benefits of making changes to improve outcomes (Christie & 
Channon, 2014). Techniques used by MI trained specialists include “reflective listening, 
shared decision making, and eliciting change talk” (Resnicow & McMaster, 2012, p. 1). 
In diabetes self-management, the client would identify an aspect of self-care that he or 
she would like to improve; this may not be the behavior that the HCP would choose. 
Hood, Rohan, Peterson, and Drotar (2010) suggest a comprehensive approach, which 
includes social, emotional, and behavioral change, yields the best outcomes.  
 As behavioral health specialists, social workers can become a regular part of 
integrated healthcare teams (Colvin, Nelson, & Cronin, 2012). Diabetes-related distress, 
which can be defined as the patient’s concerns about self-management of diabetes, 
perception of support, emotional burden, and access to quality health care  
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(Fisher, Glasgow, Mullan, Skaff, & Polonsky, 2008) has been associated with higher 
A1C and decreased engagement in diabetes self-management. Wardian and Sun (2014) 
found factors related to higher diabetes-related distress include lower self-efficacy and 
less HCP support. These findings are consistent with study participant reports of the 
value of HCP support and self-efficacy in diabetes medication adherence. On a more 
comprehensive level, patients must have confidence in their ability to manage diabetes to 
fully engage in diabetes self-management including medication adherence  
(Cherrington, Wallston, & Rothman, 2010). Social workers are uniquely trained to assist  
patients in overcoming distress, which could enable people with diabetes to overcome 
barriers to adherence and engage in other aspects of diabetes self-management.  
 There is no one-size-fits-all formulaic approach to medication adherence for 
people with diabetes. Findings from this study suggest that there are many pathways to 
adherence and knowing what the individual needs is imperative. The typologies reiterate 
this notion and provide a way of assessing the personal needs of the patient. Clinicians 
may be able to identify which typology is more closely associated with the patient and 
target intervention and support accordingly.  The resiliency and eco-systems theories 
provide guidance in identifying patient strengths and targeting the particular level within 
the eco system that needs to be changed.  
 The emerging typologies allow clinicians to see the person in environment and 
assess what type of intervention or support may increase self-efficacy in medication 
adherence. Table 12 provides a snapshot of informant attributes at all levels of the eco-
system and corresponding typologies.  For example, Trustee men and Alpha women 
would potentially benefit from comprehensive HCP support (e.g. diabetes educators, 
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nutritionists, exercise physiologists), as they are not interested in increasing informal 
support through family and friends. Moreover, HCPs have tremendous influence with 
these two typologies; therefore, being directive and making specific suggestions for 
improving health are likely to be followed. There are salient differences between these 
two typologies in their interaction with HCPs. Taking time to answer Alpha women’s 
questions is imperative in this process. Whereas Trustee men may not ask questions, 
HCPs should not assume they understand and may be well advised to confirm 
understanding by engaging in a dialogue and providing written information.    
Table 12. Qualitative Clustering of Emerging Typologies by Attributes and Eco-
system Level 
Eco-system 
level 
Attributes  Emerging Typologies 
  Alpha Networking Warrior Trustee 
Individual 
Gender Female Female Male Male 
Diabetes 
Characterization 
Weakness or 
vulnerability 
Small part of 
life 
Enemy Respect it 
Acceptance of 
diagnosis 
Yes Yes Yes Yes 
Understand 
seriousness of 
diabetes 
Yes Yes Yes Yes 
Family and 
friends 
Informal 
Support  
Low High High Low 
Community HCP support High Moderate Moderate High 
Societal Diabetes-related 
stigma 
Keep quiet  Openly 
discuss  
Openly discuss  Keep quiet  
Summary  “Strengthen me” “Join me” “Equip me” “Tell me” 
  
Policy Implications 
Participants in this study shared narratives about times when the cost of 
medication affected their ability to be adherent to diabetes medication. Moreover, the 
period of non-adherence was often associated with poorer health outcomes. Furthermore, 
participants expressed that low co-pays assisted in medication adherence by not forcing 
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them to make difficult financial choices. These findings support the notion that 
policymakers, healthcare personnel, insurers, and patients should consider actively 
supporting low cost programs designed to improve diabetes medication adherence 
(Roebuck et al., 2011). Moreover, medication adherence programs need to be culturally 
appropriate; the message must resonate with communities adversely affected by the 
outcomes of medication non-adherence.  
 Structural level devaluation of individuals with diabetes can restrict access to 
healthcare resources (e.g. DSME, medication, quality healthcare) (Link & Phelan 2001; 
Wailoo 2006). Moreover, at the individual level structural barriers can prevent seeking 
necessary healthcare (Link & Phelan 2001; Wailoo 2006). Policy and programming must 
be based on sustaining health and improving quality of life.  
The Patient Protection and Affordable Care Act 
 On October 1, 2013, open enrollment in the Patient Protection and Affordable 
Care Act (ACA) marked the most ambitious expansion of access to healthcare for adults 
age 18-64 in the United States. An analysis of the Gallup Healthways Well-Being Index 
2012-2014 data demonstrated a decrease in the percentage of Americans who are 
uninsured following implementation of the ACA with 20% in 2012 compared to slightly 
more than16% in April 2014 (Sommers et al., 2014). Arizona participated in the 
Medicaid expansion through the ACA Federally-facilitated Marketplace (FFM), which 
provided Medicaid coverage to low-income adults beginning January 1, 2014  
(Long et al., 2014; Sommers et al., 2014).  While the effect of this momentous healthcare 
provision is in its infancy, it has the potential to provide access to affordable healthcare 
for millions of Americans.  
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 Hill, Abdus, Hudson and Selden (2014) found that adults included in the recent 
expansion of Medicaid had similar or better health than those enrolled prior to ACA. 
Healthier adults in the program have the ability to balance expenses for Medicaid; 
therefore, affording states the capacity to provide adequate healthcare to both healthier 
adults and those who have diagnosed chronic conditions such as diabetes  
(Hill et al., 2014).   
 Long et al. (2014) used data from the Health Reform Monitoring Survey (HRMS) 
to determine changes in health insurance coverage over the previous year. Between 
September 2013 and March 2014, there was a decrease of 2.7% in the number of 
uninsured adults, which translates to approximately 5.4 million people. In states that 
expanded Medicaid, insurance coverage increased 4.7 percent for adults with a family 
income of ≤138% of the federal poverty line (FPL), which were targeted by ACA 
Medicaid expansion (Long et al., 2014).  Moreover, middle-income adults  
(139 to 399 percent of FPL) in these states were able to take advantage of the subsidies 
offered through the Marketplace and health insurance coverage increased by 3.6 percent 
for this population (Long et al., 2014).  
 In spite of these gains, a disparity in health insurance coverage persists in states 
like Arizona with expanded Medicaid, as 12.4% of all American adults remain uninsured 
(Long et al., 2014). The burden is borne disproportionately with nearly one-third (27.8%) 
of low-income adults uninsured and 11.4% of middle-income adults sans health insurance 
coverage (Long et al., 2014).  Moreover, people with diabetes who are poor and low 
income disproportionately bear the burden of high out of pocket costs for medication and 
other health services (Li et al., 2014).  In addition, non-white, non-Hispanic (13.8%) and 
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Hispanic (27.1%) adults are less likely to have health insurance than their white non-
Hispanic (7.1%) counterparts (Long et al., 2014). 
Reducing or Eliminating Copays for Medication 
 Some participants discussed the inability to afford their diabetes medication as the 
primary cause of periods of medication non-adherence. Furthermore, a few discussed 
complications experienced during this time were critical to their current and future health 
outcomes. For some people with diabetes, the cost of their life-saving medications puts 
an undue burden on their ability to be adherent. Those who are publicly insured 
(Medicare and Medicaid) include patient populations such as the elderly and low-income 
groups, who may be especially vulnerable to medication non-adherence when required to 
contribute copays on a fixed income (Li et al., 2014). Moreover, not taking prescription 
medication has potential to increase morbidity and healthcare costs elsewhere in the 
system according to a meta-analysis by Sinnott, Buckley, David, Bradley, and Whelton 
(2013), which demonstrated an 11% increased odds of medication non-adherence for 
publicly insured populations who had to supply a copayment. Policy-makers need to  
understand that medication non-adherence has the potential of adverse clinical outcomes 
and enormous negative economic repercussions.  
Brennan and Studdert (2010) suggest that policy makers were prudent in 
designing the ACA, which addressed the issue of medication non-adherence in elderly 
populations. While the full impact of the ACA may not be realized for many years, 
Kaplan (2011) suggests Medicare recipients will experience a shrinking of the “donut 
hole”, which currently goes into effect once the total cost of prescription drugs reaches 
$2,830.  Patients who are in the “donut hole” are responsible for the full cost of their 
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prescription drugs until the cap of $6,440 is reached and then enrollees pay no more than 
5%. While the “donut hole” does not completely close under the current ACA phase, an 
enrollee’s out of pocket responsibility is scheduled to decrease from 100% of the cost of 
prescription medication to 25% by 2020 (Kaplan, 2011). 
Furthermore, the ACA provides for programs that specifically address medication 
adherence (Kaplan, 2011). It will be increasingly imperative that consumers understand 
provisions in the ACA that relate to their own healthcare; therefore, pharmacists, 
physicians, case managers, and other HCPs must be able to accurately communicate 
information related to medication adherence, which includes copayments, diabetes  
medication adherence classes, interventions, and other programs and technology that can 
assist in ordering prescription refills and remembering to take prescription medication.  
 Even though many participants currently had some form of insurance coverage, 
they discussed times when the cost of medication copays prevented them from obtaining 
their diabetes medication. Chernew et al. (2008) examined the effect of lowering 
medication copays on adherence in an environment where private insurance is provided 
to all employees. This promising avenue for reducing the cost of prescription medications 
is Value-based Insurance Design (VBID), which proposes improving health outcomes by 
using financial incentives to promote more cost effective options and increased consumer 
choice. In the intervention group, copayment rates were eliminated for generic drugs and 
reduced by half for brand-name preferred drugs (from $25 to $12.50) and brand-name 
non-preferred drugs (from $45 to $22.50). There was a substantial increase in diabetes 
medication adherence (13%) for the intervention group as compared to the control group  
(Chernew et al., 2008).  
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 Current cost containment approaches tend to shift increased medication costs onto 
patients; however, increased cost sharing among insurance providers and corporate 
partners may lead to improved medication adherence and greater access to potentially 
life-saving medications. Employers may benefit in increased attendance and lower 
overall costs associated with absenteeism. Furthermore, the cost associated with an 
increase in the use of prescription medication may be offset by the decrease in other 
medical services such as emergency room visits and hospitalizations, related to 
medication non-adherence. Given that African Americans have higher rates of diabetes, 
poorer glycemic control than whites, and more diabetes-related comorbidities  
(Heisler, et al., 2007), measures to reduce cost-related barriers to diabetes medication 
have the potential to lower overall costs and improve diabetes-related health outcomes for 
African Americans. 
Limitations 
 This study was conducted with a small group (23 participants) in an urban area in 
Arizona where about 5.7% of the population is African American (U.S. Census Bureau, 
2014). This represents a particularly small population, especially in terms of the United 
States as a whole. Therefore, transferring findings from this study to other African 
Americans must be done with caution. While many findings are not culturally bound  
(e.g. setting up the environment for success, attaching medication taking to already 
established routines, the process of medication adherence) and some are consistent with 
other literature about promotion of medication adherence, the stigmatization of diabetes 
and reticence of family to discuss the diagnosis may be more prevalent in this cultural  
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context.  However, these findings may illuminate characteristics found in other cultural 
groups that may be useful in understanding adherence to medication.  
 Furthermore, the researcher does not suggest that the emerging typologies are 
exhaustive; in fact, it is entirely possible there are additional typologies that are adherent 
to diabetes medication. In addition, this study only included African Americans, there is 
no way of knowing whether these typologies are culturally bound or may apply to other 
cultural groups. Moreover, even though the typologies clustered according to gender, it is 
possible that they are not gender specific. For example, there could be Alpha men, 
Networking men, Warrior women, and Trustee women.  In addition, identification of an 
emerging typology required at least two people; there were four women that did not 
cluster into a particular typology, which leaves room for additional typologies that could 
be identified in future research. Thus, caution should be exercised in generalizing the 
emerging typologies to other cultural groups outside of African Americans in the 
Southwest.  
 Furthermore, the researcher acknowledges the insider/outsider concept. As a 
person with diabetes, she occupies an insider perspective; however, she is not African 
American or Black and has made a valiant effort to engage in understanding the cultural 
perspective through a review of the literature, asking for clarification from informants, 
and engaging in discussions of findings with a community cultural partners. Moreover, 
being female may have been a barrier in interviewing male participants in ways that are 
difficult to assess.  
 Moreover, the researcher does not assume that mechanisms and strategies can be 
extended to adherence to other medications. The researcher has provided rich description 
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and context for readers to make their own decisions regarding the utility of this study for 
their own work with other populations and with medication adherence for those with 
other illnesses.  
Research Implications 
 Future research may want to conduct a similar study with other cultural groups or 
African Americans in another region of America (e.g. South or Northeast) to determine if 
there are other factors contributing to medication adherence in different cultures. The 
methodology of this study and theoretical lens of resiliency can be used to uncover other 
culturally grounded strategies that can be incorporated into DSME targeting disparate 
populations. In fact, in addition to race, the differences in rural versus urban resiliency 
and strategies may yield interesting findings.  
 Moreover, the inclusion of a focus group(s) of healthcare providers may yield 
innovative strategies and support already successfully utilized to improve medication 
adherence that could be extended to patients who struggle with medication adherence. 
Use of strategies uncovered in this study may be able to increase medication adherence 
and thereby, decrease complications from inadequate glucose control, and reduce 
healthcare costs. 
 Moreover, the mechanisms leading to diabetes medication adherence need to be 
tested to determine the utility of extending these strategies to those who struggle with 
diabetes medication adherence. Hill-Briggs et al. (2006) suggest problem-solving skills 
and engagement in self-management are significantly associated with increased 
medication adherence. Thus, creating a menu of options for each phase of the process of  
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medication adherence may be useful in assisting HCPs to suggest potential solutions for 
patients.   
 Furthermore, an examination of the emerging typologies and their potential 
usefulness in assisting African American patients with medication adherence may be 
interesting. For example, Black patients could be presented with the four typologies as 
narratives to choose which one might be most relatable for them in managing their 
diabetes. Their choice of typology could provide insight into how to best work with these 
patients. Moreover, people with diabetes (or other chronic illnesses) who are not Black 
may be represented in these typologies to some degree. Future studies may want to 
ascertain how culturally bound these emerging typologies are.  
 Potentially modifiable risks such as self-efficacy, beliefs about necessity for 
medication, patient-physician relationship, social support, and conceptualization of 
diabetes all factor into adherence (Zeber, 2011). Therefore, these findings may be able to 
inform the creation of a scale for diabetes medication adherence. For example, the degree 
to which a person with diabetes accepts the diagnosis may be associated with medication 
adherence. Furthermore, social support has been associated with increased adherence and 
improved outcomes; our study suggests a difference in perception of social support 
among typologies that may be salient in increasing support for those who feel more 
isolated; thus, perception of supportive behaviors may be useful in creating a support 
system for a person with diabetes.  
 Furthermore, an investigation of other areas of diabetes self-management may 
yield interesting findings. For example, interviewing people with diabetes who have been 
able to effectively lose weight and maintain weight loss for a long period of time may 
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lead to knowledge, attitudes, and beliefs that are necessary to achieve such a remarkable 
result. Those with diabetes have additional barriers to weight loss such as medication side 
effects and insulin resistance, which may necessitate unique strategies. An in-depth look 
at the exercise and dietary approaches along with support may be enlightening. 
Moreover, the long-term strategies used by these people may be extended to others who 
struggle.   
Conclusions 
 In conclusion, the use of resiliency theory to better understand diabetes 
medication adherence extends this theoretical perspective into a new paradigm. While 
medication adherence has been primarily viewed through a deficit perspective, the 
resilience of those who are adherent to diabetes medication allows for the illumination of 
mechanisms related to adherence, which can be extended to others who are struggling. 
Strategies utilized by these remarkable people are culturally appropriate and may have 
utility in other cultural groups. 
 Individual and broader environmental mechanisms associated with adherence to 
diabetes medication must include integrated care for African Americans with diabetes to 
improve medication adherence and other aspects of diabetes self-management. At the 
minimum, the healthcare team may need to include the patient, physician, social worker, 
pharmacist, diabetes educator, family and friends. While an individualized plan for 
diabetes treatment may include broader support  
(e.g. spirituality, fitness experts, nutritionists), there are basic elements associated with 
diabetes medication adherence. At an individual level, these elements include acceptance  
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of the diagnosis, DSME to increase self-efficacy and knowledge of diabetes self-
management, and formal and informal support systems tailored to the individual.  
 The emerging typologies suggest that there are multiple paths to diabetes 
medication adherence. It is not a matter of forcing a person into a particular mold; rather 
the HCP must respect the natural bent of the patient and tailor the intervention to the 
individual. For example, if a HCP is working with an Alpha female, it might be best to 
suggest private diabetes education, trusted web-based resources or print materials and not 
push her to reveal her diabetes diagnosis to others until she is comfortable doing so. 
Additionally, not everyone desires social support from family and friends to the degree 
that Networking women and Warrior men would want; therefore, allow Trustee men and 
Alpha women to share their health status and needs at their own pace without judgment.   
 Moreover, several broader influences were identified. One influence included 
diabetes-related stigmatization in the African American community. Recruitment for this 
study suggested many African American people with diabetes continue to experience 
obesity and diabetes-related stigmatization and, therefore, may not be open to discussion 
of their condition. This may pose safety risks and reduced avenues for support and 
assistance. The participants in this study were primarily open to talking with others about 
diabetes and largely agreed that family members need to know about the family medical 
history in order to protect themselves. The reduction or elimination of stigmatization may 
allow for increased support for African Americans with diabetes, thus, improved diabetes 
self-management.   
 The Black church may be able to play an important role in reducing stigma and 
disseminating accurate knowledge about diabetes. A number of faith-based, cultural-
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grounded interventions are available to increase awareness, provide reliable diabetes  
information, and promote support for people with diabetes. These programs are 
consistent with African American church missions for holistic care over the life course.  
 Engaging in shared decision-making and problem solving has the potential to put 
the patient at the center of the treatment plan and provide exemplary patient care. The 
role of the healthcare team cannot be overstated. Participants in this study wanted HCPs 
that were strong communicators; this included physicians, pharmacists and diabetes 
educators. Communication skills were often assessed by the HCPs’ ability to attentively 
listen to the patient. HCPs have an obligation to provide treatment and medication 
options to the patient and prescribe DSME for all people with diabetes  
(ADA, 2014). Furthermore, improving communication among all HCPs might provide a 
safety net for the patient and timely renewal of prescriptions leading to increased 
medication adherence. Social workers can partner with other HCPs to promote a more 
patient-centered approach to increasing medication adherence and other diabetes self-
management behaviors.  
 An eight-step process of diabetes medication adherence derived from participants’ 
narratives must be successfully navigated in order to sustain adherence to medication. 
Furthermore, it is important to assess whether non-adherence is intentional or 
unintentional (Clifford et al., 2010). Social workers are uniquely trained to assist patients 
and other HCPs to discuss and identify the point(s) of challenge for the patient. 
Furthermore, social workers and diabetes educators can be trained to assess patient 
medication adherence needs using the AIDES method (Horne et al., 2005). MI shows 
promise for assisting patients in identifying their goals and moving toward successfully 
 174 
achieving stated goals (Christie & Channon, 2014). Both of these methods provide a 
forum for identifying challenges for patients and working with them to create a plan that 
leads to improved medication adherence. For patients who desire to improve medication 
adherence, salient strategies can be suggested from a menu created to assist in 
brainstorming strategies that may be adopted by the patient.   
 Furthermore, healthcare programming and policy is changing at an unprecedented 
pace in America. The ACA introduced the potential for more Americans to have health 
insurance coverage and assistance with prevention and treatment programs than in 
previous times and provides programming designed to improve medication adherence. 
Moreover, increased coverage for medication is an integral part of the ACA, which 
includes provisions to eliminate the “donut hole” by 2020 (Kaplan, 2011). Most 
participants in this study were receiving assistance with medication costs through health 
insurance (e.g. Medicaid, commercial insurance, Medicare, Tricare). Even with this 
coverage, several spoke of past and present burdens of out of pocket costs associated with 
medication.  
 Although challenges to improving medication adherence in the African American 
community exist, there are people who have already overcome these challenges. The 
resilient people in this study achieved diabetes medication adherence in spite of 
considerable challenges (e.g. low income, no insurance, lack of transportation, low social 
support). They may have a stronger voice with those who are struggling than they 
believe. Furthermore, they may be able to assist in decreasing stigmatization and 
promoting diabetes medication adherence in their own community and broader society, 
thereby reducing the consequences of poorly controlled blood glucose.  
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 As the resilient strategies and mechanisms for diabetes medication adherence are 
distributed throughout the local community, the empowerment of the community to 
tackle the issue of diabetes medication non-adherence remains to be seen. The 
preliminary findings from this study have been shared with HCPs, non-profit health 
organizations, government health agencies, and Black church leaders. Consistent with the 
CBPR approach, the researcher will continue to work with African American community 
partners and participants to disseminate findings to those who can use the information.  
 In this era of patient-centered care, there must be an effort to expand the roles of  
disciplines providing diabetes care. The role of the community in determining novel 
approaches to complex problems needs to be integrated into these healthcare models as 
well.  Moreover, it is imperative that new models of healthcare delivery be explored to 
determine how to best serve patients with diabetes and improve outcomes for disparate 
populations.  
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1. Do you ever forget to take your diabetes medicine?  
 ☐ yes   ☐ no 
2. Are you careless at times about taking your diabetes medicine?  
 ☐ yes   ☐ no 
3. Sometimes, if you feel better, do you stop taking your diabetes medicine?  
 ☐ yes   ☐ no 
4. Thinking about the past week, how often have you not taken your diabetes 
medicine? _________ 
Scoring: Adherence is defined as a negative response to 1-3, no more than 2 doses missed 
over the past week. 
 
Ethnicity 
☐ African American/Black 
☐ Non-Hispanic white 
☐ Hispanic/Latino 
☐ Asian 
☐ American Indian/Alaskan Native
 
Gender 
 ☐ Male   ☐ Female 
 
Age ____________ 
 
Do you have Type 2 diabetes?  
☐ yes   How long? ___________ 
☐ no    
 
What medication(s) do you take for your diabetes? 
☐ Only pills   ☐ Only insulin  ☐ Both pills and insulin 
 
Insurance 
☐ No insurance  ☐ AHCCCS
☐ Medicare   ☐ Commercial insurance
195 
 
What is the highest level of education you have completed? 
☐ < High school  ☐ High school  ☐ College  
 
What category of yearly income best describes your household? 
☐ less than 25,000     ☐ 25,000-50,000  
☐ 50,000-75,000     ☐ more than 75,000 
 
I would be willing to talk about my experience with diabetes in a (check all that apply) 
☐ Focus group  
☐ Individual interview 
 
If so, please provide the best way to contact you. 
Phone number:  (_____) ____________________________ 
Email: _________________________________________________ 
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Individual  
1. How did you find out for sure you had diabetes? (Adversity & Risk) 
2. How did you feel about it when you were told you have diabetes? What did you 
say? What did you do? (Asset & Risk) 
3. How do you take care for yourself now that you have diabetes? (Competence & 
Asset) 
4. When you did have to take medication, what did you do? (Adversity) 
5. When your doctor told you needed to take insulin. How did you feel about taking 
insulin? (Adversity & Risk) What did you do? (Competence & Asset) 
6. What helps you take your medication(s) as prescribed? (Competence & Asset) 
Everyone forgets things sometimes. What do you do if you forget? (Risk & 
Adversity) 
7. What things make it difficult for you to take your medication(s)?  (Adversity & 
Risk) How do you handle those difficulties? (Competence & Asset) 
8. How do you get your medication(s) and supplies to care for your diabetes? (Risk 
& Asset) 
9. What makes it easier for you to take your medication(s)? (Competence & Asset) 
Family & Friends   
1. What did your family and friends feel when they heard you have diabetes? What 
did they say? What did they do? (Risk & Adversity) 
2. How have your family helped you to manage your diabetes? (Asset & 
Competence) 
3. How have your friends helped you to manage your diabetes? (Asset & 
Competence) 
4. How have your neighbors helped you to manage your diabetes? (Asset & 
Competence) 
Community and Society  
1. What did you know about diabetes before your diagnosis? (Assets & 
Competence) 
2. What is your relationship with your doctor and any others who treat you for 
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diabetes like? (Asset, Competence & Adversity) 
3. Who else helps you with your diabetes? (Asset) 
4. How does your insurance help in caring for your diabetes? How does your 
insurance make it more difficult to care for your diabetes? (Asset & Adversity) 
5. Where have you gotten information about diabetes and your medication(s)? 
(Asset & Competence) 
6. Is there anything else you would like to say about caring for your diabetes that I 
have not asked about? (Asset) 
 
*Ideas shared will be written on an easel pad for all focus group participants to see. 
Prompts will include a restatement of concepts already discussed and then asking, 
“Anything else?” 
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  Would you help us understand 
Living with Diabetes 
from your point of view ? 
We are inviting people like you to participate in a 
focus group of 4-6 people to talk about diabetes 
from your point of view.  The discussion will take 
about 2 1/2 hours so that you and others will have 
plenty of time to talk about and share your 
experiences.  Everybody will be invited to add 
thoughts, ideas, and suggestions about things that 
have worked for them (or that haven’t) so we can 
have a really good discussion about how you feel 
about diabetes and how you manage it.   
To see if you are eligible to participate, please contact Jana Wardian at 
jwardian@asu.edu or call 602-478-9325. 
We are looking for 
African Americans who 
have Type 2 diabetes 
and take insulin. 
If you qualify and participate in the discussion, you will receive $50 
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Dear Community Member: 
I am Jana Wardian from Southwest Interdisciplinary Research Center (SIRC) at Arizona 
State University.  .  I am working with Dr. Flavio Marsiglia to conduct small study, or 
exploration, to better understand how people with diabetes in the African American 
community think about managing diabetes and medication(s). We are asking you to help 
us understand living with diabetes from your point of view. 
We are inviting you to participate in a focus group of 4-6 people to talk about diabetes.  
The focus group will take about 2 1/2 hours so you and others will have plenty of time to 
talk about and share your experiences.  Everybody will be invited to add thoughts, ideas, 
and suggestions about things that have worked for them (or that haven’t) so we can have 
a really good discussion about how you feel about diabetes and how you manage it.   
Because it is an exploration, the research team doesn’t have any opinions or ideas about 
any of this, so we are hoping to learn what is most important from your point of view.  
During the focus groups, you will help us deepen our understanding about the general 
knowledge about diabetes in African Americans, talk about how you manage diabetes, 
and who or what helps you to take your medication(s).   
You have the right not to answer any question,  
and to stop participating at any time. 
Your participation in this study is voluntary.  If you choose not to participate or to 
withdraw from the study at any time, there will be no penalty. To participate in the study, 
you must be 18 or older and identify as an African American with diagnosed Type 2 
diabetes. In addition, you must be taking insulin to manage diabetes. 
Although there are no direct benefits to you, possible benefits of your participation are 
the opportunity to share in an interesting conversation with people in your community 
about diabetes and increase your personal knowledge of diabetes management.  Your 
responses in this exploration will be documented to allow researchers to review the 
discussion in greater detail. Feedback from sessions will be used to inform culturally 
competent strategies to increase diabetes medication adherence in the African American 
community. It is not likely that there will be risks or discomfort to you during your 
participation. 
The discussion won’t be confidential, but we will never use your name  
in any of our reports or in any of our presentations. 
Since focus groups will consist of approximately 4-6 participants complete 
confidentiality cannot be maintained.  Although no personal information will be asked 
during the focus group, all members will be asked to observe confidentially during and 
after the session to promote honesty and build trust within the group and community.  
Interview sessions will be recorded to make sure that your words stay as you used them 
so that others do not misinterpret your comments.  Your responses will be anonymous.  
All notes from audio tapes of sessions and field notes will remove names and substitute 
made-up names to safeguard data and remove all possible information to identify 
participants.  
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The research team will make sure that others know what we find out, but what you tell us 
will be combined with other interviews.  The results of this study may be used in reports, 
presentations, or publications but your name will not be used. 
All hard copies of data, including written notes and audiotapes, will be stored in SIRC 
secured data storage, Suite 700, University Center, Downtown Phoenix campus.  Data 
will be kept for 10 years, and then all hard copies will be shredded. After transcription of 
the audio recordings, they will be erased using appropriate technology at the time.   
If you have any questions concerning the research study, please contact the research team 
at:  Jana Wardian at JWardian@asu.edu or (602) 496-0700 or Dr. Marsiglia @ 
marsiglia@asu.edu.  If you have any questions about your rights as a subject/participant 
in this research, or if you feel you have been placed at risk, you can contact the Chair of 
the Human Subjects Institutional Review Board, through the ASU Office of Research 
Integrity and Assurance, at (480) 965-6788.    
By signing below you are agreeing to participate in the study. 
 
________________________                     _________________________ 
Signature                                                            Date 
 
By signing below, you are agreeing to be audio recorded. 
 
___________________________                     _________________________ 
Signature                                                            Date 
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Dear Community Member: 
I am Jana Wardian from Southwest Interdisciplinary Research Center (SIRC) at Arizona 
State University.  I am working with Dr. Flavio Marsiglia to conduct small study, or 
exploration, to better understand how people with diabetes in the African American 
community think about managing diabetes and medication(s). We are asking you to help 
us understand living with diabetes from your point of view. 
We are inviting you to participate in personal interviews to talk about diabetes.  The 
interview will take about 1 1/2 hours so you will have plenty of time to talk about and 
share your experiences.  You will be invited to share thoughts, ideas, and suggestions 
about things that have worked for you (or that haven’t) so we can learn more about how 
you feel about diabetes and how you manage it.   
Because it is an exploration, the research team doesn’t have any opinions or ideas about 
any of this, so we are hoping to learn what is most important from your point of view.  
During the focus groups, you will help us deepen our understanding about the general 
knowledge about diabetes in African Americans, talk about how you manage diabetes, 
and who or what helps you to take your medication(s).   
You have the right not to answer any question,  
and to stop participating at any time. 
Your participation in this study is voluntary.  If you choose not to participate or to 
withdraw from the study at any time, there will be no penalty. To participate in the study, 
you must be 18 or older and identify as an African American with diagnosed Type 2 
diabetes. In addition, you must be taking insulin to manage diabetes. 
Although there are no direct benefits to you, possible benefits of your participation are 
the opportunity to help people in your community.  Your responses in this exploration 
will be documented to allow researchers to review the discussion in greater detail. 
Feedback from interviews will be used to inform culturally competent strategies to 
increase diabetes medication adherence in the African American community. It is not 
likely that there will be risks or discomfort to you during your participation. 
The interview will be confidential and we will never use your name  
in any of our reports or in any of our presentations. 
Interview sessions will be recorded to make sure that your words stay as you used them 
so that others do not misinterpret your comments.  Your responses will be anonymous.  
All notes from audio tapes of sessions and field notes will remove names and substitute 
made-up names to safeguard data and remove all possible information to identify 
participants.  
The research team will make sure that others know what we find out, but what you tell us 
will be combined with other interviews.  The results of this study may be used in reports, 
presentations, or publications but your name will not be used. 
All hard copies of data, including written notes and audiotapes, will be stored in SIRC 
secured data storage, Suite 700, University Center, Downtown Phoenix campus.  Data 
will be kept for 10 years, and then all hard copies will be shredded. After transcription of 
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the audio recordings, they will be erased using appropriate technology at the time.   
If you have any questions concerning the research study, please contact the research team 
at:  Jana Wardian at JWardian@asu.edu or (602) 496-0700 or Dr. Marsiglia @ 
marsiglia@asu.edu.  If you have any questions about your rights as a subject/participant 
in this research, or if you feel you have been placed at risk, you can contact the Chair of 
the Human Subjects Institutional Review Board, through the ASU Office of Research 
Integrity and Assurance, at (480) 965-6788. 
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